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Abstract
Chronic obstructive pulmonary disease (COPD) is increasingly common and in 80%
of the patients it is caused by cigarette smoking, often over several decades. Exercise
intolerance is a major problem in COPD and there is accumulating evidence that this
is not solely due to reduced lung function but that it also involves skeletal muscle. It
is not known if changes in skeletal muscle tissue occur before clinical symptoms of
COPD are apparent. Therefore the main aim of the work described in this thesis was
to gain insight into the extent to which cigarette smoking and hypoxaemia affect the
functional and morphological changes of skeletal muscle.
Percutaneous electrical stimulation of the quadriceps muscle (2 minutes 30 Hz with
duty cycle of 0.5; 1 s on, 1 s off) was used to assess fatigue characteristics to avoid
possible problems of differences in voluntary activation.
In non-smoking participants, women were generally more fatigue-resistant than men.
Young men with a relatively short smoking history were more susceptible to fatigue
than non-smoking, age- and physical activity-matched peers. In a larger cohort of
smokers spanning a wide range of age and smoking history, it appeared that this
lower fatigue resistance was not related to smoking history. The similar contractile
speed in smokers and non-smokers suggests that factors other than differences in
muscle fibre composition underlie the reduced fatigue resistance in smokers. The
reduced fatigue resistance might be more related to a possible acute, and possibly
reversible, impairment of smoking on the oxygen supply or the ability to use oxygen
for aerobic energy generation by the muscle.
Subsequently, the effects of chronic hypoxia on determinants of oxygen supply and
oxidative capacity were studied. Adaptations within the rat plantaris muscle to
chronic hypoxia were region- rather than fibre type-specific. Hypoxia resulted in
atrophy in all regions of the muscle. However, capillary proliferation only occurred
in the deep, oxidative region, and mitochondrial biogenesis was restricted to the
superficial, glycolytic region. Model calculations indicate that these adaptations to
hypoxia prevent the occurrence of anoxic areas in the deep region, but that in
superficial regions tissue oxygenation becomes more problematical during hypoxia.
These results are discussed in relation to their possible relevance in understanding
muscle function in COPD patients.
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CHAPTER 1
GENERAL INTRODUCTION
Parts of this chapter have been published in:
Wüst RCI & Degens H (2007). Factors contributing to muscle wasting
and dysfunction in COPD patients. International Journal of Chronic
Obstructive Pulmonary Disease 2, 289-300.
2The work described in this thesis began with an interest in the muscle problems
experienced by patients with Chronic Obstructive Pulmonary Disease (COPD). For
various reasons beyond our control, no patients were ever examined, but the interest
persisted and led to a series of studies that may eventually throw light on the
underlying physiology of this condition.
This chapter begins with an overview of COPD and the involvement of skeletal
muscle in the disease and then discusses the physiology of skeletal muscle. Smoking
is a major cause of COPD while tissue hypoxia may be one of the consequences that
may impact on skeletal muscle structure and function. The last part of this chapter
discusses the way in which the influence of these two factors on skeletal muscle
function may be investigated.
Chronic obstructive pulmonary disease (COPD)
COPD is an increasingly common disease of the lungs and can be manifested as
chronic bronchitis, in which the airways become irreversibly narrowed, and/or
emphysema characterised by loss of elasticity of the lungs and destruction of the
alveoli. Both conditions often occur simultaneously and lead to airway obstruction
during expiration and an impaired gas exchange at the alveolar level. In contrast to
asthma, the airflow limitation is irreversible and progressively worsens over time.
Infections may accelerate the progression of the disease, and such instances are
called exacerbations. Typical symptoms of the disease are shortness of breath
(dyspnoea), a persistent cough, a rapid breathing rate (tachypnoea) and tiredness. The
disease is progressive and is associated with an abnormal inflammatory response in
the lungs to noxious gasses (ATS/ERS, 1999). In 80 % of the patients the disease is
caused by smoking cigarettes for several decades but can also be caused by exposure
to industrial noxious gasses and air pollution. Genetic susceptibility certainly plays a
role as only about a fraction of smokers develop COPD (Molfino, 2004).
The disease is a major cause of morbidity and death throughout the world. In 2000
about 16 million people suffered from COPD in the USA alone (Mannino et al.,
2002) with the number of women suffering from this disorder increasing (Casaburi,
2001). The severity and progress can be moderated by actions such as smoking
cessation, careful management of infections and appropriate rehabilitation
(ATS/ERS, 1999).
3The diagnosis of COPD involves spirometry; more specifically, measuring the forced
expiratory volume in one second (FEV1), the volume of air that can be breathed out
in the first second of a maximal expiration, as well as the forced vital capacity
(FVC), the greatest volume of air that can be breathed out in a maximal expiration.
Normally at least 70 % of the FVC comes out in the first second (FEV1/FVC ratio
>70%), but in patients with COPD this ratio is <70 % even after medication to open
up the bronchi (bronchodilators) has been given (ATS/ERS, 1999).
One of the major problems of patients with COPD is exercise intolerance (Gosker et
al., 2000; Casaburi, 2001). Although the disease is characterized by reduced maximal
expiratory flow (ATS/ERS, 1999), the forced expiratory volume in 1 s (FEV1) in
patients with COPD correlates poorly with their exercise capacity (Killian et al.,
1992; Gosselink et al., 1996; Engelen et al., 2000; Gosker et al., 2003b). Likewise,
in single or double lung transplants, exercise capacity improves after surgery, but
was still lower than normal (Ambrosino et al., 1996) indicating that factors other
than lung function alone limited exercise capacity (Evans et al., 1997). Also in
patients with COPD who did not undergo a lung-transplantation, evidence is growing
that their exercise intolerance is not only related to a reduced lung function, but also
involves skeletal muscle dysfunction (Gosselink et al., 1996; Gosker et al., 2003b).
The importance of skeletal muscle dysfunction may increase over time as the
deterioration in exercise capacity is uncoupled from the progression of airflow
limitation (Oga et al., 2005). It is important, therefore, to know how muscle function
is affected, to identify the factors that contribute to the muscle dysfunction, including
muscle wasting, in COPD so as to improve the management of the disease. Such
knowledge may also have wider implications since COPD is one of a number of
common disorders, including chronic heart failure (Gosker et al., 2000) and some
cancers (Tisdale, 2005), where muscle dysfunction and wasting are serious
complications and may be brought about by similar underlying mechanisms.
Most work on skeletal muscle dysfunction and atrophy has involved patients with
moderate-severe COPD, but there is a gap in our understanding of the earlier
progression of the disease. As most patients with COPD have been smoking for more
than a decade, it is important to understand the changes observed in smokers not yet
diagnosed with COPD. A possible deterioration of muscle function and mass might
then be targeted at an early stage of the disease.
4Chronic obstructive pulmonary disease and muscle function
Many studies report muscle atrophy and alterations in the intrinsic properties of the
lower limb muscles in patients with COPD. In most studies, the vastus lateralis
muscle (part of the quadriceps muscle) was investigated and consequently this
discussion will mainly focus on results obtained from this muscle. First, the
adaptations will be discussed and, subsequently, various factors contributing to these
changes.
Muscle atrophy
A loss of skeletal muscle mass is a common observation in patients with COPD
leading to muscle weakness (Schols et al., 1993; Gosselink et al., 1996; Bernard et
al., 1998; Engelen et al., 2000) and is associated with an increased mortality.
Marquis and colleagues (2002) reported that 50% of their patients with a predicted
FEV1 <25 % and a mid-thigh cross-sectional area (CSA) <70 cm2 died within 3
years, compared to only 12 % of patients with a mid-thigh CSA >70 cm2. Schols and
colleagues (1993) found that about half of the patients with mild to severe COPD had
a reduced body weight, which could be related to both a loss of muscle and adipose
tissue. Since lean tissue depletion could even occur in overweight patients the
prevalence of muscle wasting might be even higher than the estimates based on
changes in body mass alone (De Benedetto et al., 2000).
Besides muscle wasting other factors, such as a decrease in maximal neural drive to
the working muscles (Rutherford et al., 1986), may contribute to muscle weakness
during COPD. Indeed, a reduced neural drive may well explain the decline in force
generating capacity per muscle cross-sectional area (specific tension) in vivo without
a change of in vitro specific tension of isolated bundles from the same muscle
(Debigare et al., 2003). However, COPD patients who were matched for fat free
mass index with control subjects did not show signs of muscle weakness or atrophy
(Heijdra et al., 2003; Degens et al., 2005), indicating that the neural drive is
maintained as long as fat free mass index is maintained.
Shift in muscle fibre type
Most studies of patients with mild to moderate COPD have shown a greater
proportion of type II fibres suggesting a slow-to-fast transition in fibre type
composition (Jobin et al., 1998; Gosker et al., 2002) as a result of the disease. The
5slow-to-fast transition appears to be more marked during emphysema than during
chronic bronchitis (Gosker et al., 2002) and to be related to the severity of the
disease in terms of FEV1 (Satta et al., 1997). It is unlikely that the changes in fibre
type composition during COPD, a disease that mostly becomes manifest after the age
of 50, are just a reflection of the ageing process as normal ageing is, if anything,
accompanied by a fast-to-slow transition (Degens & Alway, 2006; Korhonen et al.,
2006). It remains to be established whether the slow-to-fast fibre type transition is
sufficient to cause a change in the rates of contraction and relaxation during
electrically evoked isometric tetani, as they appeared unaltered during electrically
evoked tetani in patients with COPD (Degens et al., 2005). As type II fibres are less
efficient than type I fibres for force generation during relatively slow movements
(Stienen et al., 1996) and do not have a high mitochondrial density needed for ATP
resynthesis, the slow-to-fast-transition in fibre type composition may be a component
of the commonly observed increase in skeletal muscle fatigability (Mador et al.,
2003) and reduced mechanical efficiency of COPD patients during one leg knee
extensor exercise (Richardson et al., 2004).
Metabolism and capillarisation
Several studies have addressed the metabolic characteristics of muscles from COPD
patients (Jakobsson et al., 1990; Jakobsson et al., 1995; Jobin et al., 1998; Whittom
et al., 1998; Gosker et al., 2002) but with equivocal results. Part of the discrepancies
in the literature can be ascribed to differences in disease severity, medication and
whether locomotor or other muscles have been studied. While the oxidative capacity
of the vastus lateralis muscle of patients with moderate-to-severe COPD was found
to be significantly reduced (Jakobsson et al., 1995; Gosker et al., 2002), the
oxidative capacity in the musculature of the upper extremity was not affected (Gea et
al., 2001b). Also, the mechanical efficiency was lower in leg muscles, while arm
mechanical efficiency was not significantly affected (Franssen et al., 2002). The
different effects on upper body and leg muscles associated with COPD were so
marked that it is referred to as ‘the compartment theory’ (Gea et al., 2001a). A
simple explanation put forward for the differences between the two ‘compartments’
is the different degree of disuse they experience during COPD (Gosselink et al.,
2000; Gea et al., 2001a). These results highlight the likely importance of disuse in
the skeletal muscle adaptation during the progression of the disease. Nevertheless,
6the glycolytic capacity was elevated in both the leg (Jakobsson et al., 1995) and
upper body (Gea et al., 2001b) muscles. In advanced stages of the disease, energy
metabolism in the quadriceps femoris muscle of patients with respiratory failure
becomes increasingly compromised as reflected by lower levels of glycogen, ATP
and PCr (Jobin et al., 1998; Whittom et al., 1998; Richardson et al., 2004).
Very little is known about the capillarisation of skeletal muscle from smokers and
patients with COPD (Whittom et al., 1998). Although the number of capillaries per
fibre has been reported to be reduced in COPD (Whittom et al., 1998), the capillary
supply per fibre cross-sectional area (FCSA) and total numerical capillary density
was maintained (Richardson et al., 2004). It seems that, at least anatomically, the
capillary network is intact in COPD patients (Jobin et al., 1998). However, Oga et al.
(2007) found an almost 50 % decrease in capillary to fibre ratio and capillary density,
suggesting that a disproportionate loss of capillaries. It remains to be seen to what
extent these discrepant findings are related to the severity and/or medication of the
disease. An alternative approach to examining the extent of muscle perfusion is to
determine muscle blood flow but this is not necessarily a reliable indication of tissue
oxygenation as blood flow may be maintained, passing through arterioles, and
bearing a poor relationship to the critical capillary perfusion.
Skeletal muscle fatigue
Exercise intolerance, as reflected by a low peak oxygen uptake, is a major symptom
in patients with COPD (Aliverti & Macklem, 2001). The increased load and
consequent oxygen need of the respiratory muscles in COPD patients and reduced
venous return, due to abnormal increases in abdominal pressures during breathing
with expiratory flow limitations, results in a reduced cardiac output and oxygen
delivery to the working muscles (Aliverti et al., 2005). The result of the increased
oxygen demand by the respiratory muscles and the reduction in cardiac output is an
increased competition between respiratory and locomotor muscles, resulting in a
imbalance between oxygen demand and supply to the locomotor muscles (Aliverti &
Macklem, 2008). Under circumstances where the cardio-respiratory system is
unlikely to be the limiting factor, such as during one-leg exercise, or exercise of a
single muscle or muscle group, the capillarisation and oxidative capacity of a muscle
are important determinants of muscle fatigue resistance, which is often reported to be
7lower in patients with COPD (Serres et al., 1998; Allaire et al., 2004; Coronell et al.,
2004; Van ‘t Hul et al., 2004; Saey et al., 2005; Janaudis-Ferreira et al., 2006).
However, to what extent this reduction in oxidative capacity and capillarisation is the
primary cause for exercise intolerance has been a recent topic of discussion (Aliverti
& Macklem, 2008).
Besides changes in the muscle itself that may cause an earlier onset of muscle fatigue
in COPD patients, differences in fatigue resistance could also be caused by an altered
central drive. To date, the central component in the development of muscle fatigue in
COPD patients is poorly understood. However, it may play a role in the development
of fatigue as systemic inflammation has been shown to cause feelings of tiredness
(Spath-Schwalbe et al., 1998). However, muscle fatigability has been determined
largely with series of voluntary contractions (Serres et al., 1998; Coronell et al.,
2004; Janaudis-Ferreira et al., 2006), which makes it difficult to differentiate
between central and peripheral factors. Using electrical or magnetic stimulation,
however, one can exclude the contribution of central factors to the development of
fatigue. As far as we know, only two studies (Degens et al., 2005; Swallow et al.,
2007) have assessed peripheral muscle fatigue using electrical stimulation in patients
with COPD, with equivocal results. In the study of Degens and coworkers (2005),
neither differences in contractile properties nor fatigability were found. This
indicates that there were no apparent differences in motivation between patients and
controls matched for fat free mass index and physical activity level (Degens et al.,
2005). Several studies have explicitly stated that the COPD patients were
significantly less active than the controls (Serres et al., 1998; Coronell et al., 2004).
Many of the skeletal muscle adaptations in COPD are also found with extreme
inactivity (Gerrits et al., 1999) and hence disuse may play an important role (Serres
et al., 1998).
A factor that has not have received much attention in the literature is the effect of
smoking on skeletal muscle structure and function. As mentioned at the start of this
chapter, COPD is mainly caused by cigarette smoking. Smoking is associated with a
marked increase in inflammatory markers (e.g. TNF-α, IL-6) and an acute reduction
in the anti-oxidant capacity (Tsuchiya et al., 2002). Increases in systemic
inflammation and oxidants are commonly associated with muscle atrophy (Li et al.,
2003; Langen et al., 2006) and increased central fatigue (Robson-Ansley et al.,
82004). A selective atrophy of fast-twitch type IIb muscle fibres has been shown in
smokers (Örlander et al., 1979; Nakatani et al., 2003), which is also observed in
patients with moderate-to-severe COPD (Gosker et al., 2003a). Others, however,
found a selective atrophy of type I fibres in non-COPD smokers (Montes de Oca et
al., 2008). Moreover, recently Gosker and colleagues (2009) have shown that a small
degree of fibre atrophy was observed and mitochondrial enzyme function was mildly
impaired in mice exposed to chronic cigarette smoke. As these mice also featured
clinical symptoms of COPD (emphysema), it is not clear at what stage these changes
in the skeletal muscle tissue have occurred. However, few studies have looked at the
skeletal muscle structure and function in otherwise healthy smokers and non-
smokers.
Mild hypoxaemia may develop in patients with COPD (Chaouat et al., 1997),
resulting in tissue hypoxia. Mean arterial oxygen pressures of 63 mm Hg have been
reported for stable patients with COPD (115 mm Hg in healthy subjects) (Chaouat et
al., 1997), which is similar to what would be seen in healthy people at an altitude of
~4000 m (Wagner et al., 1986).
Impaired oxygen delivery, systemic inflammation and oxidative stress all seem to
contribute to adaptations of skeletal muscle and the development of fatigue (for a
more detailed review, see Wüst & Degens (2007) and the discussion of Aliverti &
Macklem (2008)). Skeletal muscle adaptations, such as wasting and weakness, have
frequently been observed with exposure to hypoxia (i.e. Green et al., 1989; Ferretti et
al., 1990; Cerretelli, 1992; De Paula Brotto et al., 2001; Deveci et al., 2002). For
instance, just 8 weeks at altitudes greater than 5000 m has been shown to cause as
much as a 10 % reduction in muscle mass and peak power (Ferretti et al., 1990;
Green et al., 1989). Although a decrease in fiber CSA is associated with exposure to
hypoxia, other confounding factors such as decreased food intake, due to hypoxia-
induced expression of leptin, together with detraining, may contribute to muscle
wasting (Westerterp & Kayser, 2006). Moreover, hypoxia may also induce
inflammation (Orth et al., 2005), causing muscle atrophy through inflammatory
pathways that may activate the ubiquitin proteosome pathway and hamper the
regenerative capacity of the muscle (for more details, the reader is referred to Wüst
& Degens (2007). It is therefore not surprising that hypoxaemia is thought to
9contribute to the muscle adaptations observed during COPD (Gosker et al., 2000;
Raguso et al., 2004; Wüst & Degens, 2007).
There are a variety of factors that could lead to the changes in muscle mass and
function in COPD and these include the systemic consequences of the inflammatory
changes in the lungs and tissue hypoxaemia occurring as a consequence of the
impaired lung function (Gosker et al., 2000).
Summary of skeletal muscle involvement in COPD
Although COPD is primarily a disease of the lungs there is ample evidence that
skeletal muscle is also involved in many patients and this gives rise to weakness and,
probably, excessive fatigue, all of which have deleterious effects on the quality of
life. Smoking, which is a major cause of COPD, may have direct effects on muscle
function and it is interest to know, first, whether such changes are evident before
clinical symptoms of lung disease become apparent and, secondly, the possible
mechanism of any such action. Tissue hypoxia is a likely consequence of severe lung
disease and could lead to muscle wasting, that may be detrimental, but also changes
in metabolic characteristics that could be protective.
These aspects are investigated in the chapters describing the experimental work of
this thesis but before doing so it is appropriate to consider the basic physiology of
muscle to see how structure is related to function and the factors that determine
strength, speed and fatigability.
Structure related to function in healthy muscle
Skeletal muscle constitutes 40-50% of the healthy human body mass, and provides
the means to move, communicate, feed and breathe. By any standards it is, therefore,
an important tissue. Understanding its structure and function and how these may
change with age, use, abuse and disease is a fascinating task and one that has
engaged the scientific community for over a century. The word “muscle” comes from
the Latin word musculus, being the diminutive of mus (mouse) and it is said that this
came about because the movement of muscles under the skin, possibly the twitching
of the biceps, resembles the movement of mice under a sheet.
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The primary function of skeletal muscle is to generate force and movement and this
is very dependent on the nature and physical arrangement of the contractile proteins
and associated control systems.
Figure 1.1. Organization of sarcomeres, mitochondria, T-tububles and
sarcoplasmatic reticula within the muscle fibre. MyHC: myosin heavy chain, MyLC:
myosin light chain). Adapted from Korfage et al. (2005).
An overview of skeletal muscle structure
Skeletal muscle consists of bundles of contractile muscle fibres that join a tendon at
each end, generally running over at least one joint and thus causing a moment around
that joint. The skeletal muscle fibres themselves are multinucleated cells and in
mature, undamaged fibres the nuclei are located just beneath the sarcolemma. The
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contractile material, which is mainly made up of interdigitating thin (actin) and thick
(myosin) filaments, is arranged in sarcomeres, running from Z line, or disk, to Z line
(Figure 1.1).
The contraction of skeletal muscle is controlled by the nervous system. One motor
nerve (innervated by a motoneuron in the spinal cord) can branch into tens, hundreds,
or even over a thousand branches, each one terminating on a different muscle fibre.
One motoneuron, its axonal nerve and all of the fibres that it innervates is called a
motor unit. When a motoneuron in the spinal cord is activated, an action potential is
sent down the axonal braches to the neuromuscular junction (NMJ). Upon arrival at
the NMJ acetylcholine is released from the axon terminal, binds to acetylcholine-
receptors in the post-synaptic membrane, activating ligand-gated ion channels that
allow sodium to enter and depolarize the muscle cell membrane. This depolarization
of the cell membrane spreads across the surface of the muscle fibre and into the
transverse tubules (T-tubules). Modified calcium channels (dihydropyridine
receptors) in the T-tubules are activated in response to electrical stimulation, causing
the calcium-release channels (ryanodine receptors) on the adjacent membrane of the
sarcoplasmic reticulum (SR) to open. The [calcium] in the cytosol rises from ~10-9 M
at rest to ~10-4.5 M during maximal activation and binds to troponin C which
modulates the orientation of the tropomyosin on the actin, allowing the myosin head
to bind to the thin filament. Force and movement are generated by the bending of the
neck region of the myosin which draws both Z lines closer to each other, shortening
the muscle. This process requires utilization of adenosine-5’-triphosphate (ATP). The
process from neural excitation to the activation of the thin filaments is known as
excitation-contraction coupling.
An overview of skeletal muscle function
Skeletal muscle comes in a variety of colours, forms and functions. As early as 1873,
Ranvier recognized that there are red and white muscles which exhibit different
contractile properties and functional characteristics (Ranvier, 1873). In the second
half of the twentieth century adult muscle fibres types were classified mainly
according to their expressed myosin ATPase isoforms by using histochemical
techniques (Brooke & Kaiser, 1970; Guth & Samaha, 1970).
Three functional output measures that are important in skeletal muscle function are
strength, speed and fatigability. The requirement for strength is evident when
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considering the task of simply moving the body mass or external objects, and a
certain minimum strength is required to live an independent life. The force that can
be exerted is mainly determined by the cross-sectional area of a muscle, that is, the
amount of contractile material arranged in parallel sarcomeres. The maximal speed
by which the muscle contracts depends partly on the length of the muscle but also on
the intrinsic properties of the myosin heavy and light chains that affect the rate at
which they interact with the actin filaments (Jones et al., 2004). There is a variety of
different “types” or isoforms of myosin that have been the basis for identifying
different types of muscle fibre (Sant'ana Pereira et al., 1995; Pette & Staron, 2000).
This variety in muscle fibre type is the major link between structure and function
(Harridge et al., 1996; Pette & Staron, 2000).
Muscle power is the product of force and speed of the contraction. Since work output
is the main feature of movement and mobility, the power that can be generated by a
muscle has a major impact on physical activity, whether this is in a sporting context
or determining the extent of an independent life of an elderly person or patient. Some
tasks, such as jumping or throwing require only brief efforts but many activities
associated with mobility, and therefore quality of life, require sustained efforts. In
these circumstances the ability of the muscle to withstand the development of fatigue
is important. Resistance to fatigue varies between different types of muscle fibres
and is affected by factors such as use and disuse.
Clearly, limitations in power generating capacity and an excessive loss of fatigue
resistance of the muscle can seriously limit performance and daily activities, and
these changes in muscle function can become critical in various disease states such as
cancer, HIV and COPD.
Skeletal muscle fibres
Skeletal muscle fibre types
To identify the different types of myosin ATPase in muscle sections by histological
means, they are pre-incubated at either an alkaline or acid pH. Although the values
vary somewhat from species to species, in general, fast myosin ATPase is unstable
and inactivated at acid pH (about pH <4.6) while slow myosin ATPase is inactivated
at a pH>9.4. Having pre-incubated the section and inactivated the ATPase activity in
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one set of fibres, the remaining activity can be visualised by incubating the section
with ATP and an excess of calcium at an alkaline pH. After a couple of chemical
steps that convert inorganic phosphate, the product of the ATPase reaction, into a
black or dark brown precipitate, the fibres with remaining myosin ATPase activity
can be identified (Brooke & Kaiser, 1970; Guth & Samaha, 1970). An example of
this staining method is given in Figure 1.2A.
Based on these ATPase staining methods, developed in the 1960s, muscle fibres in
all species were divided into type I, IIa and IIb. These types are a reflection of the
type of myosin heavy chain (MyHC) within the fibre with type I, IIa and IIb fibres
containing type I, IIa and IIb myosin heavy chain, respectively. Twenty years later it
Figure 1.2. Serial sections of the human vastus lateralis muscle stained for A
myofibrillar ATPase (mATPase) according to Brooks and Kaiser (1970)
(preincubation at pH 4.55), with black fibres representing type I, white are type IIa
and grey are IIx fibres, B cytosolic glycerol-3-phosphate dehydrogenase, as a marker
for glycolytic capacity, C succinate dehydrogenase (SDH) - activity, an enzyme
bound to the inner membrane of the mitochondria and D capillaries (lectin). Sections
taken from a biopsy given by a young male participant described in Chapter 6.
#,* and o depict a type I, IIa and IIx fibre respectively.
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was shown that there is also an intermediate type, sometimes known as IId (Termin
et al., 1989) but more commonly referred to as IIx (Larsson et al., 1991).
Subsequently it was shown that for human muscle, what had been classified as IIb
was similar to rat IIx myosin (Pereira Sant'Ana et al., 1997) and it appears that
human muscles do not express the IIb MyHC isoform found in smaller mammalian
species. Histochemical techniques generally demonstrate just one myosin isoform in
a fibre cross-section. However, electrophoretic separation of MyHC from single
muscle fibres or immunohistochemical staining show that while the majority of
fibres express just one isoform, they can express two, and occasionally more, MyHC
isoforms (Sant'ana Pereira et al., 1995; Yu et al., 1998).
Glycolytic capacity
It is possible to visualise a number of enzyme activities as indicators of glycolytic
potential, one commonly used being glycerol-3-phosphate dehydrogenase (GPDH)
(also known as alpha-glycerol phosphate dehydrogenase). Although this enzyme is
not part of the chain of glycolysis, it is related to the glycolytic pathway because it
shuttles NADH into the mitochondria. An example of this staining method is given
in Figure 1.2B.
Mitochondrial enzyme activities
Staining for mitochondrial activity requires a substrate that is oxidised and an
electron acceptor that is reduced by one of the components of the electron transport
chain and, as a result, changes colour. Using succinate as substrate and tetrazolium
blue as the electron acceptor gives a measure of complex II activity (succinate
dehydrogenase, SDH, Pool et al., 1979a; Pool et al., 1979b). The measured activity
is proportional to the mitochondrial density and the integrated SDH activity (SDH x
FCSA) is linearly related with the maximal oxygen uptake of the cell (in nmol mm-3
s-1, Van der Laarse 1989). An example of this staining method is given in Figure
1.2C.
Capillary supply
Ultimately, oxygen is used during oxidative phosphorylation to generate ATP from
NADH and FADH2 generated during glycolysis, fatty acid oxidation and the citric
acid cycle. For this process to take place an adequate supply of oxygen is required
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and heat, water and carbon dioxide (CO2), being waste products from this process,
have to be removed. The exchange of oxygen, heat and waste products between the
blood and tissue takes place in the capillaries. It is thus not surprising that the
capillary supply, in terms of capillary density, to a muscle fibre is higher for
oxidative than glycolytic fibres (Degens et al., 1992) and that capillary recruitment
and blood flow varies with the level of activity of the muscle fibres (Terjung &
Engbretson, 1988). Given these conditions, it is likely that the capillary supply of the
muscle plays a significant role in the resistance to fatigue, as has been observed in
control and chronically stimulated muscles (Hudlicka et al., 1977). Capillaries can be
visualized in muscle cross-sections by histological stains, e.g. alkaline phosphatase,
or lectin (Figure 1.2D). The capillary density of skeletal muscle tissue is usually
expressed as the number of capillaries per unit of tissue, or the capillary to fibre ratio.
From these measures, indications of tissue oxygenation can be obtained by modelling
oxygen transport from the capillaries to the centre of the muscle fibres (i.e. Krogh
and Hill models, Krogh (1919); Hill (1965)). There is an apparent relation between
capillary density and maximal blood flow within a muscle, but flow is primarily
determined by arterioles and not capillaries (Egginton, 2009).
Contractile properties
In general, type I fibres predominate in muscles which have a red appearance and, as
Ranvier observed, are slow contracting. Pale “white” muscles are fast contracting
(Ranvier, 1873) and contain a predominance of type II fibres. Muscle fibres
expressing mainly type I MyHC are characterised by having slow speeds of
contraction and relaxation. They also tend to be fatigue resistant and have a relatively
high activity of oxidative enzymes. On the other hand, type II fibres have short
contraction and relaxation times, they fatigue more rapidly and mostly rely on
glycolysis to obtain their energy during activity.
In mammals the soleus is an example of a red muscle that is composed mainly of
type I fibres while the extensor digitorum longus (EDL) is pale in appearance and
has mainly type II fibres. The soleus and EDL are extreme examples; most muscles
contain a mixture of different fibre types. Although mammalian skeletal muscles all
show similar varieties of fibres when classified by their histochemical properties, there
are considerable differences between species as regards contractile characteristics.
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Figure 1.3. Example of force generated during stimulations with different
frequencies in isolated mouse from A soleus and B extensor digitorum longus
muscles (25 °C). From Jones et al. (2004).
Figure 1.4. Relationship between force and stimulation frequency in isolated mouse
soleus and extensor digitorum longus (EDL) muscle. Note the left-shift in the muscle
with predominantly type I fibres. From Jones et al. (2004).
The time it takes for the muscle to achieve its maximal force (contraction time) and
the time to fully relax (relaxation time) are both much faster in the EDL compared to
the soleus muscle (see Figure 1.3). At a stimulation frequency of 10-20 Hz, the EDL
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muscle relaxes fast enough for the force to fall back to baseline before the next
impulse. However, for the soleus muscle, the next impulse comes before total
relaxation of the previous twitch is complete and the next contraction is
superimposed on the remaining force. In this way, the individual twitches fuse. The
fusion frequency at which a smooth contraction (tetanic contraction) is generated is
therefore higher in fast-twitch, compared to slow-twitch fibres and as a result, the
force-frequency relationship between these two muscle types differs (Figure 1.4).
The characteristics of a skeletal muscle are strongly related to its functional demands
(Flück & Hoppeler, 2003). Depending on the altered environmental conditions,
specific muscular adaptations occur as a result of increased use, such as an increase
in oxidative capacity in response to endurance training or hypertrophy after
resistance training (Hudlicka et al., 1977; Holloszy & Coyle, 1984), atrophy after
chronic disuse (Larsson et al., 1990; De Boer et al., 2007) and disease (De Haan et
al., 2000; Gosker et al., 2000; Debigare et al., 2003), but also environmental
conditions such as hypoxia where muscle atrophy and loss of oxidative capacity have
been observed (Ferretti et al., 1990; Green, 1992).
The mechanisms underlying differences in contractile properties
The difference in contractile properties between fibre types is mainly attributable to
differences in MyHC composition (Harridge et al., 1996), such that the maximal
speed of shortening of the fibres is in the order MyHC I << MyHC IIa<MyHC
IIx<MyHC IIb (Bottinelli et al., 1996). However, factors that control Ca2+ flow and
activation also play a role in the contractile speed and fatigability of the muscle fibre
(Allen et al., 2008b). When a muscle action potential is initiated at the NMJ, the
action potential transmission is conducted down the T-tubules to the voltage sensors
in the T-tubular membrane. Type II fibres have a higher density of dihydropyridine
receptors (Hollingworth & Marshall, 1981), a 50% times higher density of the SR
(Cullen et al., 1984) and a higher density of ryanodine receptors (Franzini-Armstrong
et al., 1988). Consequently the release of Ca2+ from the SR into the cytoplasm is
greater and faster for fast-twitch compared to slow-twitch fibres (Briggs et al., 1977).
Moreover, the isoform of troponin in type II fibres contains two Ca2+-binding sites,
rather than one for the slow type troponin isoform (Schiaffino & Reggiani, 1996).
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The SR Ca2+-pump expressed in fast fibre type (SERCA1) is faster compared to the
isoform found in type I fibres (confusingly called SERCA2). These processes
involved in the activation and deactivation of the contractile elements in different
fibre types correspond with the rate of cross-bridge interaction and account for the
differences in contractile properties such as illustrated in Figures 1.3 and 1.4.
The higher attachment and detachment rates of the type II myosin cross-bridges leads
to faster rates of shortening and higher power output but this advantage comes at the
expense of a higher ATP consumption per cross-bridge cycle (Stienen et al., 1996).
The 6-fold larger density of SR Ca2+ pumps in the type II fibres (Everts et al., 1989)
results in much quicker reuptake of Ca2+ in the SR, but also at a higher cost of ATP.
These two processes mean that ATP turnover is considerably higher in fast fibres and
leads to a more rapid depletion of intracellular energy stores if not met by a
commensurate higher energy production. The balance between rates of energy
utilization and production has a major impact on the rate at which muscle fibres
fatigue.
Muscle fatigue
Fatigue is a common phenomenon experienced in daily life and during exercise. It
may come about for a variety of reasons and has a number of consequences for
muscle function. Studies of muscle fatigue in the literature vary with regard to the
exercise model, protocol, output variables and definitions for fatigue, so that
comparison of the results is often difficult. Some studies focus on functional aspects,
such as changes in running speed; others concentrate on specific aspects of changes
in function of single muscles or muscle fibres, or changes in metabolite
concentrations. Vøllestad (1997) defined fatigue as: ‘any contraction-induced
reduction in the capacity to generate force’ although this could be amended to
include changes in contractile speed that have consequences for power output. It
might also include the stipulation that the changes should be reversible within a
“reasonable” time frame to distinguish fatigue from damage that can also result from
prolonged activity.
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The generation of force or movement involves a long chain of command originating
in the motivation of the individual, involving the motor cortex, the descending neural
pathways, the processes of excitation-contraction coupling and ending with the
interaction of the actin and myosin cross bridges. Therefore, at least in theory, a
reduction in the capacity to generate force could be the result of an impairment of
any of the factors mentioned above. Fatigue due to factors proximal to the
neuromuscular junction is conventionally called “central” fatigue while fatigue
occurring at, or distal, to the neuromuscular junction is called “peripheral” fatigue.
Although causes of failure at these two sites are generally site specific they may
sometimes affect multiple steps in the chain. For instance, fatigue due to a lack of
oxygen supply could affect central processes (cerebral hypoxia), or peripheral
(referring to the impaired energy metabolism in the muscle fibre) fatigue.
Central fatigue
Central fatigue is defined as a progressive reduction in the voluntary activation of the
muscle during exercise (see review by Gandevia, 2001). During a voluntary
contraction the central nervous system may not maximally activate all the
motoneurons of an individual muscle and this proportion may decrease during
prolonged activity as a consequence of afferent feedback from mechano-, chemo-
and/or thermo-receptors activated by the physical activity (Bigland-Ritchie et al.,
1978) or as a consequence of increased activity of inhibitory circuits within the brain
itself. An inability to voluntarily contract all the muscle fibres can be assessed by
comparing the voluntary contraction with one elicited by electrical stimulation,
usually of the peripheral nerve branches, which removes any contribution of the
central nervous system (Merton, 1954; Edwards et al., 1977; Bigland-Ritchie et al.,
1978; Rutherford et al., 1986; Newman et al., 2003).
Peripheral fatigue
Fatigue resulting from changes at or distal to the neuromuscular junction is known as
peripheral fatigue. Failure of the neuromuscular junction (exhausting stores of
neurotransmitter) does not seem to occur in maximal isometric contractions of up to
60 s (Bigland-Ritchie et al., 1982) or during electrically evoked contractions at
optimum muscle length with a frequency of 30 Hz (Sacco et al., 1994). Once an
action potential is successfully transmitted across the neuromuscular junction, it
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propagates along the surface membrane of the muscle fibre into the T-tubular system
leading to the interior of the fibre. At high stimulation frequencies (80-100 Hz in
human muscle) failure of the membrane propagation occurs already after a few
seconds (Jones et al., 1979), possibly due to a build up of a high [K+] in the T-
tubules, a phenomenon sometimes referred to as ‘high-frequency’ fatigue (Jones,
1996). However, this is thought not to be a serious problem in vivo as the initial
voluntary firing rate is around 30 Hz during sustained contractions, which then
declines as the contraction continues (Bigland-Ritchie et al., 1986).
A reduction in the calcium release from the SR can contribute to the development of
fatigue (Allen et al., 2008a). The application of caffeine, which opens the ryanodine
receptors in the SR membrane, to a fatigued muscle fibre restores most of the loss of
isometric force and provides strong evidence of an impaired Ca2+ release from the
SR, probably as a consequence of phosphate accumulating in the SR and chelating
the calcium (Fryer & Stephenson, 1996). While reductions in [ATP] do not appear to
play a significant role in the development of fatigue, increased concentrations of
inorganic phosphate (Pi), as a result of PCr breakdown, inhibit force production by
direct actions on the cross bridge function, through an impaired release of Pi from the
actomyosin complex during the force-generating step of the cross bridge cycle,
resulting in a reduction in tetanic force at a given pCa (Martyn & Gordon, 1992).
During prolonged exercise, lasting several hours, ATP resynthesis may become
limited as a result of glycogen depletion within the muscle. Although ATP is critical
for muscle contraction, there is little evidence of major changes in ATP levels in
fatigue. Nevertheless in situations where ATP synthesis is limited there are major
changes in the concentration of associated metabolites, PCr, Pi, ADP, AMP and
lactate, and it is likely that these are the critical factors giving rise to the altered
contractile function that characterise fatigue.
Fatigued muscle also demonstrates (1) slowing of contractile properties, evident as a
decrease in both rates of contraction and relaxation, (2) reductions in the maximal
shortening velocity and (3) reductions in power output during loaded contractions
(Jones et al., 2006). Relaxation of the skeletal muscle fibre involves a set of steps: 1)
SR Ca2+ release stops, 2) Ca2+ is pumped back into the SR, 3) Ca2+ dissociates from
the troponin and 4) detachment of cross-bridges (Allen et al., 2008a). All four steps
could be involved in the slowing of relaxation during fatigue in vivo although there is
little evidence that the kinetics of calcium release or re-accumulation are seriously
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affected. There is, however, clear evidence that cross bridge kinetics are affected by
fatigue (de Haan et al., 1989). More recently, Jones and colleagues (Jones et al.,
2006) showed in healthy individuals, a strong relationship between an increased
curvature of the force-velocity relationship (a/P0) and the slowed relaxation in vivo,
indicating that altered cross-bridge kinetics contributes to the slowing of relaxation in
fatigue. As the shape of the force-velocity curve, given by a/P0, is one of the main
determinants of the power output of muscle (Sargeant, 2007), a decrease in a/P0,
indicating an increased curvature, during fatigue greatly reduces power (Jones et al.,
2006).
Electrical stimulation
In the studies described in this thesis, brief electrically evoked contractions have
been used to test muscle function as opposed to voluntary contractions of the
quadriceps muscle (see Figure 1.5 for an example). Electrical stimulation of the
quadriceps muscle can be achieved by either direct stimulation of the femoral nerve,
or percutaneous stimulation of the motor nerve branches within the muscle belly.
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Figure 1.5. Example of the fatigue test with electrically-evoked contractions applied
in this study (A), with in B the first (continuous line) and last (dotted line)
contraction enlarged. Features of a post fatigued contraction are the reduced maximal
force and prolonged contraction and relaxation times.
Although percutaneous stimulation of the quadriceps muscle recruits particularly
motor nerve branches (and subsequently muscle fibres) in the superficial parts of the
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muscle, deeper areas are also activated (Adams et al., 1993). A fatigue protocol in
which the muscle is activated by electrical stimulation eliminates any change in force
generating capacity due to central factors. Although electrical stimulation of this type
activates between 30-50 % of the muscle the recruitment pattern during electrical
stimulation may differ from that during submaximal voluntary contractions of a
similar strength in that the electrical stimulation will tend to recruit a slightly greater
proportion of fast motor units. The stimulated fatigue test is therefore similar to a
series of repeated maximal contractions.
Fatigue resistance during protocols such as illustrated in Figure 1.5 is mainly
determined by the interplay of two factors, namely energy utilisation and energy
production of the fibre, that is, the differences between ATP utilisation and ATP re-
synthesis, although, as explained above, it is probably the levels of the associated
metabolites that actually affect contractile function. Type I muscle fibres require less
ATP for a given contraction at a low speed and are therefore more efficient
compared to the type II fibres. During any prolonged period of activity, the re-
synthesis of ATP depends on aerobic metabolism, and for this the mitochondrial
density and oxygen supply to the muscle are key factors.
Aim and objectives of the thesis
It can be concluded from the work discussed above that, in general, patients with
mild-to-moderate COPD have lower muscle mass and strength and experience an
earlier onset of fatigue during daily life activities. Since smoking is the principle
cause of COPD and many patients with COPD suffer from hypoxaemia during
exercise, and often at rest, the main objective of the present thesis was to obtain a
better understanding of the effects of cigarette smoking and systemic hypoxaemia on
skeletal muscle structure and function with an emphasis on fatigue resistance.
To this end, smokers were studied who did not suffer from clinical signs of COPD.
To minimise bias related to potential differences in physical activity level between
smokers and non-smokers, special care was taken to match the smoking and control
groups with regard to physical activity level.
To investigate the effect of systemic hypoxaemia on skeletal muscle morphology and
skeletal muscle oxygenation, Wistar rats were exposed to hypobaric hypoxia (410
mm Hg, equivalent to ~5000 m). After 4 weeks exposure, muscle morphology was
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investigated and the data used to estimate the skeletal muscle tissue oxygenation with
mathematical models (Krogh, 1919; Hill, 1965).
In Chapter 2 a fatigue protocol using percutaneous muscle stimulation (with and
without ischaemia) was used to assess the peripheral muscle fatigue resistance in
healthy individuals, with special relevance to sex differences in muscle fatigability.
The outcomes of the fatigue protocol were related to muscle size and contractile
properties.
Young smokers and their peers underwent the same protocol for the measurement of
maximal strength, contractile properties and fatigue to study the effect of smoking on
muscle function in young, healthy male smokers. The results and discussion of this
study are presented in Chapter 3.
As muscle strength and fatigue resistance might deteriorate faster over time in
smokers compared to non-smokers, the results from a cross-sectional study on the
relationship between smoking history and muscle function are shown in Chapter 4.
In Chapter 5 results that link capillarisation (and hence oxygen supply) to muscle
fibre size, type and oxidative capacity are presented. Moreover, the differences in
capillarity and oxidative capacity between human biopsies and animal models are
shown. Histological data from smokers and non-smokers using similar methodology
are compared in a study presented in Chapter 6 of this thesis.
In Chapter 7 changes in fibre size, oxidative capacity and capillarisation in the
plantaris muscle of Wistar rats exposed to 4 weeks of chronic hypoxia are presented.
In the general discussion in Chapter 8 the main results are summarised and
discussed, suggestions for future work are given and final conclusions are drawn.
An extended version of the methods described in each chapter can be found in the
Appendix.
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Abstract
To explore the cause of higher skeletal muscle fatigue resistance in women than men,
we used electrically evoked contractions (1 s on 1 s off, 30 Hz, 2 min), which
circumvents motivational bias and allows examination of contractile properties. We
compared 29 men (26.5 ± 7.0 yr, mean ± SD) with 35 women (25.4 ± 7.6 yr).
Strength of the quadriceps muscle was higher in men than women (P<0.001). The
lower maximal rate of relaxation in women (P=0.002) indicates that their muscles
were slower than those of men. The torque declined less in women than in men (37.7
± 10.7 % vs. 29.9 ± 10.0 %; P=0.002), and was not related to muscle strength or size,
as determined with MRI. The sex-difference in fatigability was also seen when the
circulation to the leg was occluded (torque declined 76.9 ± 10.8 vs. 59.5 ± 16.9 % in
men vs. women respectively; P=0.008). The maximal rate of relaxation correlated
with the fatigability of the muscle under all conditions (correlations ranging from
0.34 to 0.51, P<0.02). We conclude that the sex-related difference in skeletal muscle
fatigue resistance is not explicable by differences in motivation, muscle size,
oxidative capacity and/or blood flow between sexes, but might be related to
differences in fibre type composition.
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Introduction
Whilst men have, on average, bigger muscles and hence are stronger than women
there is accumulating evidence that women can sustain continuous, as well as
intermittent, muscle contractions at similar relative low to moderate intensities better
than men (Fulco et al., 1999; Russ & Kent-Braun, 2003; Hunter et al., 2004a; Hunter
et al., 2004b; Russ et al., 2005; Hunter et al., 2006b). There are many possible
causes for this phenomenon and, broadly, they can be summarised as 1) differences
in motivation and the ability to sustain central drive, 2) differences in blood supply to
the working muscles, and 3) intrinsic differences in the composition and fatigue
characteristics of the fibres making up the muscle.
The possibility that has received most attention concerns the fact that during a
contraction the blood supply to the working muscle will be occluded to some degree
and the extent of this will depend on the forces developed within the muscle
(Barcroft & Millen, 1939; Sadamoto et al., 1983). A large male muscle working at
the same percentage of maximum as a smaller female muscle will generate more
force, occlude the circulation to a greater extent and, consequently, fatigue more
rapidly during sustained submaximal contractions. The absence of sex-related
differences in fatigability during sustained and intermittent volitional contractions
under ischaemic conditions (Russ & Kent-Braun, 2003; Clark et al., 2005), where
blood flow is no longer a factor, and the observation that during sustained
contractions the time to fatigue is a function of absolute force (Hunter & Enoka,
2001; Hunter et al., 2006b) support this view. On the other hand the increased
fatigability in men during intermittent submaximal isometric contractions is not
dependent on maximal strength (Hunter et al., 2004b; Gonzales & Scheuermann,
2006) and even when matched for absolute strength, men were more fatigable than
women during both intermittent and sustained contractions (Fulco et al., 1999;
Hunter et al., 2004b; Gonzales & Scheuermann, 2006). Consequently there remains
uncertainty as to whether differences in blood flow to the working muscles can
explain the differences in fatigability of men and women.
Whether a muscle fibre fatigues or not will depend largely on the balance between
the rate of energy consumption associated with the contractile activity and the rate at
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which ATP can be regenerated by anaerobic (i.e. ATP generated by hydrolysis of
creatine phosphate and glycolysis) and aerobic (i.e. ATP generated by oxidative
phosporylation) processes. The various muscle fibre types differ, with the faster
fibres having greater energy demands but lesser capacity for oxidative
phosphorylation compared with the slower fibre types. Therefore, the proportions of
the different fibre types in a muscle will affect its fatigue characteristics. Several
studies have reported higher muscle glycolytic enzyme activities (Jaworowski et al.,
2002; Russ et al., 2005) and lower oxidative capacity (Nygaard, 1981; Green et al.,
1984) in men compared to women, which is consistent with a lower proportion of
slow, fatigue-resistant, type I fibres in men (Nygaard, 1981; Carter et al., 2001;
Roepstorff et al., 2006).
Little attention has been paid to differences in central drive. Recently, however, it
was shown with superimposing stimulation that sex-related differences in fatigue
during a series of sustained maximum voluntary isometric contractions were not
related to differences in voluntary activation but were likely to have been of
peripheral origin (Hunter et al., 2006a). Surprisingly, there appears to be no studies
in which muscles have been fatigued by the use of electrical stimulation, an
experimental situation that completely removes the volitional element and allows a
direct comparison of the extent of peripheral fatigue in men and women.
Our primary objective, therefore, was to expand on the work of Hunter and
colleagues (2006a) by using electrical stimulation to directly determine whether there
are differences in susceptibility to peripheral fatigue in men and women. Our second
objective was to determine whether any differences in fatigability during an
intermittent protocol could be attributed to differences in blood supply to the muscle.
We have done this by comparing the extent of fatigue seen with an intact circulation
with an identical fatigue protocol carried out under ischaemic conditions. The
hypothesis was that if the differences are attributed to differences in blood supply or
oxidative capacity of the muscle then no sex differences will be evident when the
blood supply is occluded.
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Methods
Participants
Sixty four volunteers (29 men, 35 women) aged between 19 and 45 years participated
in the study. Men and women were matched for age and physical activity, the latter
assessed by questionnaire (Baecke et al., 1982). Exclusion criteria were smokers,
known respiratory, cardiovascular or neuromuscular diseases, and any lower limb
injury. Written informed consent was obtained from each participant prior to testing.
The study was approved by the local Ethical Committee to the standard set by the
Declaration of Helsinki.
Experimental procedures
Muscle size
Anatomical cross-sectional area (ACSA) of the quadriceps muscle was measured at
50% femur length with magnetic resonance imaging (MRI), using a fixed 0.2-T
MRI-scanner (E-scan, ESAOTE Biomedica, Genova, Italy). Scans were obtained
with a T1-weighted, high resolution, gradient echo profile, with the following
scanning parameters: echo time: 0.016 s; repetition time: 0.1 s; field of view: 0.33 x
0.254 m; matrix: 256 x 256 and a slice thickness: 0.005 m.
Torque measurements
All torque measurements were performed on the right quadriceps femoris muscle
with a Cybex norm dynamometer (Ronkonkoma, New York, USA). Participants
were familiarised with the testing procedures on a separate occasion prior to data
collection. Participants were seated with the hips (90° flexion) and shoulders
strapped to minimise extraneous movements. The participants received visual
feedback of the torque signal and verbal encouragement during the maximal
voluntary contractions (MVC). Maximum voluntary contractions were repeated 2 or
3 times at knee joint angles of 60, 70 and 80˚ (full extension=0˚) in a random order
with two minutes of rest in between each contraction to prevent development of
fatigue. The angle at which the highest torque was achieved was defined as the
optimal joint angle. All further measurements were done at optimal knee joint angle.
To account for differences in muscle cross-sectional area between the two groups,
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maximal knee extensor torque was scaled with quadriceps ACSA (Maughan et al.,
1983) and expressed as MVC/ACSA (Nm cm-2).
Electrical stimulation
Percutaneous electrical stimulation (square wave, pulse width 50 s; DSV Digitimer
Stimulator, Digitimer Ltd., Herts, UK) was applied using carbon-rubber pads (76 mm
x 127 mm, Versastim, Conmed Corp., N.Y., USA). The anode was placed over the
proximal region of the quadriceps and the cathode over the distal third of the upper
leg.
Voluntary activation (VA)
To assess the ability of the subjects to activate the knee extensors during isometric
contractions, voluntary activation levels were determined using a variant of the
interpolated twitch technique (Shield & Zhou, 2004). For the test, a doublet (inter-
pulse interval 10 ms) was applied with the subject in a relaxed state and a second
interpolated doublet was delivered during the plateau phase of the MVC. The current
used to test for activation was determined using single pulses with the subject in a
relaxed state, starting from 100 mA, and increasing until no further increase in torque
was observed. Throughout the experiments, the voltage was kept at 400 V.
Torque-frequency relationship
The intensity of stimulation for the determination of the torque-frequency
relationship and fatigue protocols was adjusted so that a 1 s 100 Hz tetanus produced
28.6 ± 6.7 (SD) % of maximal voluntary isometric torque. Five minutes after the last
MVC, the quadriceps muscle was stimulated with 1 s 1, 10, 15, 20, 30, 50 and 100
Hz trains in random order, each separated by 1 min to assess the torque-frequency
relationship.
Fatigue tests
Five minutes after determining the torque-frequency relationship of the quadriceps
muscle, the resistance to fatigue was determined by a series of electrically evoked
isometric contractions (60 contractions, 30 Hz, 1 s on 1 s off; the standard fatigue
test)
On two subsequent occasions, a subgroup of subjects also performed two more
fatigue tests that were metabolically more demanding. In the first the rest period was
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reduced from 1 s to 0.5 s, while leaving the total duration of the test the same (12
men and 18 women). In the second test the blood supply to the muscle was occluded
with a pneumatic thigh cuff (Accoson, Harlow, UK) inflated to ~240 mm Hg before
and during the standard fatigue protocol (12 men and 10 women). The occlusion
prevented the return of blood in the intervals between the stimulated contractions and
hence oxidative recovery (Russ et al., 2002).
Analysis of variables
The torque signal was stored with a sampling frequency of 2000 Hz (Acknowledge,
Biopac Systems, Santa Barbara, CA, USA) and off-line analysis was performed
using Matlab (Matlab, the Mathwork Inc., S. Natik, MA, USA). Each torque signal
was filtered with a low-pass fourth order Butterworth filter with a 30 Hz cut-off
frequency. The maximal rate of relaxation (MRR, s-1) was determined from the 30
Hz tetanus and calculated as the lowest value of the differentiated torque signal
expressed relative to the highest torque recorded during that contraction.
Statistical analysis
Differences in MVC, ACSA and MRR between the sexes were tested using an
independent Student’s t-test for all dependent variables. Voluntary activation levels
were analysed with the non-parametric Mann-Whitney U test, because the values
were not normally distributed. Differences were considered significant at an alpha of
0.05. Results are presented as means (SD), unless otherwise stated. Torque data from
the three fatigue tests and torque-frequency relationships were analyzed using
repeated measures ANOVA with time and frequency, respectively, as within factor,
and as between-subject variable sex.
Results
Subject characteristics, muscle strength and size
Mean physical activity scores were [mean ± SD (range)]: 8.5 ± 1.3 (6.0– 0.8) vs. 8.5
± 1.0 (6.0–10.4) in men and women, respectively, indicating that we successfully
matched the sexes for physical activity level. A physical activity score < 6 indicates a
sedentary life-style, whereas values > 9 represent a high level of activity (Baecke et
al., 1982). Mean age was 26.5 ± 7.0 (20–45) vs. 25.4 ± 7.6 (19-45) years in men and
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Table 2.1. Quadriceps muscle properties.
Men (n=29) Women (n=35)
ACSA (cm2) 75.5 ± 10 55.6 ± 6.9 *
MVC (Nm) 339 ± 82 255 ± 51 *
MVC/ACSA (Nm cm-2) 4.50 ± 0.18 4.34 ± 0.15
VA (%) 93.4 ± 9.2 90.1 ± 5.3
Optimal angle (°) 75 ± 7 71 ± 9
MRR30 (s-1) -15.6 ± 2.4 -14.1 ± 1.8 *
ACSA: anatomical cross-sectional area; MVC: maximal voluntary contraction; VA:
voluntary activation; MRR30: maximal rate of relaxation from the 30 Hz stimulus,
normalised to maximal torque during that contraction; *: different from men at
P<0.01.
Figure 2.1. The torque-frequency curve of the quadriceps muscle determined by
electrical stimulation in men (●) and women (○). Values are expressed as a 
percentage of the torque generated by 100 Hz stimulation. Error bar represent SEM.
Insert shows a typical series of torque records when stimulating at 1, 10, 15, 20, 30
50 and 100 Hz.
43
women respectively. Maximal voluntary torque and ACSA were lower in women
(P<0.001), but there were no significant differences between men and women in their
ability to voluntarily activate their quadriceps muscles (Table 2.1).
Torque-frequency relationship and maximum relaxation rate
Individual torque–frequency curves were normalised by expressing the data relative
to peak (100 Hz) torque (Figure 2.1). Women generated marginally more torque at
low frequencies of stimulation, but this was not significant. Only the percentage
torque at 10 Hz was 4 % higher in women compared with men but this did not reach
statistical significance (P=0.063; Figure 2.1), while at 15 Hz and 20 Hz no
differences were observed (P=0.15 at 15 Hz and P=0.26 at 20 Hz). Contractile speed,
as assessed by the rate of relaxation (MRR30) from a 30 Hz tetanus, of the female
muscles was appreciably slower than that of the men (P=0.002; Table 2.1).
Fatigue tests
Torque
The development of fatigue, as indicated by the progressive decline in torque during
the two minutes of the fatigue tests, is shown in Figure 2. In the standard fatigue test
(Figure 2.2A) torque declined significantly more in men (by 37.7 ± 10.7 %) than in
women (by 29.9 ± 10.0 %, P<0.01).
Decreasing the recovery time between the tetani from 1 s to 0.5 s (Figure 2.2B)
increased the rate of fatigue and differences between men and women became
apparent earlier than during the standard fatigue test; i.e. after 37.5 s as opposed to
78 s into the standard fatigue test. Using this protocol, the differences in torque
decline between men and women also became more marked (55.7 ± 8.1 vs. 42.8 ±
13.4 % decline; men vs. women, P<0.01).
The standard fatigue test carried out under ischaemic conditions (Figure 2.2C)
visually showed a slightly different time course than in either of the other two
protocols.
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Figure 2.2. Torque during the fatigue protocols in men (●) and women (○). The
decline in torque is expressed as percentage of the initial torque during the fatigue
protocol for (A) 1 s on, 1 s off (29 men and 35 women), (B) 1 s on, 0.5 s off (12 men
and 18 women) and (C) 1 s on, 1 s off, with circulatory occlusion (12 men and 10
women). Data are plotted every 2 s during the complete stimulation protocol for both
sexes. Error bars represent SEM. Torque declined significantly more in men than
women (all tests P<0.01). Arrows indicate the first contraction with a significant
difference between the sexes (after 78 s, 37.5 s and 72 s for A, B and C respectively).
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Figure 2.3. Relationship between the torque during a maximal voluntary contraction
(MVC) and fatigue resistance (remaining torque as a percentage of initial torque, in
%) for men (●) and women (○). Note that while pooling all the data, significant 
correlations were observed in the non-occluded fatigue test (A: standard (29 men and
35 women) and B: 0.5 s off (12 men and 18 women)), while this relation did not
occur within sexes. In the occluded standard fatigue test (C, 12 men and 10 women),
no significant correlations were observed.
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Figure 2.4. Significant relationship between the maximal rate of relaxation (MRR)
and fatigue resistance (remaining torque as a percentage of initial torque, in %) for
men (●) and women (○) during the occluded standard fatigue test (R
2=0.40, P=0.002;
12 men and 10 women).
Significant differences between men and women became apparent after 72 s and the
difference in loss of torque between men and women (76.9 ± 10.8 vs. 59.5 ± 16.9 %;
men vs. women, P<0.01) was greater than in either of the fatigue tests with intact
circulation. Our hypothesis that sex-related differences would be abolished under
ischaemic conditions had to be rejected, as we observed that in the standard and
ischaemic fatigue test, women fatigued about a third less than men.
The subjects who had larger and stronger muscles, in general the men, also tended to
fatigue most rapidly. This was reflected by the significant correlation between MVC
and fatigue resistance (i.e. remaining torque as a percentage of the initial value) for
the pooled data of the standard fatigue test (Figure 2.3A). However, this correlation
does not necessarily indicate a causal relationship. Indeed, for the standard protocol
(Figure 2.3A) there was a weak relationship between strength and fatigability within
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the women only, but not in the men. In the second protocol, the recovery interval was
shortened (Figure 2.3B) and hence the duration of occlusion of the circulation is
longer. The weak correlation between MVC and fatigue resistance in the women
even disappeared, although for the combined data there remained a weak
relationship. To entirely remove the possible role of differences between sexes in
occlusion of the circulation during the fatigue tests an ischaemic fatigue protocol was
performed (Figure 2.3C). In this case the absolute torque would not affect blood flow
as it is already minimised. As expected no significant relationships between strength
and fatigue, either for each sex separately or for the pooled data were found.
A significant relationship existed between the MRR of the unfatigued muscle and the
decline in torque in the standard fatigue test (R2=0.12; P=0.005), the second fatigue
protocol (R2=0.26; P<0.001) and the standard fatigue test under ischaemic conditions
(R2=0.40; P=0.02; Figure 2.4). Similar results were obtained from the men and
women separately. Moreover, the correlations did not change after controlling for
MVC.
Discussion
Our results add weight to those reports suggesting women are more fatigue resistant
than men. The new finding is that the difference between men and women is evident
during electrically stimulated contractions, which eliminates any possible problems
associated with activation. Moreover, it persists during a fatigue protocol that largely
eliminated oxidative phosphorylation, indicating that the key difference does not
involve questions of blood flow or the oxidative capacity of the muscles. Our results
show that the difference in fatigability between men and women is a consequence of
higher energy utilisation in men and could be related to the differences in contractile
speed that we have observed.
Central and peripheral fatigue
Maintaining continuous, or even intermittent, muscular contractions is a demanding
task that requires concentration and motivation. It is conceivable that one sex may be
slightly better at these tasks accounting for the differences that have been reported
with fatigue protocols involving voluntary activation. However, Hunter et al.
(2006a), using a superimposed twitch technique, have shown that the decline in
activation during a series of voluntary contractions was similar in men and women.
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We have taken this one step further by both fatiguing and testing the muscle using
electrical stimulation, a situation where voluntary activation plays no role.
Consequently, the observed difference in fatigability clearly has a peripheral cause as
opposed to an origin in the central nervous system. In addition this method also
circumvents possible bias related to motor unit rotation that may occur during
voluntary contractions, all factors that have been suggested to play a role in the sex-
related differences in muscle fatigue (Hicks et al., 2001; Clark et al., 2003; Hunter et
al., 2004b; Clark et al., 2005). The question therefore is what aspect of peripheral
muscle physiology or metabolism can account for the differences in fatigability
between men and women?
Transmission failure
During repetitive electrical stimulation there is the possibility that transmission at the
neuromuscular junction may be impaired, possibly as a result of acetyl choline
depletion, or failure of action potential propagation along the sarcolemma or T-
tubule membranes. The protocol we have used was designed to minimise the
likelihood of such transmission failure by keeping the stimulation frequency
relatively low (30 Hz) and allowing repeated recovery intervals since transmission
failure recovers rapidly when the contraction stops (Jones, 1996). It would appear,
therefore, that differences between men and women are unlikely to be due to
differences in transmission across the neuromuscular junction or along the
sarcolemma and T-tubular membranes.
Oxidative metabolism
The rate of fatigue during the standard protocol we have used will be a balance
between the depletion of energy stores during activity and the extent of recovery
metabolism. In turn, the extent of aerobic recovery will depend on the oxidative
capacity of the fibres, the degree to which blood flow is occluded during the
contraction, and the duration of the recovery period between contractions. Given a
long enough interval there will be complete recovery, while shortening the interval
will increase the stress on the oxidative processes to fully replenish the energy stores.
When, in the second protocol, there was only 0.5 s between the contractions and
relatively less blood flow and thus aerobic recovery, the rate of fatigue was increased
but, interestingly, the women fatigued a third less compared to the men, similar to the
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results we found in the standard fatigue test. This could be reflection of a lower
capacity of aerobic energy regeneration in men than women and/or a higher rate of
energy utilisation in men than women.
Our male subjects were, on average, stronger and had larger quadriceps muscles and
it is possible, therefore, that the blood supply to the working muscles during the
contraction phase was impeded to a greater extent in the larger and stronger male
than female muscles. The data shown in Figure 2.3A, suggest that there may be a
small component of fatigue in the female participants which could be explained in
this way but there is not a simple relationship between force and blood flow.
Considerable intramuscular pressures are developed in even comparatively small
rabbit muscles (Degens et al., 1998) and it has been shown that the oxygenation of
the muscle depends on the relative, rather than the absolute, torque the muscle
generates during a contraction (De Ruiter et al., 2007). However, the most persuasive
argument that differences in fatigability between men and women has nothing to do
with blood flow or oxidative capacity of the muscle is our observation that the
differences between men and women were still evident when the blood flow was
occluded. This clearly shows that there are differences between male and female
muscle that must reside in the rate at which energy is used by the muscle fibres rather
than the oxidative recovery rates. We conclude that the observation that men, with
stronger muscles, also fatigue more rapidly, is coincidental and not causal, there
being some other reason for the faster rate of fatigue.
Our results contrast with the findings presented by Russ and Kent-Braun (2003), who
reported that sex differences in muscle fatigue were absent under ischaemic
conditions and concluded that blood flow and/or substrate utilisation differ between
men and women. The difference between the present study and their results may be
due to the study design. Problems of voluntary activation become very important
during sustained ischaemic contractions and this may well have obscured any
differences between male and female subjects, and it is possible that there may be
differences between the calf muscles used by Russ and Kent-Braun (2003) and the
quadriceps muscles investigated here.
Possible differences in muscle fibre characteristics between men and women
Compared to type II fibres, type I fibres have a slower speed of contraction and
consequently a slower rate of energy utilisation (Stienen et al., 1996; Hamada et al.,
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2003) and, characteristically, fatigue at different rates and this can be seen in the
fatigue characteristics of human muscle (Gordon et al., 1990; Hamada et al., 2003).
The female participants had muscles that were, on average, slower than those of the
males. There was a small, although not significant, difference in the torque-
frequency relationship (Figure 2.1) and the MRR was significantly slower (Table
2.1). The relationship between MRR and rate of fatigue (Figure 2.4) suggests that the
fatigability of the muscle is related to the contractile speed; the slower the muscle the
more fatigue resistant (Gordon et al., 1990; Hamada et al., 2003). The logic of this
argument is that female muscle should contain more type I slow fibres than male
muscle. However, there is controversy as to whether male and female muscle differ
in their fibre type composition but the available evidence tends to show a (5 %)
larger percentage of type I fibres in pre-menopausal women than men (Nygaard,
1981; Simoneau et al., 1985; Simoneau & Bouchard, 1989; Mannion et al., 1997;
Staron et al., 2000; Jaworowski et al., 2002; Roepstorff et al., 2006; Yu et al., 2007).
Interestingly, when extrapolating the data from Hamada et al. (2003), a 5 % change
in the proportion of type I fibres would result in a ~7.5 % change in fatigue
resistance during a non occluded, volitional fatigue test.
Conclusion
In conclusion, we can confirm that fatigue resistance during a series of intermittent
contractions is lower in men compared to women when matched for age and physical
activity. As the differences were observed using electrical stimulation, we can
conclude that this higher fatigue resistance has a peripheral origin. It is unlikely that
differences in blood supply and/or oxidative phosphorylation underlie this difference,
as fatigue resistance was also higher in muscles from women than men when the
circulation was occluded. Intrinsic sex-related differences in skeletal muscle
properties, such as contractile speed and rate of energy utilisation probably play a
key role in the sex related differences in fatigue.
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Abstract
To determine whether muscle function is compromised in healthy smokers in
comparison with activity-matched non-smokers, nine male smokers (aged 22.2 ± 2.5
yr: mean ± SD) with a smoking history of 2.5 ± 3.1 pack years, and ten male control
participants (25.4 ± 2.9 yr) matched for physical activity level participated in this
study. Knee extensor strength was measured using Isometric maximal voluntary
contractions. Voluntary activation of the quadriceps and co-activation of the biceps
femoris were determined using interpolated twitches and surface electromyography,
respectively. The frequency-torque relationship and fatigue resistance were assessed
with electrically evoked contractions. A fatigue index was determined as the ratio of
final torque to initial torque during series of isometric contractions (1s on 1 s off, 30
Hz, 2 min). Quadriceps anatomical cross sectional area was measured with MRI at
50 % of femur length. Maximal voluntary contraction torque, quadriceps anatomical
cross sectional area, knee extensor torque/quadriceps cross sectional area, activation,
co-activation and force-frequency relationship were similar, whereas the fatigue
index was 17 % lower in smokers than non-smokers. In young men smoking does not
significantly affect quadriceps muscle cross sectional area and contractile properties,
but does reduce fatigue resistance of the quadriceps muscle, which was not
attributable to differences in physical activity.
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Introduction
Smoking is a recognised risk factor for cardiovascular disease, lung cancer and
chronic obstructive pulmonary disease (COPD). Many patients with COPD and
chronic heart failure suffer from muscle dysfunction, which is not directly related to
changes in lung or heart function (Gosker et al., 2000). Besides muscle wasting,
which results in weakness (Franssen et al., 2005), there is a reduction in the oxidative
capacity (Gosker et al., 2000) and a shift towards faster fibre types (Satta et al.,
1997) which may explain the reduced muscle endurance in COPD patients (Van ‘t
Hul et al., 2004).
In addition to damaging the lungs, smoking may also affect skeletal muscle (Agusti
et al., 2003; Gan et al., 2004; Gan et al., 2005). Smoking has been reported to cause
a decline in muscle strength (Örlander et al., 1979; Al-Obaidi et al., 2004). As
muscle cross-sectional area is the major determinant of strength (Maughan et al.,
1983) it is likely that the lower muscle strength in smokers is attributable to a smaller
muscle mass. However, where differences in muscle strength have been reported
between smokers and non-smokers, muscle size has not been measured. Furthermore,
a shift from high-oxidative type I (slow-twitch) fibres towards a higher percentage of
low-oxidative type II (fast-twitch) fibres and a reduction in fibrillar mitochondrial
volume fraction occurs (Örlander et al., 1979); changes that are likely to result in a
reduction of fatigue resistance (Degens & Veerkamp, 1994). It has been suggested
that the differences in skeletal muscle between smokers and non-smokers is at least
partly due to a lower physical activity level of smokers (Örlander et al., 1979). It is
important to minimize this bias when studying the effects of smoking on skeletal
muscle. Indeed, disuse induces the same changes in skeletal muscle. Therefore, it is
important to take into account the physical activity level to separate the effects of
disuse from those of smoking per se.
Thus, the aim of the present investigation was to determine whether i) smokers are
weaker than non-smokers, ii) any weakness is the result of neural and/or muscular
factors, iii) there is any difference in contractile properties between smokers and non-
smokers and iv) fatigue resistance is altered in smokers compared to non-smokers.
To exclude the role of disuse, control male participants were activity-matched with
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healthy smokers. To circumvent possible differences in motivation between smokers
and non-smokers, electrically evoked muscle contractions were used to test muscle
function. Considering the role of smoking in the development of COPD and its
potential effects on skeletal muscle, the present study may reveal changes in skeletal
muscle function of young healthy smokers (i.e., free from any pre-existing medical
condition) before any clinical signs of COPD develop.
Methods
Participants
Table 3.1. Participant characteristics
Smokers (n=9) Non-smokers (n=10)
Age (years) 22.2 ± 2.5 25.4 ± 2.9
Mass (kg) 79.9 ± 14.0 76.1 ± 8.7
Height (cm) 180.2 ± 6.5 179.9 ± 6.4
BMI (kg m-2) 26.6 ± 2.3 23.5 ± 1.5
FVC (L) 4.4 ± 0.8 5.0 ± 0.6
FEV1%pred 91.3 ± 13.7 104.7 ± 9.9
Physical activity score 8.3 ± 1.6 8.7 ± 1.5
Smoking history (pack years) 2.5 ± 3.1 -
BMI, body mass index; VC, vital capacity; FEV1%pred, the percentage of the age and
height adjusted predicted FEV1.
Nine male smokers and ten male non-smokers (Table 3.1) participated in the study.
Smokers and non-smokers were matched for age and physical activity level. Written
informed consent was obtained from all participants and all procedures were
approved by the local ethics committee of Manchester Metropolitan University.
Potential participants who suffered from respiratory, cardiovascular or neuromuscular
diseases or had any lower limb injury were excluded from the study. All participants
abstained from smoking and caffeine ingestion for two hours prior to testing. Physical
activity (PA) levels were assessed using a previously validated questionnaire
(Baecke et al., 1982); where <6 indicates a sedentary lifestyle and >9 a high physical
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activity level. All participants were relatively inactive with a mean score of around 8-9
for each group (Table 3.1). Smoking history was assessed by questionnaire and
smoking volume was determined by pack-years, which is defined as the number of
cigarette packs smoked per day, multiplied by the number of years smoking. The
vital capacity (VC) and forced expiratory volume in 1 second (FEV1) was assessed
with spirometry (Vitalograph Ltd. Bucks, UK) and used to determine the percentage
of the age- and height-adjusted predicted value (FEV1%pred; Crapo et al., 1981).
Experimental set-up
Participants were familiarised with the testing procedures on a separate session prior
to data collection. All knee extension torque measurements were performed on the
right leg with a Cybex norm dynamometer (Ronkonkoma, New York, USA).
Participants were seated with the hip joint at 90° flexion with the hip and shoulders
strapped to prevent any extraneous movement. Before the experiment, participants
warmed-up by performing 5 submaximal isokinetic contractions. Torque was
displayed on a computer screen, interfaced with an acquisition system
(Acknowledge, Biopac Systems, Santa Barbara, CA, USA) used for analogue-to-
digital conversion. The sampling frequency was 2000 Hz. Each torque signal was
filtered with a low-pass fourth order Butterworth filter with a 30 Hz cut-off
frequency.
Isometric maximal voluntary contractions (MVC) torque.
The optimal angle for torque generation was 80° (full knee extension=0°) in all but
two participants (data not shown). Therefore, to reduce the influence of joint angle
on twitch characteristics all subsequent measurements were performed at a knee joint
angle of 80°. MVCs were maintained for 4 seconds (sufficient to reach a plateau)
with 2 min of rest in between each contraction to prevent development of fatigue. To
maximize performance, visual feedback of the torque signal and verbal
encouragement was given to all participants. The highest torque reached during a
contraction was recorded, and the highest value of the two contractions was given as
the MVC.
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Voluntary activation
Voluntary activation levels were determined with the interpolated twitch technique
as described previously (Allen et al., 1995). Briefly, the muscle was stimulated
percutaneously, with the anode (76 mm x 127 mm, Versastim, Conmed Corp., N.Y.,
USA), placed over the proximal region of the quadriceps and the cathode over the
distal third of the femur length. To assess the supra-maximal current, single pulses
(pulse width 50 s; DSV Digitimer Stimulator, Digitimer Ltd., Herts, UK) were
administered at 30 s intervals with increases in current of 50-100 mA, until no further
increase in torque was observed. For the interpolated twitch technique, a first doublet
(pulse width of 50 s, 100 Hz) was applied with the participant in a relaxed state and
a second during the plateau phase of the MVC. The ratio of interpolated and resting
doublets was used to provide an index of activation (Allen et al., 1995) as follows:
Voluntary activation (%)=100 x
(1 – (superimposed doublet torque/resting doublet torque))
where the superimposed doublet torque is the additional torque during the MVC
caused by the doublet.
Antagonist co-activation
To determine whether antagonist co-contraction affected the measured torque during
a knee extensor MVC, the electromyographic (EMG) activity of the biceps femoris
was recorded as described previously (Kellis & Baltzopoulos, 1997). Two 10-mm,
pre-gelled, Ag-AgCl percutaneous unipolar electrodes (Medicotest, Olstykke,
Denmark) were placed along the mid sagittal line of the biceps femoris muscle to
reduce the level of cross talk. To ensure that EMG recordings were made beyond the
motor point of the biceps femoris, electrodes were positioned at a third of total femur
length (Zipp, 1982), with the reference electrodes placed over the lateral epicondyle
of the femur. The raw EMG activity was acquired with a sampling frequency of 2000
Hz and processed with a multi channel analogue-digital converter (Biopac Systems
Inc., CA, USA). The raw EMG signal was filtered with low and high-band pass
filters set at 500 Hz and 10 Hz respectively, and amplified with a gain of 2000. The
level of co-activation of the biceps femoris was assessed using the root mean square
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(RMS) of the raw EMG signal which was integrated over 1 s about the peak MVC
torque during knee extension and was expressed as the percentage of activity
recorded from the biceps femoris during maximal knee flexion (Klein et al., 2001).
Contractile properties
The frequency-torque relationship and fatigue resistance were determined with
electrically evoked contractions essentially as described previously (Degens et al.,
2005). Briefly, the intensity of stimulation throughout the test was such that about 30
% of MVC toque was developed during a 100 Hz contraction.
Five minutes after the last MVC, the quadriceps muscle was stimulated with 1, 10,
15, 20, 30, 50 and 100-Hz trains for 1 s, separated by 1 min, to assess the frequency-
torque relationship. Frequencies were delivered in a random order. From the 100 Hz
tetanus of the frequency-torque relationship, the contraction time was measured as
the time from activation until 90 % of the maximal torque was reached, and the
relaxation time as the time for the torque to decline to 50 % of maximal torque after
cessation of stimulation (Degens et al., 2005).
Fatigue test
Five minutes after the contractions for the frequency-torque relationship the
resistance to fatigue was assessed by stimulating the quadriceps muscle with 30 Hz
trains, 1 s on 1 s off, for 2 minutes (Degens et al., 2005). Fatigue index (FI) was
expressed as the torque at the end of the test divided by that at the start of the test.
Anatomical cross-sectional area
Anatomical cross-sectional area (ACSA) of the quadriceps was measured with
magnetic resonance imaging (MRI), using a fixed 0.2 T MRI scanner (E-Scan,
ESAOTE Biomedica, Genova, Italy), at 50% of femur length. Scans were obtained
with a T1 weighted, high resolution, gradient echo profile, with the following
scanning parameters: echo time: 0.016 s; repetition time: 0.1 s; field of view: 0.33 x
0.254 m and a slice thickness of 0.005 m. Subjects were supine for 15 min prior to
the scan to make sure any fluid shifts had stabilised. To account for differences in
muscle cross-sectional area between the two groups, maximal knee extensor torque
was scaled with quadriceps ACSA (Maughan et al., 1983) and expressed as
MVC/ACSA (Nm cm-2).
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Statistical analysis
Data are reported as means (SD). To determine the effects of smoking an unpaired
two-tailed Student t-test was performed. None of the parameters violated the
assumptions of the t-test except for physical activity scores which were compared
using a non-parametric Mann-Whitney test. Differences were considered significant
at P<0.05.
Results
Subject characteristics
Table 3.1 shows the subject characteristics. Body mass, stature and body mass index
(BMI) did not differ between smokers and non-smokers (Table 3.1). The smokers
and non-smokers were successfully matched for physical activity as the PA scores
did not differ significantly (Table 3.1). Smoking history ranged from 0.4 - 11.1 pack
years, with a median of 1.7 years (Table 3.1). The non-smokers had never smoked.
VC and FEV1%pred did not differ significantly between smokers and non-smokers
(Table 3.1).
Table 3.2. Quadriceps function and contractile characteristics from male smokers
and non-smokers
Smokers (n=9) Non-smokers (n=10)
MVC (Nm) 335 ± 73 351 ± 72
ACSA (cm2) 74.9 ± 11.6 78.9 ± 6.7
MVC/ACSA (Nm cm-2) 4.5 ± 0.5 4.5 ± 0.9
Activation (%) 92 ± 3 93.3 ± 8.6
Co-activation (%) 27 ± 17 18 ± 10
Contraction time (ms) 334 ± 125 293 ± 67
Half relaxation time (ms) 112 ± 6 117 ± 8
MVC, maximal voluntary isometric knee extension torque; ACSA, anatomical cross-
sectional area; MVC/ACSA, MVC torque relative to ACSA; for further details see the
Methods section.
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Strength and muscle size
Knee extensor MVC torque was not significantly different between smokers and
non-smokers (Table 3.2). This and the similar ACSA were reflected in the absence of
a significant difference in the MVC/ACSA between smokers and non-smokers
(Table 3.2). Also, the level of voluntary activation and co-activation of the antagonist
muscles during an MVC were not significantly different between smokers and non-
smokers (Table 3.2).
Contractile properties
The contraction times of the 100 Hz tetani were not significantly different between
the smokers and non-smokers (Table 3.2). Similarly, half relaxation time was
comparable in the two groups. In line with this the frequency-torque relationship of
the quadriceps of smokers and non-smokers showed no difference (Figure 3.1).
Figure 3.1. The frequency-torque relationship in healthy young male smokers (○, 
n=9) and non-smokers (●, n=10).  
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Fatigue index
In figure 3.2 it can be seen that the quadriceps muscles of the smokers were more
susceptible to fatigue than those of the non-smokers (P<0.05); after two minutes of
30 Hz stimulation the FI was 54 ± 8 vs. 62 ± 9 % in smokers and non-smokers,
respectively. The variation in FI among the smokers did not correlate with either
smoking volume in terms of pack years (R2=0.09, P>0.05) or FEV1%pred (R2=0.28,
P>0.05).
Figure 3.2. Fatigue resistance of the quadriceps muscle in healthy young male
smokers (○, n=9) and non-smokers (●, n=10). The torque, elicited by electrical 
stimulation (1 s on 1 s off, 30 Hz) of the quadriceps muscle, is presented as relative
to the torque generated during the first contraction. The torque decline was larger in
smokers than non-smokers (P<0.05).
Discussion
The main finding of the present study was a decrease in fatigue resistance in young
male smokers compared with a group of physical activity-matched non-smokers,
while strength and other contractile properties did not differ between the groups.
Based on the present results the decrease in fatigue resistance cannot be explained by
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disuse, or restricted airflow. The electrically stimulated fatigue test eliminates the
possibility that differences in fatigability are due to differences in motivation and it is
probable that the cause of the lower fatigue resistance in smokers is located within
the muscle, at or beyond the level of the neuromuscular junction.
Strength
We observed no differences in knee extension strength between smokers and non-
smokers. Two other studies, however, have reported a decline in maximal voluntary
strength in smokers (Örlander et al., 1979; Al-Obaidi et al., 2004). Such a decline
can, at least theoretically, be a consequence of a smaller muscle mass, a reduced
ability to voluntarily activate the muscle and/or increased activation of antagonistic
muscles during a maximal contraction. These factors could be secondary to lower
levels of activity in the smokers in these previous studies. Indeed, it has been
suggested that a lower level of physical activity underlies the decline in strength
previously observed in smokers (Örlander et al., 1979). In the present study, smokers
and non-smokers were matched for physical activity level and, similarly to Larsson
et al. (1984), we did not observe a difference in strength between smokers and non-
smokers. Thus, the decrease in strength observed in previous studies is likely to be
explicable by a reduced activity level in smokers, rather than an effect of smoking
per se on maximal knee extensor strength or other determinants of strength
(activation, co-activation and ACSA).
Fatigue
Although strength was not affected by smoking, the fatigue resistance of the
quadriceps muscle was significantly reduced. Others, however, have not observed a
change in the fatigue resistance during maximal voluntary contractions in smokers
(Örlander et al., 1979; Larsson, 1984). This discrepancy is difficult to explain but
may, in part, be related to the type of fatigue tests performed. Previous studies have
used a series of fast dynamic contractions where the recovery interval between
contractions was probably around half a second, compared to the one second interval
in the present study. Dynamic contractions are more energetically demanding than
the isometric contractions we have used. Consequently, previous work may have
been testing predominantly anaerobic function whilst our protocol emphasises more
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the aerobic capacity of the muscle and the ability to recover between successive
contractions.
The acute neural stimulation effect of nicotine in cigarette smoke is well established
(Cryer et al., 1976) and Mündel and Jones (2006) have demonstrated that nicotine
has a beneficial effect on cycling endurance. It might be hypothesised that the
stimulant effect of nicotine during voluntary fatigue tests may counteract some
peripheral mechanism which contributed to the greater levels of fatigue in the
smokers in the present study.
Smoking is the primary cause of COPD, which is characterised by a decline in FEV1,
and it has been reported that smoking itself causes an increase in pulmonary airway
resistance (Nadel & Comroe, 1961). However, we did not observe a significantly
lower FEV1%pred in smokers than non-smokers, or any correlation between fatigue
resistance and FEV1%pred. Therefore, it is unlikely that lung function and the ability
to oxygenate the blood play any role in the lower fatigue resistance of smokers.
Indeed, as the fatigue test was performed on one leg, with activation of only about
30% of the quadriceps, blood oxygenation was probably not the predominant
limiting factor.
Lower levels of habitual physical activity level might lead to reduced oxidative
capacity, but in the present investigation the similar activity levels suggest that it is
cigarette smoking itself which is responsible for the observed reduction in fatigue
resistance.
A number of mechanisms (both acute and chronic) may be responsible for the
observed decline in fatigue resistance, these include alterations in muscle fibre type
composition and/or a decreased oxidative capacity (Örlander et al., 1979; Larsson,
1984). Although the frequency-torque relationship and contraction and relaxation
times are not unequivocal indicators for changes in fibre type composition, the
absence of significant alterations in these parameters indicates no major changes in
fibre type composition.
Mitochondrial enzyme activities (citrate synthase and 3-hydroxyacyl-CoA
dehydrogenase) have been reported to be decreased in the muscles of smokers
(Örlander et al., 1979). Interestingly, healthy ex-smokers did not show a decline in
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activities of enzymes of oxidative metabolism (Larsson, 1984) and COPD patients
who stopped smoking exhibited normal fatigue resistance (Degens et al., 2005). This
suggests that the smoking-induced alterations in the activity of oxidative enzymes
and muscle fatigue resistance might be reversible. Furthermore, the fact that we
found no relationship between pack years and fatigue resistance suggests an acute
effect of smoking. Cyanide and carbon monoxide (CO) in smoke are possible
candidates for acutely affecting fatigue resistance. Cyanide and CO inhibit
cytochrome c oxidase (complex IV in the mitochondrial chain), causing an overall
decline in mitochondrial function and oxidative capacity (Alonso et al., 2003), and
thus potentially a reduced fatigue resistance of the muscle.
Besides acting on cytochrome c oxidase, CO in cigarette smoke increases
carboxyhemoglobin (COHb) levels (Puente-Maestu et al., 1998), which reduces the
O2 carrying capacity of the blood. However, a reduced O2 carrying capacity of the
blood induced by breathing hypoxic air had no effect on fatigue resistance during the
same test as employed in the present study (Degens et al., 2006). COHb also
hampers the release of O2 as reflected by the left-ward shift of the O2-Hb binding
curve. Furthermore, the facilitated diffusion of O2 by myoglobin within the muscle
may be impaired by the formation of carboxymyoglobin (Wittenberg & Wittenberg,
1987). It has been reported that raised levels of COHb reduce O2 extraction during
stimulated contractions with in situ canine gastrocnemius, which was accompanied
by a reduction in muscle tension (King et al., 1987).
Besides changes in the muscle itself, another possibility for the earlier onset of
fatigue in smokers might be related to neurotransmission failure. Using direct muscle
stimulation superimposed on nerve stimulation, it has been shown that
neurotransmission failure contributes to an earlier onset of fatigue during hypoxia
(Zhu et al., 2006). With the present stimulation protocol we are unable to state
whether neural transmission failure contributed to the earlier onset of fatigue in
smokers.
We assume that the more rapid fatigue, whatever the cause, is a consequence of
changes occurring as a result of smoking. However, we cannot exclude the
possibility that there may be some genetic component that, for instance, influences
the likelihood of smoking and, at the same time, influences fatigue properties of the
muscle.
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The relationship between the changes in fatigue resistance we report here and the
muscle dysfunction frequently seen in COPD patients is unclear. Given that fatigue
resistance is not affected in COPD patients who stopped smoking (Degens et al.,
2005) and the fact that we saw no association between pack years smoked and FI, it
is likely that the reduced fatigue resistance in the present smokers is acute in nature.
If it is an acute response, the underlying factors of this fatigue are most likely
changes in the oxidative capacity of the muscle brought about, for instance, by a
reversible effect of cyanide and/or CO on mitochondrial enzyme function and tissue
oxygenation. Indeed, 28 days of smoking cessation has been shown to result in a
return to normal mitochondrial respiratory chain function (Cardellach et al., 2003).
Therefore, future studies may be directed towards the acute effects of CO, smoking
and smoking cessation on skeletal muscle function, oxygenation and fatigue
resistance.
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Abstract
Although smoking-related diseases, such as chronic obstructive pulmonary disease
(COPD), are often accompanied by increased peripheral muscle fatigability, the
extent to which this is a feature of the disease or a direct effect of smoking per se is
not known. Skeletal muscle function was investigated in terms of maximal voluntary
isometric torque, activation, contractile properties and fatigability, using electrically
evoked contractions of the quadriceps muscle of 40 smokers (19 men and 21 women;
mean ± SD) cigarette pack years: 9.9 ± 10.7) and age- and physical activity level
matched non-smokers (22 men and 23 women). Maximal strength and isometric
contractile speed did not differ significantly between smokers and non-smokers.
Muscle fatigue (measured as torque decline during a series of repetitive contractions)
was greater in smokers (P=0.014), but did not correlate with cigarette pack years
(r=0.094, P=0.615), cigarettes smoked per day (r=-0.092, P=0.628), respiratory
function (%FEV1pred) (r=-0.187, P=0.416), or physical activity level (r=-0.029,
P=0.877). While muscle mass and contractile properties are similar in smokers and
non-smokers, smokers do suffer from greater peripheral muscle fatigue. The
observation that the cigarette smoking history did not correlate with fatigability
suggests that the effect is either acute and/or reaches a ceiling, rather than being
cumulative. An acute and reversible effect of smoking could be caused by carbon
monoxide and/or other substances in smoke hampering oxygen delivery and
mitochondrial function.
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Introduction
Smoking is a recognised risk factor for many chronic diseases, such as chronic
obstructive pulmonary disease (COPD). Patients with COPD often complain of
exercise intolerance and fatigue, which can be attributed to deterioration in lung
function and systemic effects such as muscle atrophy and a slow-to-fast transition in
fibre type composition (Chapter 1). However, also otherwise non-symptomatic
smokers often complain of an increased sensation of whole body fatigability (Corwin
et al., 2002). The aetiology of this earlier onset of whole body fatigue in smokers is
unknown and it is unclear as to whether smoking itself contributes to this
phenomenon or other factors such as a decreased level of physical activity (Örlander
et al., 1979; Larsson & Örlander, 1984; Larsson et al., 1988). In Chapter 3 we
reported that in young male smokers, matched for physical activity with control
subjects, smoking itself causes a significant decline in skeletal muscle fatigue
resistance. The decline in fitness during prolonged smoking (Bernaards et al., 2003)
suggests, however, that long-term smoking may also cause a progressive
deterioration of skeletal muscle fatigue resistance.
Here, we hypothesised that the reduction in skeletal muscle function and fatigue
resistance would be related to the cumulative dose of smoking. Consequently we
have examined the muscle fatigability of subjects with a range of exposures to
smoking. To assess the effects of smoking duration on muscle function we have used
electrically evoked contractions of the quadriceps muscle of otherwise healthy
smokers. Electrical stimulation avoids possible motivational bias and also allows
determination of contractile properties such as the force-frequency relationship and
the rate of relaxation. The intermittent fatigue protocol used in this study mimics, to
some extent, the rhythmic muscle contractions involved in activities of daily life such
as cycling, walking and stair negotiation.
Methods and materials
Participants
Males and females were analysed separately, because of sex differences in fatigability
(Chapter 2), smoking reportedly only affecting the experience of fatigue in men
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(Corwin et al., 2002) and differences between sexes in vulnerability to COPD (Gan et
al., 2006). Eighty-five people volunteered for the study after giving written informed
consent. All procedures were approved by the local ethics committee and were in
accordance with the Helsinki Declaration.
Table 4.1. Subjects characteristics. Values are displayed as mean ± SD (range)
Male
non-smokers
Male
Smokers
Female non-
smokers
Female
smokers
n 22 19 23 21
Age (yr) 38.1 ± 17.8
(21 - 73)
37.0 ± 18.4
(18 - 72)
42.4 ± 20.4
(19 - 72)
37.5 ± 17.4
(18 - 66)
Body mass (kg) 77 ± 9
(63 – 95)
77 ± 12
(62 – 99)
66 ± 3
(53 - 83) **
74 ± 12
(56 – 96) **
BMI (kg m-1) 24 ± 2
(22-29)
24 ± 3
(18 – 30)
24 ± 3
(19 – 29)
27 ± 4
(22 - 34)
FVC (L) 5.4 ± 1.0
(3.6 – 7.3)
5.1 ± 1.3
(3.6 – 7.2)
3.6 ± 0.7
(2.5 – 4.8) **
3.7 ± 0.8
2.4 – 5.3) **
FEV1 (L) 4.3 ± 1.0
(2.8 – 6.1)
4.0 ± 0.9
(2.6 – 5.6)
3.0 ± 0.6
(2.0 – 3.9) **
2.9 ± 0.8
(1.5 – 4.2) **
%FEV1pred 99.3 ± 13.2
(78.7 – 125.5)
91.0 ± 11.5
(81.0 – 111.8)
101.2 ± 14.7
(76.4 – 127.8)
92.0 ± 19.5
(47.6 – 119.9)
FEV1/FVC (%) 78.7 ± 6.6
(60.2 – 91.6)
78.0 ± 9.4
(66.4 – 93.4)
81.7 ± 4.8
(71.9 – 88.6)
77.9 ± 10.5
(51.7 – 93.0)
Cigarette pack
years -
10.0 ± 12.8
(0.4 – 35.3) -
9.8 ± 8.9
(0.4 – 28.0)
Physical
activity score
8.2 ± 1.4
(6.0 – 10.8)
8.3 ± 1.4
(5.6 – 12.0)
8.1 ± 1.2
(5.8 – 9.5)
8.1 ± 1.4
(5.8 – 10.5)
No differences were observed between smokers and non-smokers, ** denotes P<0.005 from
men. FVC: forced vital capacity; FEV1: forced expiratory volume in 1 s in L or as a
percentage of predicted
The smokers and non-smokers were matched for age and physical activity. Physical
activity was assessed by questionnaire (Baecke et al., 1982). Low values (< 6) represent
a low physical activity level. Smoking history was assessed by questionnaire and
smoking volume was determined by pack-years, which is defined as the number of
cigarette packs smoked per day, multiplied by the number of years smoked. Exclusion
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criteria were known respiratory, cardiovascular or neuromuscular diseases and leg
injuries. Participants were asked to refrain from smoking and caffeine intake two
hours prior to testing. The force expiratory volume in one second (FEV1 (L)), predicted
FEV1 (%FEV1pred), forced vital capacity (FVC) and FEV1/FVC (%) were determined
with standard spirometry (Vitalograph, Buckingham, England).
Measurement of anatomical cross sectional area (ACSA)
ACSA of the quadriceps muscle at 50 % of femur length was measured with
magnetic resonance imaging (MRI) using a fixed 0.2 T MRI scanner (E-Scan,
ESAOTE Biomedica, Genova, Italy). See the appendix for more details.
Measurement of maximal isometric voluntary knee extension strength
All knee extension torque measurements were performed on the right leg with a
Cybex norm dynamometer (Ronkonkoma, New York, USA) with the hip joint at 90°
flexion. For more details on the procedures, see the appendix and the methods section
of chapter 2.
Voluntary activation
Beside muscle wasting, loss of strength can also be caused by a diminished ability to
maximally activate the muscle. This ability was determined using the interpolated
twitch technique (Shield & Zhou, 2004). Doublet pulses (pulse width 50 s, 100 Hz;
DSV Digitimer Stimulator, Digitimer Ltd., Herts, UK) were applied percutaneously
using stimulation pads (Versastim, Conmed Corp., N.Y., USA) with the anode
placed proximally and the cathode distally over the quadriceps muscle. The current
required for supra-maximal stimulation was assessed by administering single pulses
at rest. The ratio of electrically evoked force superimposed on an MVC to the force
of a pre-contraction doublet provided an index of voluntary activation (VA). After
the VA was determined the stimulation current was set at a level to produce
approximately 30 % of MVC torque when stimulating at 100 Hz and this current was
used throughout the rest of the experiment.
Torque-frequency relationship and contractile speed
The torque-frequency relationship and maximal rate of relaxation (MRR) both give
an indication of the contractile speed and fibre type composition of the muscle (Scott
et al., 2006). The force-frequency relationship of the quadriceps muscle was assessed
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by stimulating in random order at 1, 10, 15, 20, 30, 50 and 100 Hz for 1 s, each
separated by 1 min. Differences in the torque–frequency curves were assessed using
the 10/100 Hz ratio (FF10/FF100). The MRR was determined from the 50 Hz
contraction (MRR50) as peak dF/dt normalised to the maximal torque generated
during that contraction.
Fatigue test
Five minutes after determining the torque-frequency relation, fatigue resistance was
assessed by stimulating the quadriceps muscle with 30 Hz trains for 2 minutes (1 s on
1 s off). Torque and MRR for each contraction were expressed as a percentage of the
first contraction. The percentage torque remaining after 2 minutes was defined as the
fatigue index. The coefficient of variation between days was 2.3 and 5.3 % for the
force-frequency relationship and fatigue test, respectively (n=3 non-smokers).
Statistical analysis
Differences between groups were tested using a 2 x 2 ANOVA with factors: smoke
(non-smokers and smokers) and sex, with age as a covariant using SPSS (SPSS Inc.,
Chicago, IL, USA). The correlations between smoking habits and fatigability were
performed using a partial correlation, correcting for age and gender. Differences
were considered significant when P<0.05. Results are presented as means ± SEM
unless otherwise stated.
Results
Subject characteristics
Table 4.1 shows the anthropometric characteristics of the participants. Age, physical
activity levels, body mass, body mass index and lung function (FEV1, FVC or
FEV1/FVC) were similar in smokers and non-smokers, although %FEV1pred tended to
be significantly lower in smokers (P=0.092). Although we did not check whether the
airflow limitation in three smokers with an FEV1/FVC < 70 % was reversible, this value
suggests that they might have (undiagnosed) mild to moderate COPD (GOLD stage I or
II). The inclusion of their data, however, did not alter the results of the present study.
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Muscle strength, size and voluntary activation level
The VA was higher in the smokers (Table 4.2). Maximal torque capacity (MVC
corrected for VA; MTC) was lower in women than men (Table 4.2) and decreased
significantly in both men (R2=0.43) and women (R2=0.46) during ageing (P<0.001;
Figure 4.1). If we consider smoking or non-smoking there was no difference in MTC
and ACSA (Table 4.2). However, stepwise linear regression showed that height, age,
gender, physical activity level and years smoked significantly predict the ACSA
(R2=0.793; P<0.001), while cigarette pack years and cigarettes smoked per day did
not improve the model.
Table 4.2. Values for muscle strength, size and contractile properties.
Male
non-smokers
Male
smokers
Female non-
smokers
Female smokers
VA (%) 85.9 ± 3.0 92.0 ± 2.3 † 88.1 ± 2.2 90.0 ± 3.3 †
MVC (Nm) 286 ± 21 280 ± 18 190 ± 12 ** 204 ± 15 **
MTC (Nm) 330 ± 18 300 ± 19 213 ± 12 ** 219 ± 15 **
ACSA (cm2) 72 ± 2 65 ± 3 53 ± 2 52 ± 2
FF10/FF100 31.3 ± 1.4 31.4 ± 3.0 33.3 ± 1.5 * 38.0 ± 2.0 *
MRR50 (s-1) -15.1 ± 0.3 -16.0 ± 0.7 -12.7 ± 0.4 ** -12.9 ± 0.8 **
† P<0.05 from non-smokers; * P<0.05 from men; ** P<0.005 from men. VA: voluntary
activation; MVC: maximal voluntary contraction; MTC: maximal torque capacity (maximal
voluntary contraction corrected for VA); ACSA: anatomical cross-sectional area; FF10/FF100:
force frequency relationship: torque produced at 10 Hz relative to 100 Hz; MRR50 : maximal
rate of relaxation at 50 Hz.
Contractile properties
No differences were observed in the torque-frequency relationship or MRR50
between smokers and non-smokers (Table 4.2). Women however, had, on average,
slower contractile properties than men as reflected by the less negative MRR50 and
the higher FF10/FF100 (Table 4.2).
Fatigue
Figure 4.2A and 4.2B show a typical example of the fatigue test (A), and an example
of the reduction in torque and rate of relaxation from the first to the last contraction
(B). In all groups there was a progressive decline in torque (Figure 4.3) and MRR,
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the latter indicating a slowing of the muscle (Figure 4.4). Women were more fatigue
resistant than men (P<0.001), both in terms of torque and MRR. In both men and
women, the fatigue resistance was lower in smokers than non-smokers (P=0.014;
Figure 4.3). The absence of a smoke x sex interaction indicates that the effect of
smoking was similar in both sexes.
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Figure 4.1. Maximal torque capacity (MTC), maximal voluntary torque corrected for
voluntary activation of the quadriceps muscle expressed as a function of age in male
(A) and female (B) smokers and non-smokers. MTC decreased significantly with age
in men (R2=0.43) and women (R2=0.46; both P<0.001). The decrease in maximal
strength over time (and smoke exposure) was similar between smokers and non-
smokers (NS).
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Figure 4.2. Representative example of a fatigue test (A), with in B the first
(continuous line) and last (dotted line) contraction enlarged.
The fatigue index in smokers was not related to cigarette pack years (Figure 4.5),
packs smoked per day (r=-0.092, P=0.628), years smoked (r=0.242, P=0.321),
physical activity level (r=-0.029, P=0.877), age (r=0.101, P=0.557) or lung function
in terms of %FEV1pred (r=-0.187, P=0.416) or FEV1/FVC (r=0.03, P=0.824). Also,
there was no relationship between lung function (FEV1pred) and fatigue index (r=-
0.027, P=0.921) when controlling for cigarette pack years, the number of smoking
years and number of cigarettes smoked per day. Similar results were obtained for the
decline in MRR. Stepwise linear regression revealed that gender (P=0.015) and being
a smoker or non-smoker (P=0.024) explained 19.2 % of the variance in fatigue index
between the participants.
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Figure 4.3. Torque, expressed as percentage of initial value, during the fatigue
protocol is plotted every 2 s during the fatigue protocol for male (A) and female (B)
smokers (open symbols) and non-smokers (closed symbols). Women had a
significantly higher fatigue resistance (P<0.001). Both male and female smokers
fatigued more than the non-smokers (P=0.014). Note that (A) is almost identical to
Figure 3.2, but (A) includes more participants.
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Figure 4.4. Maximal rates of relaxation (MRR), expressed as percentage of initial
value, during the fatigue protocol are plotted every 2 s during the stimulation for
male (A) and female (B) smokers (open symbols) and non-smokers (closed
symbols). Significantly higher values were obtained in the females compared to the
males (P<0.001). MRR decreased to a significantly lower level in the smokers
compared to the non-smokers (P=0.008).
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Figure 4.5. Relationship between cigarette pack years and fatigue resistance of the
quadriceps muscle for male (●) and female (□) smokers of the fatigue test. Fatigue 
index was calculated as torque at the end of the test as a percentage of the initial
value. The correlation coefficient was 0.095 (P=0.618) for fatigue index and similar
results were obtained from other measures of smoking history (see text).
Discussion
We observed that smoking, in the absence of overt lung disease, is not accompanied
by muscle weakness and wasting or changes in contractile properties of the
quadriceps muscle after taking into account age, sex and physical activity. Despite an
absence in changes in contractile properties and muscle weakness, the muscles of
smokers were, however, more fatigable. This effect was similar in men and women.
In chapter 3, we have shown that young smoking men show greater fatigability and
here we hypothesised that the effect would increase with increasing smoking volume.
The absence of correlations between muscle fatigability and any measure of smoking
volume contradicts this hypothesis and suggests that the effect of smoking on
skeletal muscle fatigability is of an acute nature and/or reaches a ceiling where an
increased daily smoking volume does not aggravate the effect.
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Maximal strength, size and voluntary activation
We did not find a lower maximal voluntary torque in smokers, despite a slightly
higher voluntary activation level. The higher VA might be due to an increase in
sympathetic nerve activity in smokers (Narkiewicz et al., 1998), possibly due to a
central stimulant action of nicotine (Mündel & Jones, 2006). Yet, this effect is
insignificant as the maximal capacity of the muscle to generate torque (maximal
torque corrected for VA) was also similar between smokers and non-smokers. Others
(Örlander et al., 1979; Al-Obaidi et al., 2004), however, did report a lower maximal
strength in smokers than non-smokers, but smokers and non-smokers were not
matched for physical activity level, a factor very likely to affect maximal voluntary
force. Other factors that may contribute to muscle weakness via muscle wasting are
systemic inflammation and oxidative stress (Gan et al., 2005; Wüst & Degens,
2007). The observation that the amount of years smoked predicted the ACSA of the
quadriceps muscle suggests that long term smoking produces a small degree of
muscle wasting. Surprisingly, we did not observe similar differences in the maximal
strength of the quadriceps.
Contractile properties
The force-frequency relationship did not differ between smokers and non-smokers,
suggesting that no significant, if any, shift in fibre type composition had occurred
with smoking. Moreover, the MRR, a broad measure of muscle speed and fibre type
composition (Hamada et al., 2003), was not different between smokers and non-
smokers. In line with our observation, it has been found that different doses of
cigarette smoke did not lead to changes in fibre type distribution in the rat (Nakatani
et al., 2003). Örlander et al. (1979), however, found a lower percentage type I fibres
in smokers, but this may be related to differences in physical activity level which was
not controlled in their study.
Peripheral muscle fatigability
The main finding of the present study is a lower skeletal muscle fatigue resistance in
smokers. Interestingly, the reduction in fatigue resistance was similar in men and
women and, contrary to our hypothesis, was not related to several measures of
smoking history. The increased fatigability could be caused by neuromuscular
transmission failure, a shift to a more fatigable fibre type, reduction in oxygen supply
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to the muscle and/or the oxidative capacity of the muscle (Degens & Veerkamp,
1994).
The likelihood of electrical failure either at the neuromuscular junction or T-tubules
was minimised by keeping the stimulation frequency relatively low and allowing
sufficient recovery intervals (Jones, 1996). Therefore, the site of fatigue is most
likely distal to the neuromuscular junction (Bigland-Ritchie et al., 1982).
Another factor possibly affecting muscle fatigue is the fibre type distribution of the
muscle since type II fibres have a higher ATP turnover for the same isometric
tension than type I fibres (Stienen et al., 1996). Also, they generally have a lower
oxidative capacity and fatigue more rapidly (Degens & Veerkamp, 1994). However,
we did not observe any differences in maximal rate of relaxation or force-frequency
relationship, both a qualitative in vivo suggestion of a different fibre type
composition. It is thus unlikely that this explains the higher fatigability in smokers.
Another factor influencing muscle fatigue is the oxidative capacity of the muscle.
Earlier studies have found that smokers have a lower activity of mitochondrial
enzymes, such as cytochrome oxidase (Örlander et al., 1979; Larsson & Örlander,
1984). The present study does not allow us to draw firm conclusions regarding
oxidative capacity.
Impaired oxygen transport to skeletal muscle
The absence of a significant correlation between cigarette pack years and fatigability
of the muscle and no indication for changes in fibre type composition that could
explain the reduced fatigue resistance in smokers suggest that smoking acutely
hampers the oxygen and/or energy delivery and/or utilization. An impaired oxygen
delivery may occur if the blood flow is diminished or the oxygen content of the
blood is lower than normal. Exercise-induced vasodilatation has been reported to be
lower in smokers than physical activity matched non-smokers (Gaenzer et al., 2001),
which may be due to an impaired nitric oxide generation (Montes de Oca et al.,
2008) and/or an increased oxidative stress (Gaenzer et al., 2001; Tsuchiya et al.,
2002).
A diminished oxygen delivery can also result from a reduced oxygen content of the
blood. In smokers this could arise when the oxygen binding sites on haemoglobin
(Hb) become occupied with carbon monoxide (CO), resulting in hypoxaemia.
Indeed, carboxyhaemoglobin (COHb) may reach levels of up to 9 % in smokers
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(Rietbrock et al., 1992). Yet, we showed previously that subjects were no more
fatigable in acute hypoxia when using the same protocol (Degens et al., 2006). It
therefore seems unlikely that hypoxaemia is the factor that distinguishes the smokers
from the non-smokers. The effect of CO via its action on Hb can, however, not
completely be excluded as, in contrast to hypoxaemia, the oxygen dissociation curve
exhibits a shift to the left, inhibiting the release of oxygen from Hb (Rietbrock et al.,
1992). Indeed, inhalation of CO acutely impaired maximal oxygen consumption in
both healthy participants (Aronow & Cassidy, 1975; Seppanen, 1977; Klausen et al.,
1983) and patients with COPD (Aronow et al., 1977). Moreover, experimentally
elevating blood COHb to 6 % in non-smoking men resulted in an increased
fatigability in a test identical to our fatigue protocol (Morse et al., 2008).
Besides the effect of CO on oxygen supply to the tissue, CO might also bind to Mb,
limiting intra-cellular facilitated diffusion of oxygen. Also, CO blocks complex IV of
the mitochondrial respiratory chain causing an overall decline in mitochondrial
function (Alonso et al., 2003). Cardellach et al. (2003) showed that mitochondrial
respiratory chain function (complex III and IV [cytochrome oxidase]) in
lymphocytes was decreased in smokers, but returned to normal values after smoking
cessation.
Combined with the data in the present study this suggests that smoking may have an
acute and reversible effect on skeletal muscle fatigability caused by CO (amongst
other chemicals) in cigarette smoke. This then would result in a lower, but reversible,
fatigue resistance in smokers. It should be noted, however, that not only CO, but also
tar (Pryor et al., 1992) and cyanide (Nelson, 2006) in the cigarette smoke could
directly reduce mitochondrial respiratory chain function. This is further supported by
the similar fatigue resistance (using the same fatigue test as in the present study) in
non-smoking patients with COPD (Degens et al., 2005).
In conclusion, skeletal muscle from smokers is more fatigable than that of age- and
physical activity-matched non-smokers, while contractile properties of the skeletal
muscle were not different. The decrease in fatigue resistance was similar in men and
women and not related to smoking history. This suggests that smoking itself acutely
affects skeletal muscle fatigue resistance. We speculate that this may occur via an
acute and potentially reversible smoking-induced oxygen delivery to the working
muscle and/or impairment of the function of haemoglobin and myoglobin due to
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carbon monoxide. Moreover, CO and other factors in smoke inhibit enzymes in the
respiratory chain (such as cytochrome oxidase). If smoking indeed has an acute
effect on muscle fatigue resistance, smoking cessation may be helpful in the
management of the exercise intolerance and sensations of fatigue in smokers,
whether or not they suffer from clinical symptoms of chronic diseases such as COPD
or heart failure. It may also help to break the vicious circle of disuse in order to
prevent sensations of fatigue that in turn will cause a further decrease in physical
fitness.
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Abstract
The capillary supply of a muscle fibre is thought to be determined by its type,
oxidative capacity, size and metabolic surrounding. Size and oxidative capacity,
however, differ between fibre types. To investigate which of these factors determines
the capillary supply of a myofibre most we analysed in sections from human vastus
lateralis (n=11) and rat plantaris muscle (n=8) the type, succinate dehydrogenase
(SDH) activity, reflecting oxidative capacity, and capillary supply of individual
fibres. Capillary fibre density differed between fibre types in rat (P<0.03) but not in
human muscle. In human muscle only, the local capillary to fibre ratio (LCFR)
correlated with the integrated SDH-activity (fibre cross-sectional area x SDH-
activity) of a fibre (r=0.62; P<0.001). Backward multiple regression revealed,
however, that the LCFR was primarily determined by fibre size, type (r=0.71,
human) and surrounding of the fibre (r=0.62; rat plantaris muscle), i.e. whether it
came from the deep or superficial region of the muscle (all P<0.001) and not SDH-
activity. In conclusion, size, type and metabolic surrounding rather than
mitochondrial activity determine the capillary supply to a muscle fibre.
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Introduction
Since the pioneering work of Krogh (1919), many scientists have tried to understand
the factors underlying the distribution of capillaries in skeletal muscle (Hoppeler et
al., 1981; Mathieu-Costello et al., 1992; Degens et al., 1994; Ahmed et al., 1997).
Oxidative muscles generally having a denser capillary network than glycolytic
muscles (Saltin & Gollnick, 1983; Egginton, 1990; Degens et al., 1992), but the
capillary density of skeletal muscles varies widely between different species, muscles
and even within a single muscle (Hoppeler et al., 1981). Within the plantaris muscle
for instance the deep, oxidative region has a denser capillary network than the
superficial, glycolytic region (Degens et al., 1992). The capillary supply to individual
muscle fibres is thought to be determined by its oxidative capacity (Degens et al.,
1992; Mathieu-Costello & Hepple, 2002), size (Degens et al., 1992; Ahmed et al.,
1997) and type (Saltin & Gollnick, 1983; Degens et al., 1992). The main function of
the capillaries is often thought to be oxygen supply, but removal of metabolites and
heat and supply of substrates may be a more important function of the capillary bed.
Thus, although all oxidative capacity, size and type of the fibre have been reported to
be related to capillary supply, to what extent the capillary supply of an individual
fibre is determined by each of these factors and how these relations may vary
between human and rat is not systematically investigated.
Therefore, the primary aim of the present study is to quantify to what extent fibre
type, oxidative capacity, fibre size and metabolic surrounding determine the capillary
supply of an individual fibre, and whether or not these relations are qualitatively and
quantitatively the same in rats and humans. As a measure for the oxidative capacity
of a fibre we used sections stained for succinate dehydrogenase (SDH)-activity. It
has been shown that using our methodology, the staining intensity of a muscle fibre
for this enzyme from the citric acid cycle correlates very well with the maximum
cellular oxygen uptake (Van der Laarse et al., 1989), and hence the maximum
demand for oxygen that has to be supplied by the surrounding capillaries.
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Materials and methods
Rat biopsies
Eight male Wistar rats (11 weeks old) were killed by an intraperitoneal injection of
an overdose of pentobarbital sodium and the plantaris muscles carefully excised,
slightly stressed to minimise bias related to tortuousity of capillaries, directly frozen
in liquid N2 and stored at -80oC until further analysis.
Human biopsies
Eleven healthy participants (5 men and 6 women, age: 42 ± 18 years) volunteered to
participate in this study. Written informed consent was obtained from each
participant prior to taking the percutaneous biopsy. All procedures were approved by
the local ethics committee of the Manchester Metropolitan University (UK). After
local anesthesia with 2 % lidocaine, a percutaneous biopsy of the vastus lateralis
muscle (at ~50 % of the muscle length) was obtained using a conchotome. The
biopsy was placed on cork, frozen in liquid N2 and stored at -80oC.
Histochemistry
Transverse 10 µm sections were cut in a cryostat at -20 oC. The sections were stored
at -80 °C until further analysis, unless otherwise stated.
Fibres were classified as type I, IIa, or IIx (IIx/b in rats) based on the pH sensitivity
of their myofibrillar ATPase, using the methods first described by Brooke & Kaiser
(1970); type I myofibrillar ATPase is acid stable and alkaline labile, while type IIa
myofibrillar ATPase is acid labile and alkaline stable with that of IIx/b in between.
The fibres thus appear dark, white and grey after acid pre-incubation, respectively
(Figure 5.1). Sections were pre-incubated for 10 minutes in a buffer containing 0.1 M
NaAc and 0.1 M KCl at pH 4.55 set with acetic acid, quickly rinsed in 20 mM glycin
and 20 mM CaCl2 at pH 9.4 (set with NaOH) and subsequently incubated for 25-30
minutes at 37°C in 40 mM glycin, 20 mM CaCl2 and 2.5 mM ATP at pH 9.4 (set
with NaOH). Sections were quickly rinsed with 1 % CaCl2, left in 2 % CoCl2 for 3
minutes, washed with distilled water and coloured in 2 % (NH4)2S and washed in
water.
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Figure 5.1. Example of a plantaris muscle of the Wistar rat. On the left, the section is
stained for SDH-activity (see text), while the right serial section was stained for acid
myofibrillar ATPase (pH=4.55). The dark fibres on the right are classified as type I,
while the white fibres are classified as type IIa and the grey fibres as type IIx/b. One
can observe that the type I and IIa fibres have, as expected, a higher SDH-activity.
Note that on the right hand corner of the muscle, a small part of the gastrocnemius
muscle is still visible.
A serial section was stained for SDH-activity (Van der Laarse et al., 1989; Figure
5.1). Succinate dehydrogenase (SDH) is an enzyme in the citric acid cycle and part
of the respiratory chain. It has been shown by our lab that the calibrated
histochemical method described below is linearly related to the maximum rate of
oxygen uptake by the muscle fibre (Van der Laarse et al., 1989). Immediately after
cutting, sections were dried for 15 min and stained for SDH-activity (Van der Laarse
et al., 1989; Pool et al., 1979). Thereto, the sections were incubated at 37°C in the
dark for 20 min in a medium consisting of 37 mM sodium phosphate buffer (pH 7.6),
74 mM sodium succinate and 0.4 mM tetranitroblue tetrazolium (TNBT). The
reaction was stopped with a 30 s incubation in 0.01 M HCl and fixed in 10 %
formalin for 20 min. The staining intensity was determined as the optical density of
the final reaction product using an interference filter of 660 nm at a magnification of
x 20 (ImageJ, National Institute of Health, Bethesda, USA) and was calculated as the
absorbance at 660 nm per μm section thickness per second of staining time (ΔA660
μm-1 s-1).
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Another serial section were stained with alkaline phosphatase (rat; Degens et al.,
1992) or lectin (human; Ahmed et al., 1997) to depict capillaries. In short, rat
sections were fixed in chloroform-aceton (1:1; 4°C), quickly rinsed in distilled water
and subsequently stained for 1 h in 0.01 % nitro blue tetrazolium (NBT) and 0.002 %
5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt in 6.9 mmol MgSO4.7H2O and
27.5 mmol Na2B4O7.10H2O buffer adjusted to pH 9.2 with boric acid. After quickly
rinsing the sections in distilled water and a postfixation in 10% formalin (4 %
formaldehyde), slides were mounted in gelatin-glycerol.
Human sections were fixed in acetone (4°C), kept in HEPES for 15 minutes,
incubated in PBS containing 0.9 % 30 % H2O2 for 30 minutes to reduce background
staining and subsequently incubated with lectin (Ulex Europeus) in HEPES with 1 %
BSA (2000 μg/ml). The capillaries were visualised using a Vectastain ABC and
DAB substrate kit (Vector Laboratories, Peterborough, UK) before mounting in
gelatin-glycerol.
Determination of capillarisation
The capillarisation was analyzed with the method of capillary domains (Hoofd et al.,
1985; Degens et al., 1992). In short, domains were constructed around capillaries,
defined as the area surrounded by a capillary delineated by equidistant boundaries
from adjacent capillaries. The fibre cross-sectional area (FCSA) was determined by
tracing the outlines of the fibres on the digitizing tablet. The capillary supply to a
fibre was given as the local capillary to fibre ratio (LCFR), calculated as the sum of
the fractions of the capillary domains overlapping a given fibre.
Statistics
A 3x3 ANOVA was performed with as factors fibre type and muscle origin using
SPSS (SPSS Inc., Chicago, IL, USA). If interactions were found, a repeated
measures ANOVA (with Bonferroni post-hoc tests) was done to detect differences
between fibre types within a muscle or muscle region, and an ANOVA (with
Bonferroni post-hoc tests) for muscle origin was done to detect whether a certain
fibre type differed between human and rat deep or superficial region. To test which
factor predicted the capillary supply of the muscle most, backwards multiple
regression analysis was performed. Correlations and differences were considered
significant at P≤0.05. Data are presented as mean ± SD.
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Results
Per animal/human, 45 ± 7 fibres were analysed for the deep plantaris region, 70 ± 18
fibres for the superficial plantaris and 40 ± 10 fibres for the human quadriceps. The
results from fibre size, capillary supply and oxidative capacity are given in Table 5.1.
The overall capillary to fibre ratio (C/F) and capillary density (CD) are shown in
Table 5.1 under ‘Total’. In line with previous observations (Bekedam et al., 2003)
we found a significant correlation between the LCFR and SDH x FCSA in human
(r=0.62; P<0.001), but not in rat muscle. However, backward multiple regression
revealed that the local capillary to fibre ratio was not determined by SDH-activity,
but determined by fibre size and type in the human vastus lateralis muscle (r=0.71)
and also surrounding of the fibre (r=0.62; rat plantaris muscle); i.e. whether it came
from the deep or superficial region of the muscle (all P<0.001). Figure 5.2A shows
the positive correlation between LCFR and FCSA for each muscle.
There was even a negative relation within fibre types between LCFR and capillary
fibre density (CFD=LCFR/FCSA) with SDH-activity of a fibre, as shown in Figure
5.2B and C for the deep region of the rat plantaris muscle. However, if we controlled
for FCSA and fibre type, the correlations between SDH-activity and capillarisation
disappeared (r<0.1, NS). As mitochondria are not homogenously distributed within a
muscle cell we plotted the mitochondrial distribution against the fraction of the
intercapillary distance, where capillaries were located at opposite sites of the muscle
cell. The mitochondrial density was highest in close proximity of the capillaries
(subsarcolemmal mitochondria) and exhibited a steep decline to the centre of the
myofibre (interfibrillar mitochondria) in the oxidative type I and IIa fibres.
Furthermore, the profile of the mitochondrial density was flatter in glycolytic type
IIx/b than in the more oxidative type I and IIa fibres (Figure 5.2 D-F). Where in
human muscle type IIx fibres have a higher LCFR than type I and IIa fibres, the
opposite was found in rat muscle. This apparent discrepancy is largely related to
fibre size (Table 5.1). To take this into account we also
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Table 5.1. Indices of fibre size and capillary supply in the human vastus lateralis
(VL) and the deep and superficial region of the plantaris muscle of male Wistar rats.
Area %
FCSA
(µm2)
LCFR
CFD
(mm-2)
SDH-activity
(ΔA660 μm-1 s-1)
Human VL
I 52.2 ± 5.4#+† 4068 ± 1300 #+ 1.51 ± 0.68 +† 362 ± 145 # 1.64 ± 0.12
x 10-5 +†
IIa 45.3 ± 5.3 #+† 3754 ± 1555 #+ 1.33 ± 0.70 + 325 ± 138 # 1.34 ± 0.22
x 10-5 +†
IIx 2.5 ± 1.9 #+ 3669 ± 1382 0.90 ± 0.69 # 254 ± 105 # 1.28 ± 0.12
x 10-5 +
Total
(n=426)
3897 ± 1387 # 1.33 ± 0.67 349 ± 140 # 1.42 ± 0.10
x 10-5 #
Rat plantaris, deep region
I 8.8 ± 4.7 +Δ† 1694 ± 218 † 1.28 ± 0.35 +† 765 ± 245
+Δ†
1.26 ± 0.55
x 10-5 +†
IIa 24.3 ± 5.3 † 1998 ± 452 † 1.24 ± 0.25 † 640 ± 148 +† 1.57 ± 0.69
x 10-5 +†
IIx/b 66.8 ± 8.3 3116 ± 641 1.81 ± 0.37 613 ± 174 + 0.87 ± 0.49
x 10-5 +
Total
(n=571)
2581 ± 523 + 1.55 ± 0.31 + 638 ± 170 + 1.14 ± 0.49
x 10-5 +
Rat plantaris, superficial region
I (n=5) 0.8 ± 1.0 Δ† 1271 ± 266 † 0.56 ± 0.26 +† 494 ± 268 † 1.04 ± 0.49
x 10-5 †
IIa 14.4 ± 20.0 † 2174 ± 1103 † 0.76 ± 0.33 † 395 ± 119 0.88 ± 0.48
x 10-5 †
IIx/b 83.8 ± 20.2 3605 ± 739 1.09 ± 0.23 329 ± 58 0.50 ± 0.38
x 10-5
Total
(n=347)
3453 ± 449 1.07 ± 0.16 334 ± 55 0.50 ± 0.23
x 10-5
VL: vastus lateralis; FCSA: fibre cross-sectional area; LCFR: local capillary to fibre ratio;
CFD: capillary fibre density. #: significantly different from rat plantaris deep region at
P<0.02; +: significantly different from rat plantaris superficial region at P<0.02; Δ: different
from type IIa of same origin at P<0.05; †: different from type IIx (or IIx/b) of same origin
at P<0.05.
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Figure 5.2. Relationships between (A) FCSA and LCFR for rat deep region, rat
superficial region and human vastus lateralis, (B) SDH-activity and LCFR and (C)
SDH-activity and CFD for the deep region only. SDH-activity between two
capillaries are shown in D-F (D: type I, E: type IIa, F: type IIx (IIx/b)).
determined the CFD for each fibre type and it appeared that type I fibres had a higher
CFD than type IIx/b fibres in both the deep and superficial region of the rat plantaris
muscle (Table 5.1), but not in human muscle.
Table 5.1 and Figure 5.1A show that the relation between LCFR and FCSA is not
fixed, but differs between human and rat muscle and also between the deep and
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superficial region of the rat plantaris muscle. In terms of CFD, the capillary supply to
a fibre is highest in the deep region of the plantaris muscle and no significant
difference was observed between the CFD of fibres from the human vastus lateralis
muscle and the superficial region of the rat muscle, even though the SDH-activity of
the human fibres was higher.
Discussion
The main observation of the present study is that in both human and rat muscle the
capillary supply to a fibre is primarily determined by its type and size, while the
oxidative capacity plays no significant role.
Many studies have shown a significant relation between capillarisation and oxidative
capacity in muscle tissue (Saltin & Gollnick, 1983). Also the capillary supply to
individual fibres has been reported to be related to mitochondrial volume or
integrated SDH-activity, in hummingbirds (Mathieu-Costello et al., 1992) and
humans (Bekedam et al., 2003). As there is a hyperbolic relationship between fibre
size and SDH-activity (Van der Laarse et al., 1998), correlations between capillary
supply and oxidative capacity may be confounded by fibre size. Indeed, it has been
observed in both rat (Degens et al., 1994) and human muscle (Ahmed et al., 1997)
that size is an important determinant of capillary supply to a fibre. Here we took into
account both fibre size and SDH-activity and found that not SDH-activity, but fibre
size was an important determinant of capillary supply to a fibre in both rat and
human muscle (Figure 5.1A). Moreover, in rat muscle (integrated) SDH-activity did
not correlate significantly with capillary supply to a fibre. Thus, taking into account
both fibre size and oxidative capacity it appeared that size, rather than oxidative
capacity is a significant predictor of the local capillary to fibre ratio.
Although Ahmed et al. (Ahmed et al., 1997) suggested that there was no effect of
fibre type we did observe with backward regression that also the type of the fibre had
an impact on the capillary supply of a fibre. Nevertheless, in line with what we found
they observed that the average LCFR was type I > IIa > IIx/b. The effect of type is,
however, rather small, as both Ahmed et al. (1997) and we observed that the CFD,
which takes into account the size of the fibre, was similar in each fibre type. In the
rat plantaris muscle, on the other hand, the CFD of type IIx/b fibres was lower than
that of type I and IIa fibres, but this difference was not explicable by differences in
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SDH-activity between fibre types as revealed with backward regression for type and
SDH-activity. Even the spatially integrated SDH-activity, as a measure for the total
demand for O2 of the myofibre (Bekedam et al., 2003), did not significantly correlate
with the capillary supply to a fibre in the rat plantaris muscle.
As the mitochondria ultimately consume O2 one would have expected that the
oxidative capacity is the main determinant of the capillary supply to a fibre. It should
be noted, however, that mitochondria are not homogenously distributed within the
fibre, where the density is highest at the sarcolemma, decreasing steeply to the
interior of the cell (Hoppeler et al., 1981). Here, we confirm that observation and
show that the density distribution shows a flatter profile in human than rat fibres and
in type IIx/b than type I and IIa fibres. Such a profile would considerably shorten the
diffusion distance to the majority of the mitochondria, and hence result in an
adequate O2 supply to the mitochondria. This would, at least partly, explain why
there is no significant relation between the oxidative capacity of a fibre and its
capillary supply.
Finally, in line with previous observations (Degens et al., 1992) we observed that the
capillary supply to a fibre is modulated by the metabolic surrounding of the fibre.
This is reflected by the different slope of the FCSA-LCFR relation and the lower
CFD for each fibre type in the superficial than the deep region of the muscle.
In conclusion, in both rat and human muscle size and type rather than mitochondrial
activity is the primary determinant of capillary supply to a muscle fibre.
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Abstract
We investigated whether the lower fatigue resistance in smokers than non-smokers is
caused by a compromised muscle oxidative metabolism. Using calibrated
histochemistry, we found no differences in succinate dehydrogenase (SDH)-activity,
myoglobin concentration and capillarisation in sections of the vastus lateralis muscle
of five smokers and five non-smokers. The relationship between fatigue resistance
and SDH-activity in non-smokers (r=0.93, P=0.02) is absent in smokers. This
indicates that the lower muscle fatigue resistance of smokers is likely due to other
causes than differences in oxidative metabolism and local capillarisation.
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Introduction
Chronic obstructive pulmonary disease (COPD) is associated with a reduced exercise
tolerance and, in general, reduced muscle fatigue resistance (Gosselink & Decramer,
1998; Chapter 1). The main determinants of skeletal muscle fatigue resistance are:
oxygen delivery to the muscle, oxygen transport from interstitial space to the core of
the muscle fibres, fibre type composition and the oxidative capacity (Degens &
Veerkamp, 1994), which is proportional to succinate dehydrogenase (SDH) activity
(Van der Laarse et al., 1989). The oxygenation of muscle tissue is largely dependent
on capillary density (Hoofd et al., 1985), myoglobin concentration (Richardson et
al., 2001) and fibre cross-sectional area (Hill, 1965). In patients with COPD, muscle
fibre atrophy and a reduction in capillarisation and oxidative capacity all negatively
affect muscle fatigue resistance (Maltais et al., 1996; Jobin et al., 1998; Green et al.,
2008; Chapter 1). As cigarette smoking is associated with over 80 % of the COPD
cases (Yawn & Kaplan, 2008), smoking may be an important factor in the muscle
adaptations that compromise the strength and fatigue resistance of COPD patients;
skeletal muscle fatigue resistance is already lower in young, healthy smokers than
age- and physical activity-matched non-smokers (Chapter 3). Although inhaled
carbon monoxide (CO), a constituent of cigarette smoke, that reached 6 %
carboxyhemoglobin (COHb) resulted in a 8 % reduction in the fatigue resistance of
non-smoking subjects (Morse et al., 2008), it is not clear whether this is the sole
explanation. Given the determinants of skeletal muscle fatigue resistance described
above, we hypothesised that in skeletal muscle mitochondrial volume density,
capillary density and/or myoglobin concentration would be lower in smokers, and/or
that the proportion of fast muscle fibres would be higher in the skeletal muscle of
smokers than of non-smokers.
Methods
Participants
Five non-smokers (2 men and 3 women) and 5 smokers (2 men and 3 women)
participated in this study. Exclusion criteria were known cardiovascular,
neuromuscular or respiratory diseases. Written informed consent was obtained from
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each participant prior to testing. All procedures were approved by the local ethics
committee of the Manchester Metropolitan University (UK). The age of the non-
smokers (range: 23-72 years, median: 45 years) and smokers (range: 25-72 years,
median: 40 years) was similar. The smokers smoked on average 15 ± 9 cigarettes d-1,
while the non-smokers never smoked. Mean cigarette pack years (packs smoked d-1 x
the number of years of smoking) was 12.9 (range: 2.6-35.0, median: 9.9) pack years.
The physical activity score of the subjects assessed by questionnaire (Baecke et al.,
1982), was 8.1 ± 1.3 and 7.1 ± 1.2 for the non-smokers and smokers, respectively
(P=0.20). A physical activity score of < 6 indicates a sedentary lifestyle, whereas
scores > 9 represent a high level of activity.
Maximal strength, fatigue resistance and anatomical cross-sectional area
Maximal strength of the quadriceps muscle was determined as the highest value
during a maximal voluntary contraction at optimal knee angle (for more details, see
Chapter 2, 3 and 4). Fatigue resistance of the quadriceps muscle was assessed using
electrical stimulation (1 s on 1 s off, 30 Hz, 2 min; constant stimulus intensity
corresponding to 22 ± 4 % of maximal strength in the non fatigue state). Anatomical
cross sectional area (ACSA) was measured at 50 % of femur length with magnetic
resonance imaging (MRI). The procedures are detailed in chapter 2, 3 and 4 and in
the appendix.
Skeletal muscle biopsy
A percutaneous biopsy of the vastus lateralis muscle was obtained from each
participant using a conchotome. The site of the biopsy was anesthetised with 2 %
lidocaine and a 1-cm incision was made at ~20 cm above the patella. The biopsy was
frozen in liquid nitrogen and stored at -80 oC.
Enzyme histochemistry
Transverse 10 µm sections were cut in a cryostat at -20 oC. Sections were stained for
myofibrillar adenosine triphosphatase (mATPase), after pre-incubation at pH 4.7, to
classify fibres as type I or type II (Brooke & Kaiser, 1970, Chapter 5). Serial sections
were incubated for myoglobin concentration (Van Beek-Harmsen et al., 2004) and
SDH-activity (Bekedam et al., 2003, Chapter 5), which is proportional to the
maximum rate of oxygen consumption when oxygen is not rate-limiting (Van der
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Laarse et al., 1989). SDH-activity is given as the absorbance increase at 660 nm per
micrometer section thickness and per second of incubation time (ΔA660 μm-1 s-1).
The myoglobin concentration in individual muscle fibres was determined as
described previously (Van Beek-Harmsen et al., 2004). Frozen sections were
defrosted in vacuum to avoid condensation and consequent redistribution of
myoglobin. Sections were then vapour-fixed for 1 h in paraformaldehyde at 70°C.
Subsequently, the sections were fixed for 10 min at room temperature in 2.5 %
glutaraldehyde in 0.07 M sodium phosphate buffer (pH=7.4) and quickly rinsed with
distilled water. To detect myoglobin sections were incubated for 1 h at room
temperature in a medium containing 59 ml 50 mM TRIS/80 mM KCl buffer
(pH=8.0), 25 mg ortho-toluidine dissolved in 2 ml 96 % ethanol (at ~50°C) and 1.43
ml 70 % tertiary-butyl-hydroperoxide. Sections were then washed with distilled
water, mounted and scanned on a calibrated DMRB microscope (Leica, Wetzlar,
Germany) with an interference filter of 436 nm. A 3rd order calibration line was
obtained before scanning each section using grey filters with a known absorbance.
The red blood cells in the capillaries contain haemoglobin which was visible as dark
spots at the edges of the muscle fibres. The myoglobin concentration was, however,
homogeneously distributed within the cell and therefore the mean optical density was
obtained from the centre of each fibre. After subtracting the optical density of the
background (a part of the section that did not contain myoglobin), optical density
values were converted to absorbance values. Using a calibration line, obtained from
absorbance values from 10 µm sections cut from a gelatin block containing 0.1, 0.2,
0.3 and 0.4 mM myoglobin, absorbance values were converted into concentrations
(Van Beek-Harmsen et al., 2004).
Capillarisation
Another serial section was stained with lectin to depict capillaries (Ahmed et al.,
1997, Chapter 5). Capillarisation was analysed with the method of capillary domains
described by Degens et al. (1992). This method gives not only the overall indices of
capillary density and capillary to fibre (C/F) ratio, it also takes into account the
presence of different fibre types and the heterogeneity in capillary spacing (standard
deviation of the log-transformed radius of the capillary domain (LogRSD)). Domains
were defined as the area surrounded by a capillary delineated by equidistant
boundaries from adjacent capillaries. The fibre cross-sectional area (FCSA) was
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determined by tracing the outlines of the fibres on a digitizing tablet (Model MMII
1201, Summagraphics Digitizers, Austin, Tex, USA). The capillary supply to a fibre
was given as the local fibre to capillary ratio (LFCR), calculated as the sum of the
fractions of the capillary domains overlapping a given fibre. The capillary fibre
density (CFD in mm-2) was calculated as the LCFR/FCSA.
Statistical analysis
We used multilevel analyses to evaluate differences between smokers and non-
smokers (MLwiN version 2.0, Bristol, UK). This method incorporates nominal
variables (Twisk, 2006), as well as variance at the level of the cell and the individual.
Slow and fast fibres were analysed separately and gender, age and physical activity
were included as covariates. Significance level was set at P<0.05. Unless otherwise
stated, values are given as means ± standard error of the mean (SEM).
Results
The correlation coefficient between the physical activity score and the fibre-type
weighted mean SDH-activity was 0.87 for non-smokers (P=0.06) and 0.88 for
smokers (P=0.01). All participants had a normal respiratory function (data not
shown).
Maximal strength and fatigue resistance
Maximal torque and ACSA were not different in non-smokers and smokers, with 201
± 24 vs. 203 ± 35 Nm (P=0.96) and 61 ± 4 vs. 54 ± 6 cm2 (P=0.32) for torque and
ACSA respectively. Fatigue resistance, however, was significantly reduced by
smoking: torque dropped to 77.4 ± 4.5 vs. 61.4 ± 4.5 % of initial value in non-
smokers and smokers, respectively (P<0.05). The correlation coefficient between
physical activity levels and fatigue index was 0.83 (P=0.08) and -0.88 (P=0.05) for
the non-smokers and smokers, respectively. No significant relationship was observed
between cigarette smoking history and the fatigue index: correlation coefficients
were 0.73, -0.32 and 0.45 for cigarettes d-1, years of smoking and cigarette pack
years, respectively.
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Figure 6.1. Serial cross-sections of a representative sample and results of fibre types and
fibre cross-sectional area (A + E), capillary staining and local capillary to fibre ratio or
capillary to fibre ratio (for ‘total’; B + F), calibrated succinate dehydrogenase (SDH)-activity
(C + G) and myoglobin concentration (D + H). The white bars represent the non-smokers
and the grey bars represent the smokers. Total is the weighted average of the type I and II
cells. Bars in photomicrographs indicate 100µm and * indicate the same fibre. In A, black is
type I, white is type IIa and grey is type IIx. Values are mean (SEM). In E-H, # and * denote
statistical differences between type I and II and between smokers and non-smokers
respectively.
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Muscle biopsies
On average 160 (SD: 45) fibres were analysed for each subject. Figure 1 shows
examples of mATPase staining (Figure 6.1A), capillaries (Figure 6.1B), SDH-
activity (Figure 6.1C) and myoglobin concentration (Figure 6.1D). The fibre type
composition was similar in smokers and non-smokers, with 55 ± 4 vs. 59 ± 11 % and
45 ± 4 vs. 41 ± 11 % for type I and II, respectively. Although no differences were
observed in ACSA, mean FCSA was 25 % lower in smokers than in non-smokers
(P=0.001; Figure 6.1E). Although ~50% lower in the smokers, capillarisation in
terms of LCFR for both fibre types and overall C/F ratio did not differ between
smokers and non-smokers, with 1.07 ± 0.23 vs. 1.53 ± 0.35 for smokers and non-
smokers, respectively (Figure 6.1F), but was higher in type I than type II fibres
(P<0.001). The CFD, however, was similar for type I and type II fibres and did not
differ between smokers and non-smokers (365 ± 69 vs. 354 ± 95 for type I and 344 ±
63 vs. 289 ± 109 for type II fibres in non-smokers and smokers, respectively).
Similarly, the overall capillary density did not differ significantly between smokers
and non-smokers (314 ± 72 vs. 333 ± 60 mm-2). The logRSD was also similar in both
groups: 0.098 ± 0.009 vs. 0.108 ± 0.016 for non-smokers and smokers, respectively.
SDH-activity was higher in type I than type II fibres (P<0.001). However, the SDH-
activity (Figure 6.1G) and FCSA x SDH-activity (spatially integrated SDH-activity)
of each fibre type were similar in the two groups, indicating a similar total oxidative
capacity of the muscle cells in smokers and non-smokers. The myoglobin
concentration was higher in type I than type II cells (P<0.001), but was not
significantly altered by smoking (Figure 6.1H).
Interestingly, the correlation coefficients of the fatigue resistance and overall SDH-
activity was 0.93 (P=0.02) in controls, but was not significant in smokers (r=-0.67;
P=0.21; Figure 6.2). The slope of the relationship between SDH-activity and fatigue
resistance was significantly different between smokers and non-smokers: 3.56 ± 0.8
x 106 vs. -2.43 ± 1.52 x 106 % s µm A660-1 for non-smokers and smokers respectively
(P=0.01).
The correlation of the percentage of type I fibres and the fatigue resistance in the
non-smokers was 0.97 (P=0.01), while it was not significant in the smokers (r =-0.60,
P=0.28).
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No significant relationships were observed between the capillarisation or myoglobin
concentration and fatigue resistance in either group. Neither were any parameters
(percentage type I, SDH-activity, capillarisation, myoglobin) related to smoking
history in terms of cigarettes d-1 or cigarette pack years (data not shown).
Figure 6.2. Effects of smoking on the relation between succinate dehydrogenase
(SDH)-activity and fatigue index. The fatigue index is the torque at the end of the
fatigue resistance test, expressed as a percentage of the initial torque. A linear
relationship between SDH-activity and fatigue resistance was found for the non-
smokers (P=0.02), but was absent in the smokers (P=0.21).
Discussion
The main observation of this study is that the lower fatigue resistance in smokers
compared with non-smokers (Chapter 3) is not related to differences in fibre type
composition, oxidative capacity, myoglobin concentration or capillarisation. The
correlation between SDH-activity and fatigue resistance in non-smokers was lost in
smokers. These data suggest that the reduced fatigue resistance in smokers is not due
to alterations in determinants of oxidative metabolism, but may be related to factors
in cigarette smoke that affect the delivery of oxygen and the function of the
respiratory chain.
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We took special care to match the physical activity level of the non-smokers and
smokers. This is important as there is a positive correlation between physical activity
and SDH-activity (Den Hoed et al., 2008), which we also observed in our data
(r=0.83). The absence of a significant relationship between myoglobin concentration
or capillary density and fatigue resistance in the vastus lateralis muscle of smokers
and non-smokers suggests that these parameters are not determinants of the fatigue
resistance elicited by our protocol using electrical stimulation. Interestingly, the
SDH-activity did not correlate with fatigue resistance in smokers (Figure 6.2).
Because of the small sample size there is a risk for false negative effects. We
minimised this risk by selecting subjects for age, gender and physical activity level,
and by using multilevel analysis. In addition, power analysis revealed that for a
power of 0.8 for most of the parameters, except for LCFR, more than 50 subjects
were required to reach significance for non-significant differences in figure 6.1,
indicating that the differences between the means of these parameters are small
anyway, and unlikely to explain the difference in fatigue resistance.
Cigarette smoking has been associated with an enhanced expression of factors
involved in muscle protein degradation (Petersen et al., 2007) and type I fibre
atrophy (Montes de Oca et al., 2008). Although the decline in ACSA was not
significant, we observed that the FCSA of both type I and type II fibres in smokers
was significantly smaller than in non-smokers. This reduction in FCSA would result
in reduced oxygen diffusion distances from the periphery to the centre of the fibre
(Hill, 1965) which may delay the development of fatigue. Reduced FCSA is
associated with a lower minimal interstitial oxygen tension, which prevents an
anoxic core in maximally working fibres (PO2crit), calculated with Hill’s oxygen
diffusion model, including myoglobin-facilitated oxygen diffusion (for details, see
Van Beek-Harmsen et al. 2004) in the type I and type II fibres in smokers than non-
smokers, with 9.1 ± 1.8 vs. 6.8 ± 3.4 mm Hg in type I and 6.6 ± 1.7 vs. 4.3 ± 2.6 mm
Hg in type II for non-smokers and smokers respectively. Despite this (non-
significant) 25 to 34% reduction in PO2crit at the level of the muscle fibre, overall
fatigue resistance was lower in the smokers.
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Taken together, the results of this study suggest that other factors determining
oxygen supply and/or the ability to utilise oxygen are affected by smoking and limit
muscle performance in smokers. A diminished oxygen supply may also occur when
COHb is formed; the inhalation of CO until COHb reached 6% caused an 8%
reduction in fatigue resistance (Morse et al., 2008). Because the PO2crit is reduced and
the mean blood COHb level in smokers is reported to vary from 4 – 5 % (Hampson
et al., 2006), less than half of the difference in the fatigue index between smokers
and non-smokers can be explained by this effect of CO. However, CO also causes a
left-shift of the HbO2 dissociation curve, hampering the release of oxygen, and it
impairs the facilitated transport of oxygen within the muscle cell by binding to
myoglobin (Gorman et al., 2003). Finally, CO inhibits the function of complex IV of
the electron transport chain (Alonso et al., 2003). A combination of these factors
attenuates not only delivery but also utilisation of oxygen. The delivery of oxygen
may further be hampered by an impaired peripheral blood flow in smokers
(Ronnemaa et al., 1999), due to endothelial dysfunction through oxidative stress and
the reduced bioavailability of nitric oxide (Ambrose & Barua, 2004; Montes de Oca
et al., 2008). The nature and relative contribution of each of these factors in
determining smoking-related fatigue warrant further investigation.
We conclude that while muscle fibre size was smaller in the smokers, fibre type
distribution, capillarisation and SDH-activity of the muscle are similar in physical
activity-matched smokers and non-smokers. We suggest that the main cause of
increased peripheral fatigue may be impaired oxygen delivery and/or utilisation by
the muscle through acute effects of smoking, such as those conveyed by CO in
cigarette smoke.
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Abstract
Chronic exposure to hypoxia is generally associated with muscle atrophy (i.e.
reduction in muscle fiber cross-sectional area), reduced oxidative capacity and
capillary growth. As some controversy still exists in the literature to what extend
these changes are muscle and fiber type specific, we hypothesize that different
regions of the same muscle would also respond differently to severe chronic hypoxia.
To investigate this we compared the deep (oxidative) and superficial (glycolytic)
region of the plantaris muscle of 8 male rats exposed to 4 weeks hypobaric hypoxia
(410 mm Hg) with those of 9 normoxic rats. The haematocrit was higher in chronic
hypoxic than control rats (59 vs. 50 %; P<0.001). Using histochemistry, we observed
a 10% fibre atrophy (P<0.05) in both regions of the muscle, but no shift in fibre type
composition and myoglobin concentration of the fibres. In hypoxic rats, the succinate
dehydrogenase (SDH)-activity was elevated in fibres of each type in the superficial
(25 %, P<0.05), but not in the deep region, while in the deep, but not the superficial
region, the number of capillaries supplying a fibre was elevated (14 %, P<0.05).
Model calculations showed that the region-specific alterations in fibre size, SDH-
activity and capillary supply to a fibre prevented the occurrence of anoxic areas in
the deep region, but not in the superficial region. We conclude that the determinants
of tissue oxygenation show region specific adaptations, resulting in a marked
differential effect on tissue oxygen tension.
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Introduction
Chronic hypoxia has been suggested to be one of the factors that contribute to
changes in muscle structure and function in patients suffering from chronic
respiratory and cardiovascular diseases (Serres et al., 1998; Gosker et al., 2000;
Raguso et al., 2004; Chapter 1). Oxygen is crucial for aerobic energy metabolism
and even a brief reduction in oxygen supply due to hypoxia leads to an acutely
diminished muscle performance (Hogan et al., 1999; Degens et al., 2006b; Romer et
al., 2007). During long-term exposure, skeletal muscle adapts to the reduced oxygen
tension by marked changes in skeletal muscle fibre size and cellular metabolism
(Green et al., 1989a; Ferretti et al., 1990; Hoppeler & Vogt, 2001; Mathieu-Costello,
2001; Yun et al., 2005).
An increase in capillary density in rat muscle after 6 weeks of exposure to 12%
oxygen (Deveci et al., 2001, 2002) may serve to facilitate oxygen supply to the
muscle cells by reducing the diffusion distances of oxygen in the muscle tissue. This
response is realised by angiogenesis (Deveci et al., 2001, 2002) and/or a decrease in
fibre cross-sectional area (FCSA, Banchero, 1987; Ferretti et al., 1990; Bigard et al.,
1991). These results, however, are not consistent as an unaltered FCSA (Snyder et
al., 1985; Deveci et al., 2002) and/or capillarisation (Sillau, 1980; Abdelmalki et al.,
1996) in response to chronic hypoxia have also been reported.
A factor that is often overlooked, but may have a major impact on the tissue
oxygenation is the distribution of the capillaries: a more homogeneous distribution of
capillaries might enhance tissue oxygenation, while a strong heterogeneous
distribution of capillaries may result in anoxic areas (Piiper & Scheid, 1991; Degens
et al., 2006a; Goldman et al., 2006). Differences between and within muscles have
been observed, where capillaries in oxidative muscles and muscle regions are less
heterogeneously distributed than glycolytic areas and muscles (Egginton et al., 1988;
Degens et al., 1992). Hypoxia may result in a more homogeneously distributed
capillary network, enhancing the tissue oxygenation.
Besides adaptations in capillarisation, chronic hypoxia might also affect energy
metabolism. In both human and rat muscle a decreased oxidative capacity has been
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reported and is accompanied by an increased glycolytic capacity (Green et al.,
1989b; Hoppeler et al., 1990; Howald et al., 1990; MacDougall et al., 1991;
Abdelmalki et al., 1996; De Palma et al., 2007). Others, however, report that the
oxidative capacity is unchanged (Leon-Velarde et al., 1993) or even increased after
exposure to hypoxia (Gimenez et al., 1977; Hochachka et al., 1983).
It is clear that different adaptations to chronic hypoxia are reported in the literature.
The observation that adaptations to hypoxia are muscle-specific and even specific to
the region within a muscle could explain these discrepancies (Sillau & Banchero,
1977; Snyder et al., 1985; Deveci et al., 2001; Faucher et al., 2005; Esteva et al.,
2008; Panisello et al., 2008). Part of the controversy might be related to the duration
and severity of exposure to normobaric or hypobaric hypoxia, the addition of a
training programme to the exposure to hypoxia and/or the study of different muscles.
Indeed, it has been reported that slow and fast muscles respond differently to chronic
exposure of hypoxia (Deveci et al., 2001; Faucher et al., 2005), but also to chronic
stimulation (Badr et al., 2003) or disuse (Stevens et al., 2000). Even within one
muscle with a non-uniform fibre type distribution, the capillary adaptation to hypoxia
seems to depend on the region of the muscle, where the hypoxia-induced
angiogenesis was greater in muscles with a overall higher oxidative capacity and
regions within a muscle with a lower oxidative capacity (Deveci et al., 2001).
To date, most studies have focussed only on one aspect of adaptation of skeletal
muscle to hypoxia, such as alterations in either oxidative capacity (Howald et al.,
1990), capillarisation (Deveci et al., 2001; Mathieu-Costello, 2001; Deveci et al.,
2002), fibre type composition (Bigard et al., 1991) or myoglobin concentration
(Reynafarje, 1962). Of course the overall ability to utilize oxygen of the muscle cell
depends on the interplay between capillary supply, myoglobin concentration and
oxidative capacity and while there may be no adaptation in one factor, the muscle
may still adapt to ensure adequate tissue oxygenation by alterations in other factors.
To investigate whether adaptations to chronic hypoxia were fibre type- and/or
region-specific we used the rat plantaris muscle that contains distinct oxidative and
glycolytic regions. Rats were exposed for 4 weeks to chronic hypobaric hypoxia
(equivalent to an altitude of ~5000 m). We used an integrative approach to assess the
skeletal muscle fibre adaptations to chronic hypoxia by determining changes in fibre
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type, size, capillary supply, oxidative capacity and myoglobin concentration in
individual muscle cells in serial histological sections. We hypothesised that (a)
overall there is atrophy and a decrease in oxidative capacity, (b) in the superficial
region of the muscle angiogenesis is more pronounced than in the deep region and
(c) that these adaptations prevent the occurrence of anoxic areas during hypoxia in
both regions of the muscle. To address the latter hypothesis and to obtain an
indication whether possible adaptations are sufficient to prevent anoxic tissue areas,
we used a Krogh (Krogh, 1919; Hoofd, 1995) and a Hill model (Hill, 1965; Des
Tombe et al., 2002) to calculate the critical capillary and interstitial oxygen tensions
required to prevent anoxic core at the muscle fibre’s maximal oxygen consumption
( V O2max).
Methods
A more detailed description of the methods applied in this chapter are given in the
appendix.
Animals
Seventeen male Wistar rats, aged 8 weeks at the start of the study, were used. The
experimental rats (n=8) were housed in a hypobaric hypoxic chamber at a barometric
pressure of 410 mm Hg and 20.9 % O2 (equivalent to ~5000 m altitude). The
normobaric rats (n=9) lived in the same room, but at ambient pressure (~760 mm
Hg). All rats were kept at room temperature and a 12 h light-dark cycle. Food and
water were given ad libitum and the cage was opened for cleaning maximal half an
hour every week. After 4 weeks exposure to hypobaric hypoxia or the normobaric
condition, the rats were anaesthetised by intraperitoneal injection of pentobarbital
sodium (70 mg kg-1) and the plantaris muscle was dissected from the surrounded
tissue blotted dry and weighed. Then the muscle was pinned on cork in a slightly
stretched condition to minimise any bias in the determination of fibre cross-sectional
area and capillary parameters, related to differences in muscle length, quickly frozen
in liquid nitrogen and stored at -80 °C until further analysis. All protocols and
procedures were approved by the University of Nijmegen institutional animal care
and use committee.
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Haematocrit
The haematocrit was determined in blood samples taken from the right orbita.
Myosin heavy chain composition
To determine the myosin heavy chain (MyHC) composition (type I, IIA, IIX and IIB)
of the plantaris muscle we used a modification of the SDS-PAGE method used
previously (Degens et al., 1998). In short, a 10 µm section was dissolved in 300 µl
Laemmli buffer (Laemmli, 1970) and 11 µl was loaded onto 6 % acrylamide gels.
Gels were run at 250 V for 25 hours and subsequently stained with a Silverstain Plus
Kit (Biorad, Hemel Hempstead, UK).
Histological section staining
Serial 10 μm sections from the middle of the plantaris muscle were cut on a cryostat
at -20 °C and mounted on polylysine-coated slides. The sections were stored at -80
°C until further analysis, unless otherwise stated. All sections were mounted in
glycerin-gelatin after staining.
Myosin ATPase
Unfixed sections were stained for myosin ATPase to classify fibres as I, IIa and IIx/b
after pre-incubation at pH 4.55, as described previously (Brooke & Kaiser, 1970;
appendix). The fibre type distribution was given as the area percentage of each fibre
type.
Succinate dehydrogenase (SDH) activity
The SDH-activity in individual muscle cells in histological sections was determined
immediately after cutting as described previously (Pool et al., 1979; appendix).
Myoglobin concentration
The myoglobin concentration in individual muscle cells was determined as described
previously (Van Beek-Harmsen et al., 2004; appendix).
Capillarisation
Capillaries were depicted by staining sections for alkaline phosphatase as described
previously (Degens et al., 1992; Deveci et al., 2001, 2002; appendix). The
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capillarisation was analysed using the method of capillary domains (Hoofd et al.,
1985; Degens et al., 1992; appendix).
Modelling of skeletal muscle tissue oxygenation
We applied the Hill and an extended Krogh model to obtain some insight on how the
observed adaptations affected tissue oxygenation during hypoxia. Both models
assume that oxygen diffuses over the cell membrane and through the cytoplasm into
the mitochondria and take into account myoglobin-facilitated oxygen diffusion. The
Hill model assumes a homogeneous oxygen tension (PO2) in the interstitial space
around the fibre, while the Krogh model assumes that oxygen diffuses from point-
sources of oxygen (capillaries). We assumed that at V O2max the flow through and
PO2 in all capillaries is the same.
Hill model
The critical extra-cellular oxygen tension required to prevent the development of an
anoxic core in a cylindrical cell (PO2crit in mm Hg) at maximal rate of oxygen
consumption of the muscle fibre ( V O2max) was calculated with the Hill model (Hill,
1965; Murray, 1974):
PO2crit=( V O2max · FCSA - 4π · DMb · [MbO2]R) / 4π · αM · DO2
where V O2max in mM s-1 is calculated using SDH-activity (Van der Laarse et al.,
1989), FCSA in mm2, DMb is the radial diffusion coefficient of myoglobin (0.27 x 10-
4 mm2 s-1, Baylor & Pape (1988)), [MbO2]R is the concentration of oxygenated
myoglobin at the sacrolemma (in mM) and calculated using the methods described in
Des Tombe et al. (2002), αM is the solubility of oxygen in skeletal muscle, DO2 is the
diffusion coefficient for oxygen in skeletal muscle. The product of the latter two (αM
· DO2) is known as the Krogh’s diffusion coefficient (2.00 nM mm2 mm Hg-1 s-1,
Van der Laarse et al., 2005).
Krogh model
The critical oxygen tension at the capillary required to prevent the development of
anoxic tissue areas when the muscle is working at V O2max (PO2cap in mm Hg) was
calculated using a universal Krogh’s tissue model (Hoofd, 1995). We used
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photomicrographs of sections with a representative capillarisation for each region
and condition. For the model calculations the capillary radius was set at 2.4 μm. The
weighted average V O2max and myoglobin concentration were fed into the model.
Where the Hill model calculates a PO2 that should be uniformly present around a
muscle fibre, Krogh’s tissue model calculates a minimal PO2 at the capillary that
ensures the absence of anoxic areas.
We also used the Krogh’s tissue model to estimate the distribution of oxygen
pressure within the muscle tissue during normoxia (PaO2 100 mm Hg), acute
hypoxia (40 mm Hg, both conditions using tissue characteristics of the normoxic
situation) or chronic hypoxia (40 mm Hg, using the tissue characteristics of the tissue
adapted to hypoxia).
Statistical analysis
Independent t-tests were used to compare means between the two groups. Multilevel
analysis (MLwiN, version 2.02, Centre for Multilevel Modelling, London, UK) was
used to test for significant differences in capillarity, oxidative capacity, myoglobin
concentration and fibre size between region, fibre type and hypoxia/normoxia.
Multilevel analysis can be considered as an extension to the commonly used linear
regression analysis, which has the disadvantage that only a continuous outcome
variable can be analysed (Twisk, 2006). Differences were considered significant at
P<0.05. Values are presented as mean ± SEM.
Results
The body mass of the hypoxic (357 ± 12 g) and control (382 ± 8 g) rats were not
significantly different. The mass of the hypoxic plantaris muscle was 7 % lower
compared to the control, but was not significantly different (397 ± 23 vs. 370 ± 13
mg in control and hypoxia, respectively). The hypoxic rats had a higher haematocrit
than the control rats: 50 ± 1 vs. 59 ± 1 % (P<0.001). In total, 990 control and 1130
hypoxic fibres were analysed. For each fibre all parameters were assessed in serial
sections; a typical example is shown in Figure 7.1.
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Fibre type composition and fibre cross sectional area (FCSA)
The overall myosin heavy chain composition of the plantaris muscle did not change
significantly after exposure to hypoxia (Figure 7.2). The deep region had a higher
proportion of type I fibres and a lower proportion of type IIx/b fibres than the
superficial region (P<0.001), while there was no significant regional difference in the
proportion of type IIa fibres. In line with the myosin heavy chain data, hypoxia did
not result in an altered fibre type composition (Figure 7.3A).
In both regions, the size of the fibres was in the order I < IIa < IIx/b (P<0.05). Type I
fibres in the deep region were larger and type IIx/b fibres smaller than those of the
superficial region (P<0.05), while type IIa fibres had a similar size in both regions.
Hypoxia resulted in an overall 10% reduction in FCSA (P<0.05; Figure 7.3B). The
absence of an interaction between fibre type and/or region with hypoxia indicates
that this effect was similar for each fibre type and independent of region.
Figure 7.1. Typical example of serial sections stained for (A) ATPase after pre-
incubation at pH 4.55, (B) capillaries, (C) succinate dehydrogenase (SDH) activity
and (D) myoglobin concentration (note the dark spots stained for haemoglobin).
Type I cells (stained dark for ATPase) had a higher capillary fibre density, higher
SDH-activity and more myoglobin. * indicates same fibre in each section; bar
presents 50 µm.
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Figure 7.2. (A) Myosin heavy chain (MyHC) composition in the EDL (lane 1),
normoxic plantaris muscle (lane 2-4), hypoxic plantaris muscle (lane 5-7) and soleus
muscle (lane 8) of rats using 6% gel electrophoresis. (B) No significant differences
were observed between normoxia (n=8) and hypoxia (n=9).
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Figure 7.3. (A) Effects of hypoxia on the muscle fibre type distribution (percentage
area occupied) and (B) fibre cross sectional area (FCSA) in the deep and superficial
region of the plantaris muscle. The deep (oxidative) region has a significantly higher
percentage of type I fibres (P<0.001) compared to the superficial (glycolytic) region.
No significant fibre type shift was observed after 4 weeks of hypoxia. FCSA
decreased significantly after exposure to hypoxia (P<0.05) in all fibre types and both
regions. See Results section for further statistically significant differences between
types and regions.
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Succinate dehydrogenase (SDH) activity
SDH-activity in type IIx/b fibres was lower than that in the other fibres (P<0.001;
Figure 7.4A). Interestingly, in the deep region only, the SDH-activity of type IIa
fibres was higher than that of type I fibres (P<0.001). Overall, the SDH-activity was
26% lower in the superficial region than the deep region (P<0.001). This was
explicable by the larger number of type IIx/b fibres in the superficial than the deep
region. In addition, the SDH-activity in the type IIx/b fibres in the superficial region
was lower than that in the deep region (P<0.001), while there was no significant
difference in activity in the type I and IIa between the two regions. Hypoxia induced
a 25% increase in the SDH-activity in fibres of each type in the superficial region
(P<0.05), while no change in the SDH-activity occurred in the deep region.
The integrated SDH-activity is proportional to the V O2max per mm fibre length (in
nmol mm-1 s-1) of the cell (Van der Laarse et al., 1989). In the control rats, type I
fibres had a lower integrated SDH-activity compared to type II fibres (IIa and IIx/b;
P<0.001), while there was no difference between IIa and IIx/b fibres (Figure 7.4B).
The integrated SDH-activity was higher in fibres from the deep compared to the
superficial region (P<0.001). This was due to a higher integrated SDH-activity of
type II (P<0.001), but not type I fibres, in the deep than the superficial region of the
muscle. After exposure to hypoxia, this difference between the two regions
disappeared (P=1.00)
Myoglobin concentration
Overall, fibres in the superficial region of the plantaris muscle had a 30% lower
myoglobin concentration ([Mb]) than those in the deep region (P<0.001, Figure 7.5).
The [Mb] of type IIa fibres in both the deep and superficial region was higher than
that of type I fibres (P<0.05), while type IIx/b fibres had the lowest [Mb] (P<0.001).
Hypoxia did not significantly affect [Mb] in fibres of all type or region.
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Figure 7.4. (A) Succinate dehydrogenase (SDH)-activity and (B) spatially integrated
SDH-activity in different fibre types and regions of the plantaris muscle after 4
weeks hypoxia compared to normoxia. The SDH-activity in the superficial region
was increased by 25% in the hypoxic group (P<0.05), but this did not occur in the
deep region. The difference in spatially integrated SDH-activity between the deep
and superficial region which was apparent in the control rats (P<0.001), disappeared
after hypoxia (P=1). See Results section for further statistically significant
differences between types and regions.
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Figure 7.5. Myoglobin concentration in different fibre types and regions of the
plantaris muscle after 4 weeks hypoxia compared to normoxia. No significant
differences were observed after exposure to hypoxia. See Results section for
statistically significant differences between fibre types and regions.
Capillarisation
The local capillary to fibre ratio (LCFR) for each fibre type and the overall capillary
to fibre ratio (C/F, depicted as ‘total’) are displayed in Figure 7.6A. In both regions
the LCFR of type IIx/b fibres was higher than that of the other fibres (P<0.001). In
the deep region, type I and IIa fibres had a similar LCFR, while in the superficial
region the LCFR of the type IIa was higher compared to type I fibres (P<0.001). The
LCFR for each fibre type was higher in the deep compared to the superficial region
(P<0.001). There was an interaction between region and hypoxia (P<0.001), which
was apparent as a 14% increase in LCFR after hypoxia of fibres in the deep (P<0.05),
but not in the superficial region.
The capillary fibre density (CFD) of fibres of each type was lower in the superficial
than the deep region (P<0.001, Figure 7.6B). The CFD of type IIx/b was lower than
that of type I and IIa fibres (P<0.001), which had a similar CFD. Hypoxia resulted in
a 24% higher CFD in the deep (P<0.01), but not the superficial region of the
muscles.
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The heterogeneity of capillary spacing (logRSD) was larger in the superficial
compared to the deep (0.097 ± 0.013 vs. 0.112 ± 0.011) region (P<0.001), but was
not significantly changed by hypoxia in either region (0.091 ± 0.010 and 0.118 ±
0.022; deep and superficial region, respectively).
Relationships between capillarisation, SDH-activity and FCSA
To investigate how the adaptations in response the hypoxia affected oxygen supply
and demand, we calculated the relationships between LCFR, SDH-activity and
FCSA for all fibre types. In Figure 7.7 the relations for type IIa and IIx/b fibres are
shown, as they are the predominant fibres in the plantaris muscle.
As expected, LCFR was linearly related to the maximal oxygen uptake of the cell (as
reflected by the spatially integrated SDH-activity) in type I (R2 ranging from 0.165 -
0.640 for each region and condition, P<0.001), type IIa (R2 ranging from 0.110 -
0.336, P<0.001, Figure 7.7A) and in type IIx/b (R2 ranging from 0.070 - 0.284,
P<0.001, Figure 7.7B), except for type IIx/b fibres in the normoxic superficial region
(R2=0.012, P=0.06). After hypoxia, the correlation coefficient and slope of this
relation increased for the type IIx/b fibres in both regions (P<0.001). There was no
significant relationship between LCFR and SDH-activity for the type I (R2 ranging
from 0.000 - 0.144) and IIa fibres (R2 ranging from 0.008 - 0.052, Figure 7.7C) and
in the type IIx/b fibres in the superficial region a slight negative relationship was
observed (R2=0.018, P<0.01, Figure 7.7D dotted line), which disappeared (P<0.03)
after exposure to hypoxia (R2=0.000).
While no correlation was found between LCFR and the SDH-activity, LCFR did
positively correlate with FCSA in type I (R2 ranging from 0.226 – 0.487), IIa (R2
ranging from 0.115 – 0.491, Figure 7.7E) and IIx/b fibres (R2 ranging from 0.127 –
0.341, Figure 7.7F). For all fibre types, the slope between FCSA and LCFR
significantly increased in the deep (P<0.05), but not in the superficial region after
hypoxia. Interestingly, while the region-specific difference in the slope was not
significant in normoxia, hypoxia amplified the difference in the slope between the
deep and superficial region for all fibre types, which was entirely due to an increased
slope in the deep region only. This indicated that at a given FCSA the type I, IIa and
IIx/b fibres in the superficial region had a similar LCFR, while those in the deep
region had a higher LCFR after hypoxia (P<0.001). This was reflected by the
increased CFD for each fibre type in the deep, but not in the superficial region during
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Figure 7.6. (A) Local capillary to fibre ratio (LCFR) and (B) capillary fibre density
(CFD) in different fibre types and regions of the plantaris muscle after 4 weeks
hypoxia compared to control values. Note that the total value in both regions is the
overall capillary to fibre ratio (C/F) (A) or overall capillary density (CD) (B).
Hypoxia increased LCFR in the deep region (P<0.05), but not in the superficial
region. CFD increased in the deep (P<0.01), but not in the superficial region. See
Results section for further statistically significant differences between types and
regions.
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Figure 7.7. Relationship between LCFR and spatially integrated SDH-activity (A
and B), SDH-activity (C and D) and FCSA (E and F) for type IIa (A, C and E) and
IIx/b fibres (B, D and F). See legend for the conditions and regions. The correlation
between the spatially integrated SDH-activity and the capillary supply (A and B) was
due to a significant correlation between FCSA and LCFR (E and F), rather than a
correlation between LCFR and SDH-activity (C and D). For R2 and P-values, see
Results section.
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hypoxia (Figure 7.6B). Overall, the CFD of type I fibres was higher than that for type
IIa fibres. Type IIx/b fibres had the lowest CFD (P<0.001).
Model calculations
Model calculations were used to asses the functional consequences of the observed
adaptations. During normoxia the PO2crit for each individual muscle fibre (Hill
model) was higher in the deep compared to the superficial region (P<0.001; Figure
7.8A). In response to chronic hypoxia, the regional difference in PO2crit disappeared,
due to a decrease in the deep and an increase in the superficial region (interaction
between hypoxia and region, P<0.001). The decrease in PO2crit in the deep region
was caused by muscle fibre atrophy, while the increase in the superficial region
resulted from an increase in SDH-activity.
Subsequently, we calculated the PO2 that is required in the capillaries to prevent the
occurrence of any anoxic area at V O2max (as was calculated for PO2crit), which is
referred to as the critical capillary PO2 or PO2cap. Thereto, we chose photographs
with representative capillary distributions for each region and condition. The PO2cap
in the superficial region was higher compared to the deep region. The PO2cap in the
deep region did not differ between normoxia and hypoxia, but hypoxia resulted in a
25% increase in PO2cap in the superficial region of the muscle (Figure 7.8B).
The PO2 distribution, shown as a cumulative curve (in %), in the muscle tissue at
V O2max was calculated using the Krogh model in normoxia (Figure 7.9A capillary
PO2 set at 100 mm Hg), acute hypoxia (Figure 7.9B capillary PO2 set at 40 mm Hg)
and during hypoxia (capillary PO2 set at 40 mm Hg) in the adapted situation (Figure
7.9B). While during normoxia no anoxic regions were present in either the deep or
superficial region of the muscle (Figure 7.9A), acute hypoxia (40 mm Hg) resulted in
a marked left-shift in the PO2 distribution in the tissue; during acute hypoxia
approximately 10% of the skeletal muscle tissue in the superficial region was anoxic,
while hardly any anoxic regions were observed in the deep region. The adaptations
of the skeletal muscle tissue to chronic hypoxia resulted in a marked region-specific
adaptation: while in the deep region a right-shift occurred compared to the acute
hypoxic situation, indicating an improved tissue oxygenation, an unexpected left-
shift was observed in the superficial region.
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Figure 7.8. Minimal oxygen tension around the fibre (Hill model, A) and in the
capillary (Krogh model, B) that prevents the development of an anoxic core when the
fibres work at their maximal oxygen consumption ( V O2max). The region-specific
difference in PO2crit in (A) disappeared after exposure to hypoxia. Using the Krogh-
model (incorporating the capillary supply), the critical capillary PO2 did not change
in the deep region, while it increased with 25% in the superficial region.
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Figure 7.9. The cumulative PO2 distribution (in %) in the muscle tissue calculated at
V O2max using the Krogh model in normoxia (A, PaO2=100 mm Hg), during acute
hypoxia (B: ● and ▲, PaO2=40 mm Hg) and after adaptations to chronic hypoxia (B:
○ and Δ). A marked differential response in both regions can be observed. 
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Discussion
Using an integrative approach to study the parameters determining the oxygen
delivery and utilization, we observed that the muscular adaptations to chronic
hypoxia are region-specific and not fibre type-specific, which was in accordance
with our hypothesis. Overall, hypoxia did cause a ~10% muscle fibre atrophy,
irrespective of fibre type and muscle region. In the deep oxidative region of the
plantaris muscle this and angiogenesis resulted in improved capillarisation. In the
superficial glycolytic region there was no angiogenesis, but contrary to our
expectations, a 25% increase in the oxidative capacity, indicating mitochondrial
biogenesis. The absence of a change in the oxidative capacity in the deep (oxidative)
region of the muscle indicates that the loss of mitochondria was proportional to the
degree of atrophy. While the adaptations to chronic hypoxia in the deep region
attenuated the reduction in tissue PO2 and prevented the occurrence of anoxic areas
during hypoxia, the increased oxidative capacity in the superficial region appeared to
aggravate problems with tissue oxygenation during conditions of elevated oxygen
demand by the muscle.
What determines the capillary supply in skeletal muscle in normoxia and hypoxia?
The general idea is that in many species, including birds (Mathieu-Costello et al.,
1992), humans (Bekedam et al., 2003) and rats (this Chapter; Chapter 5) the capillary
supply to a fibre is related to its oxidative capacity. This relationship is modulated by
the metabolic surrounding of a fibre, where a fibre in an oxidative region has a larger
capillary supply than a similar fibre surrounded by glycolytic fibres (Degens et al.,
1992). Here we show using quantitative histochemistry that although the number of
capillaries supplying a fibre (LCFR) was indeed related to its V O2max, as estimated
from its integrated SDH-activity, LCFR correlated more with fibre size (Figure 7.7,
Maxwell et al., 1980; Chapter 5). The lack of a correlation between SDH-activity per
mm-2 and LCFR could be due, at least in part, to the fact that the mitochondrial
density within a fibre decreases from the periphery to the centre of the fibre
(Swatland, 1984; Chapter 5). We observed that the capillary supply per unit fibre
perimeter is more or less constant (data not show; Degens et al., 2006a;), suggesting
that diffusion distance or capillary contact per fibre perimeter, rather than the total
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number of mitochondria in a cell, is a more important determinant of the capillary
supply to a fibre.
Capillaries do not only supply oxygen, but also remove waste products and heat from
the exercising muscle cell. This may explain the absence of a positive relationship
between the integrated SDH-activity and LCFR of the glycolytic fibres with a low
oxidative capacity (type IIx/b) in the glycolytic region of the muscle (Figure 7B).
During exposure to hypoxia the integrated SDH-activity in these fibres increased and
the relationship between spatially integrated SDH-activity and LCFR became
stronger for the type IIx/b fibres only. This suggests that during hypoxia the function
of the capillaries to deliver oxygen to the (previously low oxidative) muscle cells
becomes more important.
Overall adaptations to chronic hypoxia
Similar to previous studies, we observed no differences in the fibre type composition
(Green et al., 1989b; Panisello et al., 2008). Hypoxia did, however, cause a ~10%
muscle atrophy (Ferretti et al., 1990; Bigard et al., 1991; Desplanches et al., 1996;
Deveci et al., 2001) in fibres of each type and region, which may serve to decrease
the diffusion distance from the capillaries to the interior of the muscle fibres.
The heterogeneity of capillary spacing (logRSD) may have a significant impact on
tissue oxygenation. A homogeneous capillary spacing would improve tissue
oxygenation (Piiper & Scheid, 1991; Goldman et al., 2006; Degens et al., 2006a In
the deep oxidative region of the muscle, with a higher demand of oxygen, the
capillaries were more homogenously distributed than in the superficial glycolytic
region. Yet, we did not observe a more homogeneous distribution of capillaries after
exposure to hypoxia, not even in the glycolytic region that became more oxidative.
Also during hypertrophy (Degens et al., 2009) and atrophy (Degens et al., 2008) the
heterogeneity of capillary spacing remains unaltered, and it has been suggested that
the absence of changes might be related to physical constraints, determined by the
morphology of the muscle fibres, of placing new capillaries (Degens et al., 2009).
Myoglobin might act to facilitate diffusion of oxygen (Scholander, 1960). An
elevated myoglobin concentration during hypoxia (Reynafarje, 1962) might thus
serve to enhance intracellular oxygen transport and ensure an adequate tissue
oxygenation. In agreement with previous observations (Van der Laarse et al., 1985),
we observed that oxidative type I and IIa fibres contain more myoglobin than
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glycolytic IIx/b fibres (Van Beek-Harmsen et al., 2004). Although the oxidative
capacity of fibres in the superficial region was elevated after hypoxia, we observed
no change in the myoglobin concentration in fibres of any type or region after
exposure to hypoxia. Other studies also report no change in the myoglobin protein
content (Sillau & Banchero, 1977), even when endurance training was superimposed
(Masuda et al., 2001). Iron deficiency in the diet may limit the formation of
functional myoglobin as it has been shown that elevated myoglobin mRNA levels do
not necessarily translate into elevated myoglobin protein levels (Robach et al., 2007).
Iron deficiency, however, would also hamper mitochondrial synthesis (Hood et al.,
1992), something that did not appear to be limited in our study. Whatever the cause
of the unchanged myoglobin content, our model calculations show that the
facilitation of oxygen diffusion by myoglobin in our tissue was at most equivalent to
a reduction of 5 mm Hg in the required PO2cap (data not shown).
Region-specific adaptation to hypoxia
We observed that the deep oxidative and superficial glycolytic region of the muscle
differed in their adaptations in capillarisation and oxidative capacity to chronic
hypoxia. While in the deep region capillary proliferation took place, as reflected by
the increased LCFR, no capillary proliferation occurred in the superficial region. On
the other hand, the spatially integrated SDH-activity, reflecting the total number of
mitochondria per fibre, decreased in the deep and increased in the superficial region.
Our model calculations showed that the improved capillarisation in the deep region
served to improve tissue oxygenation, while in the superficial region the adaptations
did not appear to improve tissue oxygenation, as reflected by both an increased
proportion of anoxic tissue areas and an elevated PO2crit.
In the deep region the decreased integrated SDH-activity per fibre is explicable by
atrophy. This, together with an unaltered SDH-activity per mm2, reflecting the
number of mitochondria per volume of tissue (Takekura & Yoshioka, 1989),
indicates that atrophy is accompanied by a proportional loss of mitochondria in the
deep region. The increased integrated SDH-activity in the superficial region, on the
other hand, indicates that though atrophy also occurred in this region, mitochondrial
biogenesis was elevated.
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It is interesting to note that the adaptations were region- and not fibre type-specific.
In other words, no matter what type a fibre was, its integrated SDH-activity was
increased in the superficial and its capillary supply in the deep region. This is
surprising as training appears to result in a fibre type-specific change in oxidative
capacity (Takekura & Yoshioka, 1989). During training, however, only a subset of
fibres may be recruited, while during hypoxia all fibres are affected. Nevertheless,
though speculative, it might be that paracrine factors, such as VEGF, and/or other
substances are excreted by or diffuse out of the cell in relatively larger quantities
from cells that are recruited more, such as in the deep region (Clanton & Klawitter,
2001) than elsewhere, and hence affect the adaptation processes of fibres in different
regions differently, overwhelming the fibre type-specific adaptations.
Possible explanation for differences in regional adaptation to hypoxia
Region-specific increase in capillarity
Similar to us, other investigators have also observed region-specifc adaptations in
capillarisation (Deveci et al., 2001, 2002; Badr et al., 2003). During submaximal
exercise particularly the deep oxidative region of the muscle is recruited (Kernell,
1998). To deliver the same amount of oxygen the blood flow to the muscle at a given
submaximal workload is increased as is the extraction of oxygen (King et al., 1987)
and it is thus expected that particularly in the deep, and less so in the superficial
glycolytic region, the endothelium is exposed to elevated shear stress, which is a
potent stimulant for angiogenesis (Hudlicka et al., 1992). Also in the superficial
region an increased blood flow and shear stress is to be expected, which may,
however, be too little to induce angiogenesis; if so it would suggest that there is a
threshold in duration and/or magnitude of elevated blood flow, above which shear-
stress would induce angiogenesis.
Region-specific adaptation in oxidative capacity
During hypoxia, even during submaximal exercise an accelerated breakdown of PCr
and fall in pH occur (Hogan et al., 1999). The increased rate of accumulation of
metabolites may require the earlier recruitment of glycolytic fibres, even during
submaximal activity. This more frequent recruitment may be compared to an
endurance training programme inducing an increase in the oxidative capacity. An
additional 5 % duration of recruitment has been shown to be sufficient to increase the
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oxidative capacity of a muscle cell as seen with electrical stimulation (Kernell et al.,
1987) and also training during hypoxia induces an increase in the oxidative capacity
(Terrados et al., 1990; Abdelmalki et al., 1996). It is not clear why the oxidative
capacity in the deep region is not affected, but our observations are analogous to the
observation that the increase in oxidative capacity following electrical stimulation is
inversely related to the original oxidative capacity of the muscle or muscle region
(Reichmann et al., 1985).
The Hill model indicated that in the superficial region the PO2 allowing the muscle
cell to work at V O2max was elevated during hypoxia. This corresponded with an
increase in the capillary PO2, calculated with the Krogh model, required for the
tissue to work at V O2max without the development of anoxic tissue areas. The higher
PO2cap than PO2crit can be ascribed to the different assumptions of both models
(homogeneous PO2 around the fibre in the Hill model vs. oxygen diffusing from
point sources in the Krogh-model). The increased oxidative capacity in the
superficial region after chronic hypoxia does not appear to help, but rather to
aggravate the situation as reflected by the increased prevalence of anoxic tissue areas
as estimated with the Krogh model. Thus in terms of tissue oxygenation this seems to
be an inappropriate adaptation to hypoxia. The respiration of the mitochondria is a
hyperbolic function of the PO2 the mitochondria experience and when the PO2
becomes too low the respiration of the mitochondria will decrease (Gnaiger et al.,
2000). Yet, the demand for ATP by the fibres in the superficial region may increase,
because of a more frequent recruitment as discussed above. An increase in
mitochondria may enhance the flux of oxygen and hence total respiration, even
though each individual mitochondrion is not working maximally (Hochachka et al.,
1983). According to our model calculations there are virtually no anoxic areas during
hypoxia in the deep region of the muscle, suggesting that the mitochondria may still
be able to work near-maximally. It is thus not necessary to increase their number to
enhance flux in this region of the muscle.
Potential mediators for the region-specific adaptation in oxidative capacity are
factors that are involved in transcriptional regulation of mitochondrial genes, such as
PPARγ and its ligand PGC-1α (Kramer et al., 2006). However, there are no studies
on region-specific expression after exposure to hypoxia.
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Conclusions
In conclusion, the adaptation of skeletal muscle to hypoxia is region- rather than
fibre-type specific. Overall, hypoxia results in muscle atrophy. In oxidative regions,
hypoxia results in angiogenesis which helps to attenuate a reduction in tissue PO2,
while fibres in a more glycolytic region of the muscle increase their oxidative
capacity. Though the latter may cause problems with tissue oxygenation, we
hypothesise that the increased oxidative capacity may serve to ensure an adequate
aerobic ATP generation during hypoxia by maintaining the flux of oxygen. It is
currently unknown which cellular pathways underlie these region-specific
adaptations to chronic hypoxia.
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CHAPTER 8
GENERAL DISCUSSION
149
The aim of this final chapter is to provide an overview of what the results described
in this thesis have added to the literature in this area and to discuss their possible
relevance for patients with COPD. Subsequently, suggestions for future studies will
be given.
The main objective of the present thesis was to investigate the effects of smoking and
hypoxia on skeletal muscle structure and function. Smoking is the main cause of
COPD, a condition where muscle weakness and, probably, premature fatigue
seriously exacerbate the problems associated with the primary lung disease. Chronic
systemic hypoxaemia is commonly observed in these patients and it is thus likely that
this factor can contribute to muscle wasting and dysfunction.
The first three experimental chapters report the results of studies looking for changes
in muscle function in subjects who were smokers but did not have any symptoms of
lung disease. There were no obvious difference in strength or muscle sizes between
the smokers and matched control subjects. A difference was detected, however, in
fatigability but because there appeared to be sex differences it was necessary to
examine this further to understand the basis of this difference.
In Chapter 2, 3 and 4 we have used a fatigue test involving electrical evoked
contractions of the quadriceps muscle (2 minutes 30 Hz with duty cycle of 0.5; 1 s
on, 1 s off at an intensity equal to 30 % of MVC). Using such protocols, peripheral
fatigue can be distinguished from central fatigue and contractile properties can be
measured. This differs from more widely used methods that have used voluntary
contractions to study muscle fatigue. Using voluntary contractions to assess skeletal
muscle fatigue resistance does not allow one to distinguish between peripheral and
central causes of fatigue. As electrical stimulation by-passes central motivation and
neural causes of fatigue, protocols using electrically evoked contractions reflect only
the contribution of factors beyond the motoneuron to muscle function and fatigue.
In Chapter 2 we report that, using this protocol, women were less prone to peripheral
muscle fatigue than men, as already suggested by Hunter et al. (2006). We also
observed slightly slower contractile properties in women than men suggesting that
women may have a higher percentage of slower muscle fibres giving them an
advantage in terms of aerobic metabolism or energy utilization. Several studies have
150
shown that women do have a higher proportion of type I fibres than men (Nygaard,
1981; Simoneau & Bouchard, 1989; Staron et al., 2000; Jaworowski et al., 2002;
Roepstorff et al., 2006), and the question arises what caused these differences. We
have carefully selected our participants with regards to physical activity level, as a
high level of physical activity is associated with a high fatigue resistance (Gerrits et
al., 2002), although probably by increasing aerobic capacity rather than changing
MHC expression.
The fact that differences in fatigability between the sexes persisted even when the
muscle was made ischaemic indicates that the difference probably lies in the rate of
energy utilisation rather than energy supply, implicating differences in MHC content.
One possibility that could be explored in future studies is whether, and to what
extent, contractile properties are affected by differences in circulating hormones
between men and women. That this might play a role is suggested by an increase in
frog skeletal muscle fibre size and faster contractile properties (maximal shortening
velocity, contraction and relaxation time) after testosterone supplementation
(Girgenrath & Marsh, 2003). However, to what extent these findings can be
extrapolated to humans and how circulating hormones affect fatigue resistance is
currently unknown. While hypogonadism has been observed in male patients with
COPD (Van Vliet et al., 2005), possible changes in exercise intolerance and muscle
structure and function after testosterone supplementation have not been extensively
studied (Casaburi et al., 2004). The few that are available indicate that testosterone
supplementation in patients with COPD enhances muscle strength, while no data is
currently available describing possible effects on contractile properties and muscle
fatigue.
The results described in Chapter 3 suggest that young men with a mild smoking
history were less fatigue resistant than non-smoking, age- and physical activity-
matched peers. The lower fatigue resistance was not related to the duration of the
smoking when testing a cohort of smokers of a wide range of age and smoking
history (Chapter 4) or with a lower oxidative capacity or changed fibre type
(Chapter 6). Although the results from this last study need confirmation using a
larger cohort of smokers, the results suggest that the higher muscle fatigability is not
necessarily dose-related, but rather related to an acute, and possibly reversible,
impairment either in the supply or ability to use oxygen for aerobic energy
151
generation by the muscle. In this respect the difference between smokers and non-
smokers is not the same as between male and female control subjects discussed
above. If the difference is due to altered oxygen supply or utilisation we would
expect that smokers and non-smokers would have similar fatigue profiles when the
muscles were made ischaemic. Unfortunately we were unable to test this hypothesis
as the smokers were unwilling to undergo an ischaemic fatigue test (too painful) but
this is clearly something that should be included in any future studies in this area.
CO is a major toxic component of cigarette smoke that causes a left-shift of the HbO2
dissociation curve, hampering the release of oxygen. It also impairs the facilitated
transport of oxygen within the muscle cell by myoglobin as its oxygen binding site is
occupied by CO (Gorman et al., 2003) and inhibits the function of complex IV of the
electron transport chain (Alonso et al., 2003). A combination of these factors
attenuates not only delivery but also utilisation of oxygen. The delivery of oxygen
may further be hampered by an impaired peripheral blood flow in smokers
(Ronnemaa et al., 1999), due to endothelial dysfunction through oxidative stress and
the reduced bioavailability of nitric oxide (Montes de Oca et al., 2008). A diminished
oxygen supply may also occur when COHb is formed; the inhalation of CO until
COHb reached 6 % caused an 8 % reduction in fatigue resistance (Morse et al.,
2008). The mean blood COHb level in smokers is reported to vary from 4 – 5 %
(Hampson et al., 2006), somewhat less than the levels used by Morse et al. (2008)
suggesting that CO may not be the entire explanation for the increased fatigability.
There are, however, other toxic substances in tobacco smoke, such as CN, that would
have similar effects to CO.
Future work might focus on the effects of smoking cessation on muscle function and
fatigue. If muscle fatigue is increased due to an acute impairment in oxygen delivery
and/or utilization, then it is likely that the effect will be fairly rapidly reversed on
smoking cessation. Earlier work on short-term smoking and smoking abstinence has
already pointed in this direction. Smoking 3 cigarettes per hour for 5 hours has a
detrimental effect on maximal oxygen uptake in humans (Hirsch et al., 1985) and
smoke inhalation acutely reduces swimming endurance in rats (Hrubes & Battig,
1970). A six or seven day abstinence, on the other hand, prolonged the time to
exhaustion, mainly due to an improved oxygen transport to the muscles (Hashizume
152
et al., 2000). Also mitochondrial respiratory chain function (activity of complex IV),
measured in peripheral lymphocytes, was lower in heavy smokers, but returned to
normal values after 28 days of smoking abstinence (Cardellach et al., 2003).
However, to what degree skeletal muscle fatigue resistance will improve after
smoking cessation is not known and a study to determine this would clearly be an
important continuation of the present work.
Muscle fatigue protocols involving percutaneous electrical or magnetic stimulation
are uncommon, but have been used successfully in patients with advanced COPD
(Degens et al., 2005; Swallow et al., 2007). Using a comparable intensity and duty
cycle to the present study, Swallow et al. (2007) observed that COPD patients
experienced a higher muscle fatigability, while Degens et al. (2005) did not observe
a difference in fatigue resistance between COPD patients and controls. The
discrepancy in results might be related to the significantly lower physical activity
levels in COPD patients than controls in the study by Swallow et al. (2007) while in
the study by Degens et al. (2005) patients and control subjects were matched for
physical activity level. It is interesting to note that all the COPD patients tested by
Degens et al. (2005) had stopped smoking at the time of the experiment (H. Degens,
personal communication) while it is not clear whether the patients in the Swallow
study were smoking. Firm conclusions about the role of smoking in the exercise
intolerance in patients with COPD cannot be drawn as long as smoking
characteristics are not mentioned (or controlled).
The muscle atrophy and dysfunction seen in many patients with COPD is likely to
have multiple causes including factors such as disuse, inflammation, reactive oxygen
species and/or hypoxia. A small, but significant degree of muscle fibre atrophy was
found in the small subgroup of smokers compared with non-smokers. Recently, it has
been reported that smokers (without COPD) have a lower FCSA of type I fibres than
non-smokers (Montes de Oca et al., 2008), but it is not clear to what extent this result
was due to an inappropriate selection of the control group (Wagner, 2008; Wüst et
al., 2008). The observation that the rate of protein synthesis in skeletal muscle is
lower in smokers might be an explanation for the observed muscle atrophy (Petersen
et al., 2007).
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The aim of the work described in Chapter 7, was to determine the effects of
hypoxaemia per se on skeletal muscle. Rats were exposed for 4 weeks to chronic
hypobaric hypoxia equivalent to a PO2 of 410 mm Hg. As in other studies, a 10 %
muscle atrophy was observed in the plantaris, an important muscle for locomotion,
indicating that hypoxia could be an significant factor contributing to muscle atrophy
in conditions where oxygen supply is compromised. It was found that the adaptation
to chronic hypoxia was region- rather than fibre type-specific: capillary proliferation
occurred only in the deep, oxidative region, while only in the superficial glycolytic
region did mitochondrial biogenesis occur. The implication for patients with COPD
is that some muscles or muscle regions may be more or less affected by hypoxia than
others.
The aetiology of skeletal muscle dysfunction and its relationship to reduced exercise
tolerance are poorly understood. The results from this thesis on smokers before they
developed COPD and rats exposed to chronic hypoxia provide indications that
smoking and hypoxia might contribute to peripheral fatigue and muscle atrophy in
clinical situations. In the future, the relative contribution of smoking (amongst other
factors, such as hypoxia, inflammation and disuse) should be studied to come to an
integrative theory about muscle dysfunction and fatigue in patients with COPD.
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APPENDIX
METHODOLOGY
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In this appendix, the procedures described in this thesis are explained in more detail.
First, the in vivo measurements of skeletal muscle size and function are described
including some comparison of data obtained on a custom-made isometric chair with
those that were gathered from the same subjects on the apparatus used in this body of
the work. Finally, the detailed protocols of the histochemical staining methods and
analyses are provided and discussed.
In vivo measurements of skeletal muscle size and function
Anatomical cross-sectional area
The anatomical cross-sectional area (ACSA) of the quadriceps was measured with
magnetic resonance imaging (MRI), using a fixed 0.2 T MRI scanner (E-Scan,
ESAOTE Biomedica, Genova, Italy), at 50% of femur length. Using ultrasound, the
head of the trochantor and the most distal point of the femur were identified with the
participant in a supine position (with the knee joint in an extended position).
Reference markers were placed along the upper leg on the skin to indicate 50% of the
total length. Subjects were supine for 15 min prior to the scan to make sure any fluid
shifts had stabilised.
After pilot studies, the following scanning parameters were chosen to give the best
images of the four heads of the quadriceps muscle. Scans were obtained with a T1
weighted, high resolution, gradient echo profile, with the following scanning
parameters: echo time: 0.016 s; repetition time: 0.1 s; field of view: 0.33 x 0.254 m
and a slice thickness of 0.005 m.
Muscle function: Cybex dynamometer
The type of Cybex norm dynamometer (Ronkonkoma, New York, USA) used in
these studies is widely used for measurement of in vivo skeletal muscle contractile
properties (Harridge et al., 1996; Reeves et al., 2004; Morse et al., 2007). All torque
measurements were performed on the right quadriceps femoris muscle. Participants
were seated with the hips at 90° flexion and shoulders strapped to minimise
extraneous movements. The lateral epicondyle was aligned with the axis of rotation
of the dynamometer identified by a laser beam from the centre of rotation of the
dynamometer. Since the maximal voluntary torque requires the participants’
maximal effort, they were first familiarized with the setup on a separate occasion and
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during the actual data collection visual feedback of the torque signal was given
together with verbal encouragement (McNair et al., 1996). |Maximum voluntary
contractions (2-3 seconds each) were repeated 2 or 3 times at knee joint angles of 60,
70 and 80˚ (full extension=0˚) in a random order with two minutes rest between each
contraction to prevent the development of fatigue. The angle at which the highest
torque was achieved was defined as the optimal joint angle and the maximum torque
was the highest torque achieved during the three repetitions at that angle. All further
measurements were done at optimal knee joint angle.
Percutaneous muscle stimulation
Percutaneous electrical stimulation (square wave, pulse width 50 s; DSV Digitimer
Stimulator, Digitimer Ltd., Herts, UK) was applied using carbon-rubber pads (76 mm
x 127 mm, Versastim, Conmed Corp., N.Y., USA). The anode was placed over the
proximal region of the quadriceps and the cathode over the distal third of the upper
leg. The voltage was set at 400 V and was kept constant during the course of the
experiment.
Voluntary activation
To assess the ability of the subjects to activate the knee extensors during isometric
contractions, voluntary activation (VA) levels were determined using a variant of the
interpolated twitch technique (Shield & Zhou, 2004). To increase the sensitivity of
the test, a doublet (inter-pulse interval 10 ms) was applied instead of a single twitch.
The current used to test for activation was determined using single pulses with the
subject in a relaxed state, starting from 100 mA, and increasing until no further
increase in torque was observed. The first doublet was applied with the subject in a
relaxed state and a second (interpolated) doublet was delivered during the plateau
phase of the MVC. The ratio of interpolated and resting doublets was used to provide
an index of activation (Allen et al., 1995) as follows:
Voluntary activation (%) = 100 x
(1 – (superimposed doublet torque/resting doublet torque))
where the superimposed doublet torque is the additional torque during the MVC
caused by the doublet.
160
Torque-frequency relationship
The stimulation current for the determination of the torque-frequency relationship
and fatigue protocols was adjusted so that a 1-s 100-Hz tetanus produced ~30 % of
maximal voluntary isometric torque. Five minutes after the last MVC, the quadriceps
muscle was stimulated with 5 single twitches at 1Hz and then 1s tetani at 10, 15, 20,
30, 50 and 100 Hz applied in random order, each separated by 1 min.
Fatigue tests
Five minutes after determining the torque-frequency relationship of the quadriceps
muscle, the resistance to fatigue was determined by a series of electrically evoked
isometric contractions (60 contractions, 30 Hz, 1 s on 1 s off (or 0.5 s off) at the
current used to determine the torque-frequency relationships). Generally the test was
carried out with the circulation to the leg intact but in one series the blood supply to
the leg was occluded with a pneumatic thigh cuff (Accoson, Harlow, UK) inflated to
~240 mm Hg.
Analysis of variables
All torque signals were sampled at a frequency of 2000 Hz (Acknowledge, Biopac
Systems, Santa Barbara, CA, USA) and off-line analysis was performed using
Matlab (Matlab, the Mathwork Inc., S. Natik, MA, USA). Each torque signal was
filtered with a low-pass fourth order Butterworth filter with a 30 Hz cut-off
frequency to reduce the noise in the signal.
From the 30 or 100 Hz tetanus of the frequency-torque relationship, the contraction
time was measured as the time from activation until 90% of the maximal torque was
reached, and the relaxation time as the time for the torque to decline to 50% of
maximal torque after cessation of stimulation. The maximal rate of relaxation (MRR,
s-1) was determined from the 30 Hz tetanus and calculated as the lowest value of the
differentiated torque signal expressed relative to the highest torque recorded during
that contraction.
The fatigue index was expressed as the highest torque recorded during the last
contraction divided by that during the first contraction (expressed as a %). To obtain
an indication of the time course of fatigue, the torque and maximal relaxation rate
(MRR) for each contraction during the fatigue protocol were expressed as
percentages of the initial value.
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Compliance in the system
One of the key parameters for assessing contractility is the maximal rate of
contraction and relaxation (MRC and MRR respectively). To ensure a rapid
contraction and relaxation, the system needs to be rigid, such that the torque exerted
by the muscle can be transferred to the transducer without first stretching a
compliance. Two factors that affect the transduction of the torque exerted by the
muscle to the transducer of the Cybex dynamometer are the compliance of the patella
tendon and the stiffness of the Cybex dynamometer. The first is a biological factor
and was not of principle interest in the present study. Therefore, no measurements
have been made to account for this factor. Tendon compliance is related to the
physical activity level of the participant (Reeves et al., 2003; De Boer et al., 2007),
and the participants in the present studies were carefully matched for physical
activity level. It is unlikely therefore that the results discussed in Chapter 2 (gender-
related differences in fatigue resistance) and in Chapter 3 and 4 (smokers vs. non-
smokers) are explicable by differences in the tendon compliance. Further studies,
however, might be interesting to determine the contribution of tendon compliance to
the torque-frequency relationship and fatigue resistance since the greater the
compliance the more movement and work is done and this would be reflected in the
energy demands of the fatigue tests.
The other factor, the stiffness of the Cybex dynamometer has been reduced as far as
possible. The shin pad was modified such that the cushion was replaced with a more
rigid pad and care was taken when strapping the participant in the seat (Figure 9.1A).
In addition, a counterweight was placed on the Cybex lever arm to decrease the slack
in the system. However, these changes have not totally ensured the measurements
were ‘slack-free’, as it was observed in a previous study that the knee joint can move
up to 20 degrees during a maximal voluntary contraction (MVC) (Tsaopoulos et al.,
2007). We have recently obtained a custom-made isometric chair (MMUscle) that is
stiffer, and specially designed by the Department of Physical and Medical
Technology at the VU University Amsterdam (Figure 9.1B), which allows testing the
contractile properties of the quadriceps muscle with a stiffer system.
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Figure 9.1. (A) Participant in the Cybex NORM dynamometer. The anatomical axis
of rotation of the knee joint was aligned with the machine's axis of rotation and
safety stops placed at the extremes of extension and flexion. Note the weights on the
lever arm used to reduce the slack in the system. (B) Participant in the MMUscle
chair. No alignment of the axis of rotation of the knee joint is needed, as the forces
are transferred through the shin pad.
Figure 9.2. Torque-frequency relationship of four healthy men tested on the Cybex
and on the MMUscle chair (A). A significant left-shift was found when tested in the
MMUscle chair. In (B) and (C) a typical example of one participant on both systems
are shown. Note the smoother rise in torque in the stiffer set-up (C). Values are
shown as mean and SD. * denotes significant difference (P<0.05).
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Figure 9.3. The maximal rate of contraction (MRC, A and B) and relaxation (MRR,
C and D) were determined from each frequency during the torque-frequency
relationship and calculated as the highest and lowest value of the differentiated
torque signal respectively. In A and C this value was expressed relative to the highest
torque recorded during the same contraction, while this value was expressed as the
highest torque recorded during the 100 Hz contraction in B and D. This enables
comparison between the stiffness of both systems. Significant differences at lower
frequencies were observed in the MRC (B, P<0.05), but not in the MRR (D).
In a validation study the contractile properties of four healthy male volunteers were
compared on both systems. Figure 9.1 shows a representative example of one
participant on both systems.
The maximal rate of contraction (MRC) and relaxation (MRR) were determined at
each frequency during the torque-frequency relationship and calculated as the highest
(MRC) and lowest (MRR) value of the differentiated torque signal normalised to the
maximal torque during that contraction. Because the higher contribution of the slack
during the lower frequencies (especially the single twitch), the MRR and MRC were
expressed relative to the highest torque recorded during the 100 Hz contraction. The
torque-frequency relationship was found to be significantly shifted to the left in the
stiffer MMUscle chair (P<0.05; Figure 9.2A). This left-shift was mainly caused by a
significantly higher MRC relative to the maximal torque at 100 Hz at the lower
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frequencies (Figure 9.3B), resulting in a more rapid transmission of torque from the
muscle to the transducer.
The results from this validation study show that the torque-frequency relationship
can be affected by the stiffness of the system on which the participant is tested. This
is mainly due to a faster and therefore higher rise in torque at the lower frequencies
(1-15 Hz). Paradoxically, the oscillation in the 10, 15 and 20 Hz torque signals seem
to be slightly less when tested with the MMUscle chair. An explanation of this might
be that the contractions in the Cybex are not fully isometric, so the muscle fibres
themselves are shortening, resulting in a lower torque (due to the torque-velocity
relationship) during contractions with a low stimulation frequency. This might also
explain the significantly quicker rise in torque in the MMUscle chair at lower
frequencies (Figure 9.3B). At higher frequencies, the results from the Cybex seem to
be comparable with the MMUscle chair (Figure 9.3B and D).
The relationship between contractile properties and muscle fibre type
A factor that has received little attention in the literature is the extent to which the in
vivo contractile properties of the quadriceps muscle are related to the fibre type
distribution of the muscle. From the data shown in the Introduction (Fig 1.X) , rat
muscles such as the soleus muscle have slower maximal rates of contraction (MRC)
and relaxation (MRR) compared to fast muscles, such as the EDL muscle. However,
in a mixed muscle, such as the quadriceps muscle, the relationship between fibre type
and contractile speed is less obvious (Wiles et al., 1979). In the few participants
from which both the MRR and the fibre type of the quadriceps muscle (n=10) were
obtained no correlation (R2=0.47; P=0.163) was observed between MRR at 30 Hz
and the area percentage of type I. Nevertheless, it was interesting to note that one old
male participant in this study had only type I fibres in the quadriceps muscle (99.7
%), and also had the slowest MRR at 30 Hz (-11.1 s-1), compared to -15.0 ± 2.3 s-1 in
the others with 52.4 ± 11.0 % type I fibres. The cause of the absence of a strong
relationship might relate to the distribution of fibre types within the quadriceps
muscle (Lexell et al., 1983). As was also observed in the rat plantaris muscle (Figure
7.3 and 9.4), a predominance of type I fibres has been shown in the deeper regions of
the quadriceps muscle (Lexell et al., 1983). Therefore, it may not be possible to
extrapolate the fibre type composition obtained from one specific region of the
vastus lateralis muscle to the whole quadriceps muscle group, and hence directly
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relate fibre type composition to in vivo contractile speed. Nonetheless, a significant
correlation (R2=0.40, P=0.002) existed between the MRR and the results from the
fatigue test under ischemia (Figure 2.4), indicating that the slower the muscle at the
start of the fatigue test, the less the muscle will fatigue which is consistent with the
expected behaviour of different mixtures of fibre types.
Histochemical staining methods
Results of histochemical staining methods on sections of muscle tissue of rats and
humans are reported and discussed in Chapter 5, 6 and 7.
Wistar rats (11-week-old, all male) were kept at room temperature and a 12 h light-
dark cycle. Food and water were given ad libitum. They were killed by an
intraperitoneal injection of an overdose of pentobarbital sodium (70 mg·kg-1). The
plantaris muscles was carefully excised, blotted dry, weighed, slightly stretched to
minimise bias related to tortuousity of capillaries, directly frozen in liquid N2 and
stored at -80oC. All protocols and procedures were approved by the University of
Nijmegen Institutional Animal Care and Use Committee.
Eleven healthy participants volunteered to provide a biopsy of their vastus lasterlis
muscle. Written informed consent was obtained from each participant prior to taking
the percutaneous biopsy. All procedures were approved by the local ethics committee
of the Manchester Metropolitan University (UK). The entire procedure was carried
out under aseptic conditions. After local anesthesia with 2 % lidocaine, a small
incision was made with a scalpel and the percutaneous biopsy of the vastus lateralis
muscle (at ~50 % of the muscle length) was obtained using a conchotome. The
wound was closed with steristrips and covered with bandage for up to 2 days. The
biopsy was placed on cork with the longitudinal axis of the fibres perpendicular to
the surface of the cork, quickly frozen in liquid N2 with vigorous shaking to prevent
development of ice-crystals, and stored at -80oC.
Histochemistry
Transverse serial 10-μm sections were cut on a cryostat at -20°C and mounted on
polylysine-coated slides. The sections were stored at -80°C until further analysis,
unless otherwise stated. All sections were mounted in glycerine-gelatine after
staining. The thickness of the slices was verified by cutting 10 μm sections of a
gelatine block containing a homogeneous myoglobin concentration (see below) on a
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recently calibrated cryostat and compared to identical sections cut on the cryostat
where the human and rat samples were cut. Serial sections were used to identify the
same fibres stained for different enzyme activities or structural features. In this way,
fibre type, SDH-activity, capillary density and myoglobin concentration were
determined in the same fibre. To our knowledge, this is the first study that has
determined all this number of variables in the same muscle fibre.
Figure 9.4. Example of a plantaris muscle of the Wistar rat (taken from chapter 7).
On the left, the section is stained for SDH-activity (see text), while the right serial
section was stained for acid myofibrillar ATPase (pH=4.55). The dark fibres on the
right are classified as type I, while the white fibres are classified as type IIa and the
grey fibres as type IIx/b. One can observe that the type I and IIa fibres have, as
expected, a higher SDH-activity. Note that on the right hand corner of the muscle, a
small part of the gastrocnemius muscle is still visible.
In the rat plantaris muscle two regions with different fibre type composition can be
distinguished (Figure 9.4); near the tendon, a higher proportion of type I fibres (and
SDH-activity) can be observed (this region is referred to as the deep, or oxidative
region), while at the other side of the muscle hardly any oxidative fibres can be
found (referred to as the superficial, or glycolytic region).
Determination of fibre type
Fibres were classified as type I, IIa, or IIx (IIx/b in rats) based on the pH sensitivity
of their myofibrillar ATPase, using the methods first described by Brooke & Kaiser
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(1970); type I myofibrillar ATPase is acid stable and alkaline labile, while type IIa
myofibrillar ATPase is acid labile and alkaline stable with that of IIb/x in between.
The fibres thus appear dark, white and grey after acid pre-incubation, respectively.
Sections were pre-incubated for 10 minutes in a buffer containing 0.1 M NaAc and
0.1 M KCl at pH 4.55 set with acetic acid, quickly rinsed in 20 mM glycin and 20
mM CaCl2 at pH 9.4 (set with NaOH) and subsequently incubated for 25-30 minutes
at 37°C in 40 mM glycine, 20 mM CaCl2 and 2.5 mM ATP at pH 9.4 (set with
NaOH). Sections were quickly rinsed with 1% CaCl2, left in 2% CoCl2 for 3 minutes,
washed with distilled water and coloured in 2% (NH4)2S and washed in water.
Determination of SDH-activity
Succinate dehydrogenase (SDH) is an enzyme in the citric acid cycle and part of the
respiratory chain. It has been shown by our lab that the calibrated histochemical
method described below is linearly related to the maximum rate of oxygen uptake by
the muscle fibre (Van der Laarse et al., 1989). Immediately after cutting, sections
were dried for 15 min and stained for SDH-activity (Pool et al., 1979; Van der
Laarse et al., 1989). Sections were incubated at 37°C in the dark for 20 min in a
medium consisting of 37 mM sodium phosphate buffer (pH 7.6), 74 mM sodium
succinate and 0.4 mM tetranitroblue tetrazolium (TNBT). The reaction was stopped
with a 30 s incubation in 0.01 M HCl and fixed in 10% formalin for 20 min. The
staining intensity was determined as the optical density of the final reaction product
using an interference filter of 660 nm at a magnification of x 20 (ImageJ, National
Institute of Health, Bethesda, USA). A 3rd order calibration line was obtained before
scanning each section using grey filters with a known absorbance. By carefully
outlining the muscle fibre, the mean optical density for each fibre was obtained.
After subtracting the optical density of the background (a part of the section that did
not express SDH-activity), optical density values were converted to staining rate,
expressed as absorbance units (ΔA660) per micrometer section thickness per second
of incubation time (ΔA660 μm-1 s-1). Besides giving an estimate of the aerobic
capacity of the fibre, another advantage of this method is that values from different
samples and studies can be compared, as the values are calibrated.
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SDH-activity and physical activity level
The human participants discussed from Chapter 6 were matched for their physical
activity level, which was assessed with a physical activity questionnaire (Baecke et
al., 1982). The questionnaire has been validated with pedometers (Baecke et al.,
1982) and with maximal oxygen uptake (Jacobs et al., 1993; Richardson et al.,
1995). In addition, the data in the thesis show a strong correlation (r=0.83, P=0.001)
between the overall SDH-activity (weighted for fibre type) and physical activity level
(Figure 9.5).
Figure 9.5. Relationship between physical activity score measured with the Baecke
questionnaire and the oxidative capacity, measured as the SDH-activity. Pearson’s
correlation coefficient for non-smokers is r=0.87 (P=0.06) and r=0.88 (P=0.01) for
smokers. Overall, the correlation coefficient was 0.83 (P=0.001).
Determination of capillarisation
Sections were stained with alkaline phosphatase (rat; Degens et al., 1992) or lectin
(human; Ahmed et al., 1997) to identify capillaries.
Rat sections were fixed in chloroform-acetone (1:1; 4°C), quickly rinsed in distilled
water and subsequently stained for 1 h in 0.01% nitro blue tetrazolium (NBT) and
0.002% 5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt in 6.9 mmol
MgSO4.7H2O and 27.5 mmol Na2B4O7.10H2O buffer, adjusted to pH 9.2 with boric
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acid. After quickly rinsing the sections in distilled water and a post-fixation in 10%
formalin (4% formaldehyde), slides were mounted in gelatine-glycerol.
Human sections were fixed in acetone (4°C), kept in HEPES for 15 minutes,
incubated in PBS containing 0.9% 30% H2O2 for 30 minutes to reduce background
staining and subsequently incubated with lectin (Ulex Europeus) in HEPES with 1%
BSA (2000 μg/ml). The capillaries were visualised using a Vectastain ABC and
DAB substrate kit (Vector Laboratories, Peterborough, UK) before mounting in
gelatine-glycerol.
Capillaries were analyzed using the method of capillary domains (Hoofd et al., 1985;
Degens et al., 1992). This method not only provides the overall indices of capillary
to fibre ratio (C/F) and capillary density (CD), but also provides measures of the
capillary supply to individual fibres of different fibre types, even when they lack
direct capillary contacts. Since the deep and superficial region of the muscle differ in
their fibre type composition and capillary supply, these regions were analysed
separately. Photomicrographs of cross-sections of the human vastus lateralis muscle
and the deep and superficial region of the rat plantaris muscle were taken. The fibre
type distribution was assessed and the outlines of the muscle fibres as well as
location of each capillary were digitised on a calibrated digitising tablet (Model
MMII 1201, Summagraphics Digitisers, Austin, Tex, USA). The overall capillary
density (CD) was defined as the number of capillaries mm-2 of tissue. Capillary
domains, defined as the area surrounding a capillary delineated by equidistant
boundaries from adjacent ones, were constructed and their surface area calculated.
From the overlap of the domains with muscle fibres, the local capillary to fibre ratio
(LCFR) and the capillary fibre density (CFD) were obtained. The LCFR for a fibre
was defined as the sum of the fractions of each domain area overlapping the fibre.
This variable has a continuous distribution and is more sensitive than e.g. capillaries
around a fibre. It also allows determination of the capillary supply to a fibre even
when it lacks direct capillary contacts. Such situations were observed occasionally in
the glycolytic region of the rat plantaris muscle. CFD, which is LCFR divided by the
FCSA, provides the capillary density of that fibre and is expressed as the number of
capillaries mm-2.
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Determination of myoglobin concentration
The myoglobin concentration in individual muscle cells was determined as described
previously (Van Beek-Harmsen et al., 2004). Frozen sections were defrosted in
vacuum to avoid condensation and consequent redistribution of myoglobin. Sections
were then vapour-fixed for 1 h in paraformaldehyde at 70°C. Subsequently, the
sections were fixed for 10 min at room temperature in 2.5% glutaraldehyde in 0.07
M sodium phosphate buffer (pH=7.4) and quickly rinsed with distilled water. To
detect myoglobin sections were incubated for 1 h at room temperature in a medium
containing 59 ml 50 mM TRIS/80 mM KCl buffer (pH=8.0), 25 mg ortho-toluidine
dissolved in 2 ml 96% ethanol (at ~50°C) and 1.43 ml 70% tertiary-butyl-
hydroperoxide. Sections were then washed with distilled water, mounted and
scanned on a calibrated DMRB microscope (Leica, Wetzlar, Germany) with an
interference filter of 436 nm. A 3rd order calibration line was obtained before
scanning each section using grey filters with a known absorbance.
The red blood cells in the capillaries contain haemoglobin which was visible as dark
spots at the edges of the muscle fibres. The myoglobin concentration was, however,
homogeneously distributed within the cell and therefore the mean optical density was
obtained from the centre of each fibre. After subtracting the optical density of the
background (a part of the section that did not contain myoglobin), optical density
values were converted to absorbance values. Using a calibration line, obtained from
absorbance values from 10 µm sections cut from gelatine blocks containing 0.1, 0.2,
0.3 and 0.4 mM myoglobin, absorbance values were converted into concentrations
(Van Beek-Harmsen et al., 2004).
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